
<html lang="en"     class="pb-page"  data-request-id="c756ee6d-13ad-4abd-b6f2-4170f19ffa1f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2016.59.issue-14;article:article:10.1021/acs.jmedchem.6b00245;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides" /></meta><meta name="dc.Creator" content="Eleni  Pitta" /></meta><meta name="dc.Creator" content="Maciej K.  Rogacki" /></meta><meta name="dc.Creator" content="Olga  Balabon" /></meta><meta name="dc.Creator" content="Sophie  Huss" /></meta><meta name="dc.Creator" content="Fraser  Cunningham" /></meta><meta name="dc.Creator" content="Eva Maria  Lopez-Roman" /></meta><meta name="dc.Creator" content="Jurgen  Joossens" /></meta><meta name="dc.Creator" content="Koen  Augustyns" /></meta><meta name="dc.Creator" content="Lluis  Ballell" /></meta><meta name="dc.Creator" content="Robert H.  Bates" /></meta><meta name="dc.Creator" content="Pieter  Van der Veken" /></meta><meta name="dc.Description" content="In this study, a new series of more than 60 quinoline derivatives has been synthesized and evaluated against Mycobacterium tuberculosis (H37Rv). Apart from the SAR exploration around the initial hi..." /></meta><meta name="Description" content="In this study, a new series of more than 60 quinoline derivatives has been synthesized and evaluated against Mycobacterium tuberculosis (H37Rv). Apart from the SAR exploration around the initial hi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 12, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00245" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00245" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00245" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00245" /></link>
        
    
    

<title>Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00245" /></meta><meta property="og:title" content="Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0016.jpeg" /></meta><meta property="og:description" content="In this study, a new series of more than 60 quinoline derivatives has been synthesized and evaluated against Mycobacterium tuberculosis (H37Rv). Apart from the SAR exploration around the initial hits, the optimization process focused on the improvement of the physicochemical properties, cytotoxicity, and metabolic stability of the series. The best compounds obtained exhibited MIC values in the low micromolar range, excellent intracellular antimycobacterial activity, and an improved physicochemical profile without cytotoxic effects. Further investigation revealed that the amide bond was the source for the poor blood stability observed, while some of the compounds exhibited hERG affinity. Compound 83 which contains a benzoxazole ring instead of the amide group was found to be a good alternative, with good blood stability and no hERG affinity, providing new opportunities for the series. Overall, the obtained results suggest that further optimization of solubility and microsomal stability of the series could provide a strong lead for a new anti-TB drug development program." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00245"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00245">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00245&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00245&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00245&amp;href=/doi/10.1021/acs.jmedchem.6b00245" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6709-6728</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00056" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00252" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eleni++Pitta">Eleni Pitta</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maciej+K.++Rogacki">Maciej K. Rogacki</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Olga++Balabon">Olga Balabon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sophie++Huss">Sophie Huss</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fraser++Cunningham">Fraser Cunningham</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eva+Maria++Lopez-Roman">Eva Maria Lopez-Roman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jurgen++Joossens">Jurgen Joossens</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Koen++Augustyns">Koen Augustyns</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lluis++Ballell">Lluis Ballell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+H.++Bates">Robert H. Bates</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pieter++Van+der+Veken">Pieter Van der Veken</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universitieitsplein 1, B-2610 Wilrijk, Belgium</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos Madrid, Spain</span></div><div class="corresp-info"><strong>*</strong>For R.H.B.: phone, +34 6503 95 529; E-mail, <a href="/cdn-cgi/l/email-protection#a8dac7cacddadc86c086cac9dccddbe8cfdbc386cbc7c5"><span class="__cf_email__" data-cfemail="a2d0cdc0c7d0d68cca8cc0c3d6c7d1e2c5d1c98cc1cdcf">[emailÂ protected]</span></a></div><div class="corresp-info"><strong>*</strong>For P.V.V.: phone, +32 3265 27 08; E-mail, <a href="/cdn-cgi/l/email-protection#ddadb4b8a9b8aff3abbcb3b9b8afabb8b6b8b39da8bcb3a9aab8afadb8b3f3bfb8"><span class="__cf_email__" data-cfemail="f2829b97869780dc84939c969780849799979cb287939c8685978082979cdc9097">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00245&amp;href=/doi/10.1021%2Facs.jmedchem.6b00245" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6709â6728</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 27, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 February 2016</li><li><span class="item_label"><b>Published</b> online</span>12 July 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 July 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00245" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00245</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6709%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DEleni%2BPitta%252C%2BMaciej%2BK.%2BRogacki%252C%2BOlga%2BBalabon%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D14%26contentID%3Dacs.jmedchem.6b00245%26title%3DSearching%2Bfor%2BNew%2BLeads%2Bfor%2BTuberculosis%253A%2BDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2BNovel%2B2-Quinolin-4-yloxyacetamides%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6728%26publicationDate%3DJuly%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00245"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2410</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">26</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00245" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Eleni&quot;,&quot;last_name&quot;:&quot;Pitta&quot;},{&quot;first_name&quot;:&quot;Maciej&quot;,&quot;last_name&quot;:&quot;K. Rogacki&quot;},{&quot;first_name&quot;:&quot;Olga&quot;,&quot;last_name&quot;:&quot;Balabon&quot;},{&quot;first_name&quot;:&quot;Sophie&quot;,&quot;last_name&quot;:&quot;Huss&quot;},{&quot;first_name&quot;:&quot;Fraser&quot;,&quot;last_name&quot;:&quot;Cunningham&quot;},{&quot;first_name&quot;:&quot;Eva&quot;,&quot;last_name&quot;:&quot;Maria Lopez-Roman&quot;},{&quot;first_name&quot;:&quot;Jurgen&quot;,&quot;last_name&quot;:&quot;Joossens&quot;},{&quot;first_name&quot;:&quot;Koen&quot;,&quot;last_name&quot;:&quot;Augustyns&quot;},{&quot;first_name&quot;:&quot;Lluis&quot;,&quot;last_name&quot;:&quot;Ballell&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;H. Bates&quot;},{&quot;first_name&quot;:&quot;Pieter&quot;,&quot;last_name&quot;:&quot;Van der Veken&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;6709-6728&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00245&quot;},&quot;abstract&quot;:&quot;In this study, a new series of more than 60 quinoline derivatives has been synthesized and evaluated against Mycobacterium tuberculosis (H37Rv). Apart from the SAR exploration around the initial hits, the optimization process focused on the improvement of the physicochemical properties, cytotoxicity, and metabolic stability of the series. The best compounds obtained exhibited MIC values in the low micromolar range, excellent intracellular antimycobacterial activity, and an improved physicochemical profile without cytotoxic effects. Further investigation revealed that the amide bond was the source for the poor blood stability observed, while some of the compounds exhibited hERG affinity. Compound 83 which contains a benzoxazole ring instead of the amide group was found to be a good alternative, with good blood stability and no hERG affinity, providing new opportunities for the series. Overall, the obtained results suggest that further optimization of solubility and microsomal stability of the series could prov&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00245&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00245" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00245&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00245" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00245&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00245" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00245&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00245&amp;href=/doi/10.1021/acs.jmedchem.6b00245" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00245" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00245" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00245%26sid%3Dliteratum%253Aachs%26pmid%3D27348630%26genre%3Darticle%26aulast%3DPitta%26date%3D2016%26atitle%3DSearching%2Bfor%2BNew%2BLeads%2Bfor%2BTuberculosis%253A%2BDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2BNovel%2B2-Quinolin-4-yloxyacetamides%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D14%26spage%3D6709%26epage%3D6728%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292317" title="Ethyl groups">Ethyl groups</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/jmcmar.2016.59.issue-14/20160728/jmcmar.2016.59.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00245&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In this study, a new series of more than 60 quinoline derivatives has been synthesized and evaluated against <i>Mycobacterium tuberculosis</i> (H37Rv). Apart from the SAR exploration around the initial hits, the optimization process focused on the improvement of the physicochemical properties, cytotoxicity, and metabolic stability of the series. The best compounds obtained exhibited MIC values in the low micromolar range, excellent intracellular antimycobacterial activity, and an improved physicochemical profile without cytotoxic effects. Further investigation revealed that the amide bond was the source for the poor blood stability observed, while some of the compounds exhibited hERG affinity. Compound <b>83</b> which contains a benzoxazole ring instead of the amide group was found to be a good alternative, with good blood stability and no hERG affinity, providing new opportunities for the series. Overall, the obtained results suggest that further optimization of solubility and microsomal stability of the series could provide a strong lead for a new anti-TB drug development program.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70345" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70345" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tuberculosis (TB) is a worldwide pandemic caused by <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>). The threat it represents to global health is escalating because of the increased prevalence of multidrug resistant TB (MDR-TB) and extensively drug resistant TB (XDR-TB) strains. The World Health Organization has estimated that one-third of the worldâs population is infected with <i>Mtb</i>, resulting in 1.5 million TB deaths in 2014.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">The first-line drugs for the treatment of drug-susceptible TB are isoniazid, pyrazinamide, rifampicin, ethambutol, and streptomycin.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The current treatment regimen for drug-sensitive TB consists of a combination of 3â4 first-line drugs that must be taken for six months or longer.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Infection relapse and emergence of drug-resistant strains have been reported in many cases as often patients partly or completely drop the therapy due to its side effects and long duration.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In case of drug-resistant strains, treatment consists of second-line drugs which are administered for two years or longer. Apart from the high cost, many second-line drugs are toxic and have severe side effects, posing a significant challenge to health systems.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">Consequently, the need for novel, more effective drugs is evident. Ideally, any new drug should be able to shorten the duration of treatment, avoid significant drugâdrug interactions with current regimens, be efficacious against MDR-TB and XDR-TB, and preferably operate via a new mode of action.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">One approach to address this drug discovery need is through high throughput phenotypic screening of small molecule libraries directly against mycobacteria in order to identify a variety of new active scaffolds.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> A high throughput screening (HTS) campaign performed by GlaxoSmithKline (GSK) delivered several compound families that passed multiple drug-like property filters and were progressed for further profiling.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The quinoloxyacetamides (QOA) constitute one of these families, and the two most active hit compounds (<b>1</b> and <b>2</b>, shown in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) were selected for further structureâactivity relationship (SAR) studies and optimization of their properties. It is noteworthy that quinolines represent a common substructure of several known antitubercular drugs, e.g., bedaquiline, mefloquine, and fluoroquinolones such as moxifloxacin and gatifloxacin.<a onclick="showRef(event, 'ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11 ref12">(8-12)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Hit compounds <b>1</b> and <b>2</b> and SAR design.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00245&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, the hit compounds <b>1</b> and <b>2</b> were found to possess significant antimycobacterial activity with minimum inhibitory concentration (MIC) values 1.9 and 1.4 Î¼M, respectively, against <i>M. tuberculosis</i> (H37Rv). The cytotoxicity (HepG<sub>2</sub>) of the initial hits was also evaluated, and hit <b>1</b> displayed a level of cytotoxicity (IC<sub>50</sub> 19.95 Î¼M) while hit <b>2</b> did not exhibit cytotoxic effects. Moreover, two key physicochemical parameters (solubility and permeability) were investigated, revealing workable, but suboptimal properties of <b>1</b> and <b>2</b>. Also, the mouse and human microsomal stabilities were determined, and the results indicated that further optimization was required before progressing to an in vivo proof-of-concept.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biological Profile for the Hit Compounds <b>1</b> and <b>2</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0008.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Upon retesting the obtained data were found to differ in some cases from the data published in ref <a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">6</a>.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">MIC against <i>Mycobacterium tuberculosis</i> (H37Rv).</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">HepG<sub>2</sub>, human caucasian hepatocyte carcinoma.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Artificial membrane permeability.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">In vitro profiling for kinetic aqueous solubility (CLND, chemiluminescent nitrogen detection).</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">In vitro microsomal fraction stability (mouse and human) results: intrinsic clearance (Cl<sub>int</sub>) and half-life time (<i>t</i><sub>1/2</sub>) are reported; imidazolam was used as control with Cl<sub>int</sub> = 27.5 Â± 0.4 and 6.4 mL min<sup>â1</sup>g<sup>â1</sup> in mouse and human, respectively, and <i>t</i><sub>1/2</sub> = <5 and 9 min in mouse and human, respectively.</p></div></div><div></div></div><div class="NLM_p last">On the basis of the promising initial data, a library of more than 60 novel analogues was designed and synthesized, relying on iterative logic-based SAR exploration of the chemical space around the hits. Along with identifying the structural parameters that govern the antimycobacterial properties of these molecules, the primary goals were to optimize physicochemical properties and to improve metabolic stability. For practical reasons, hit <b>1</b> was selected as a reference and divided into three substructures to help organize the SAR exploration: the quinoline, the linker, and the northern aryl part (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). This was done by preparing three compound subseries in which each of the substructures was modified separately while keeping the rest of the molecule identical to the reference compound. Practically, the process of compound optimization was organized around iterative cycles of design, synthesis, and evaluation. At each stage, experimentally obtained antimycobacterial, physicochemical, and in vitro toxicity data were used to refine the decision model used for synthetic planning.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30037" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30037" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">More than 60 novel compounds were synthesized for this study. The target compounds are clustered according to the modification type they contain relative to reference compound <b>1</b>. Lastly, three compounds which contain amide bond replacements are presented.</div><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i5" class="anchor-spacer"></div><h4 class="article-section__title" id="_i5"> Modification of the Quinoline Substitution Pattern</h4><div class="NLM_p">An important goal of these compounds was to investigate the contribution to antimycobacterial activity of the 6-methoxy and 2-methyl quinoline substituents in <b>1</b>. The selection of substituents was carried out in a highly exploratory manner and comprises groups with widely differing impact on the sterics and electronics of the quinoline system. The general synthetic strategy to obtain the target compounds (<b>1</b>, <b>8</b>â<b>24</b>) consisted of coupling the modified quinoline core <b>5a</b>â<b>r</b> to 2-bromo-<i>N</i>-(3,5-dimethylphenyl)acetamide <b>7</b> in the presence of potassium carbonate (K<sub>2</sub>CO<sub>3</sub>) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Construction of the 2-methyl and 2-trifluoromethyl quinolin-4-ols (<b>5a</b>â<b>c</b>, <b>5f</b>, <b>5h</b>â<b>m</b>, <b>5o</b>,<b>p</b>) was achieved by condensation of a number of commercially available anilines (<b>3</b>) with ethyl acetoacetate (<b>4a</b>) or ethyl 4,4,4-trifluoroacetoacetate (<b>4b</b>) following a ConradâLimpach protocol.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> The moderate to low yields obtained with the used ConradâLimpach protocols were considered acceptable for our purposes. However, further optimization of the quinolone synthesis would be required in case of upscaling. The <i>N</i>-aryl haloacetamide building block <b>7</b> was obtained in excellent yield by acylation of aniline <b>6</b> with bromoacetyl bromide in the presence of triethylamine (TEA).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds with Quinoline Substitution Modifications<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00245&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Dowtherm A, H<sub>2</sub>SO<sub>4</sub>, 240â250 Â°C, 35â60 min; (b) 130 Â°C, 90 min, then Dowtherm A, 250 Â°C, 1 h; (c) acetic acid, toluene, reflux, 2 h, then Dowtherm A, 240 Â°C, 1 h; (d) triethylamine, anhydrous DCM, rt, 2 h; (e) potassium carbonate, anhydrous DMF, rt, 3 h to 4 days.</p></p></figure></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7"> Modification of the Linker</h4><div class="NLM_p">SAR investigation of the linker region was focused on three main approaches: (1) introduction of substituents on the acetylâs methylene group, (2) conformational constraint of the linker, and (3) other modification types (<a class="ref internalNav" href="#sch2" aria-label="Schemes 2">Schemes 2</a>, <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, and <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, respectively).</div><div class="NLM_p">The synthetic approach to target compounds with the first modification type (<b>27</b>â<b>30</b>, summarized in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) was analogous to the general strategy described earlier (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The reaction of 3,5-dimethylaniline (<b>6</b>) with acyl halides <b>25a</b>â<b>d</b> gave intermediates <b>26a</b>â<b>d</b>. The bromoalkylacyl bromides <b>25a</b>â<b>c</b> were commercially available, while 2-bromo-2-phenylacetyl chloride (<b>25d</b>) was prepared from phenylacetyl chloride in the presence of <i>N</i>-bromosuccinimide and 2,2â²-azobis(2-methylpropionitrile) (AIBN) according to a literature procedure.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The final products <b>27</b>â<b>30</b> were subsequently obtained by alkylation of 2-methyl-6-methoxy-quinolinol (<b>5a</b>) with these halides (<b>26a</b>â<b>d</b>) in the presence of sodium hydride (NaH).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds with Introduction of Substituents on the Linker<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00245&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) triethylamine, anhydrous DCM, rt, 2 h to overnight; (b) sodium hydride, (potassium iodide), anhydrous DMF, rt, 6â48 h.</p></p></figure><div class="NLM_p">Next, four conformationally constrained analogues were prepared (compounds <b>31</b>, <b>32</b>, <b>37</b>, and <b>40</b>, <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). While the synthetic preparation of the target compounds <b>31</b> and <b>32</b> could be achieved using the general alkylation procedure, a more lengthy approach was required for compound <b>37</b>. Nitration and subsequent zinc/ammonium chloride (Zn/NH<sub>4</sub>Cl) reduction of 2-methyl-6-methoxyquinolin-4-ol (<b>5a</b>) yielded 3-aminoquinolin-4-ol <b>34</b>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The latter compound was <i>N</i>-acylated with intermediate <b>35</b>, which was prepared from oxalyl chloride and 3,5-dimethylaniline (<b>6</b>). Dehydration of the obtained intermediate <b>36</b> with phosphorus pentasulfide (P<sub>4</sub>S<sub>10</sub>) led to the assembly of the annulated thiazole ring of thiazoloquinoline <b>37</b>. The associated formation of a thioamide in <b>37</b> during P<sub>4</sub>S<sub>10</sub>-mediated dehydration was not considered problematic, and the obtained compound was allowed to enter biological evaluation after purification. Comparable attempts to prepare the oxazole analogue of <b>37</b> (compound <b>38</b>) by dehydration of <b>36</b> with phosphorus pentoxide (P<sub>4</sub>O<sub>10</sub>) were not successful. Compound <b>40</b> was obtained from the acylation reaction of intermediate <b>35</b> with the commercially available 2-methyl-4-amino-6-methyl quinoline <b>39</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds with Conformational Constraint of the Linker<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00245&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) 7-(bromomethyl)quinoline or 3-bromo-1-phenylpyrrolidin-2-one, potassium carbonate, anhydrous DMF, rt, 2â72 h; (b) nitric acid, propionic acid, 110 Â°C, 2 h; (c) Zn, THF/satd aq NH<sub>4</sub>Cl: 2/1, rt, 1 h; (d) 0 Â°C, 1 h; (e) anhydrous DCM:DMF (10:1), 0 Â°C, 1 h; (f) phosphorus pentasulfide, anhydrous pyridine, reflux, overnight; (g) phosphorus pentoxide, anhydrous pyridine, reflux, overnight; (h) sodium hydride, anhydrous DMF, rt, overnight.</p></p></figure><div class="NLM_p">Subsequently, three more analogues (<b>42</b>, <b>45</b>, <b>47</b>) were prepared with linker modifications that were not covered in the aforementioned sets (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The synthetic approach to <b>42</b> was completely analogous to the general strategy mentioned earlier, while for the preparation of <b>45</b>, the hydroxy group of quinolinol <b>5a</b> was converted to bromine by phosphorus tribromide (PBr<sub>3</sub>), leading to intermediate <b>43</b>. Separately, the reaction of 3,5-dimethylaniline (<b>6</b>) and 2-bromoethanol resulted in intermediate <b>44</b>, which was subsequently coupled with <b>43</b> to yield the target compound <b>45</b> using Cu(I)-catalysis (Ullmann reaction).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> For the synthesis of <b>47</b>, intermediate <b>43</b> was coupled with glycine ethyl ester under nucleophilic aromatic substitution conditions to yield the carboxylic ester <b>46a</b>.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> After basic hydrolysis of <b>46a</b> in methanol, carboxylate <b>46b</b> was obtained in quantitive yield and then it was converted to the acyl chloride <b>46c</b> using thionyl chloride (SOCl<sub>2</sub>). Amide bond formation between intermediate <b>46c</b> and 3,5-dimethylaniline (<b>6</b>) was achieved using basic acylating conditions to afford final compound <b>47</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds Which Contain Other Modifications Types<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00245&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) potassium carbonate, anhydrous DMF, rt, 26 h; (b) PBr<sub>3</sub>, DMF, 50 Â°C, 4 days; (c) 90 Â°C, 4 h; (d) CuI, TMEDA, cesium carbonate, anhydrous DMF, 95 Â°C, 2 days; (e) glycine ethyl esterÂ·HCl, phenol, 120 Â°C, overnight; (f) sodium hydroxide, MeOH, reflux, 90 min; (g) thionyl chloride, anhydrous DCM, reflux, 2 days; (h) 3,5-dimethylaniline (<b>6</b>), anhydrous DCM, rt, 16 h.</p></p></figure></div><div id="sec2_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Modification of the Northern Aryl Fragment</h4><div class="NLM_p">Analogues in this section are divided into three categories: (1) derivatives with modified phenyl substitution (<b>49</b>â<b>66</b>), (2) compounds with heteroaryl groups (<b>70</b>â<b>78</b>), and (3) hybrid molecules in which known antitubercular drugs replace the aniline of the hits (<b>79</b>â<b>81</b>) (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). The synthesis of the first set of compounds (<b>49</b>â<b>66</b>) relied on the general alkylation-based methodology. Thus, haloacetamide intermediates <b>48a</b>â<b>r</b> were first prepared by acylation of a number of commercially available anilines coupled with bromoacetyl bromide, as depicted in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a> (method A). Subsequently, <i>O</i>-alkylation of the quinolinol <b>5a</b> with these halides resulted in the final products <b>49</b>â<b>66</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds with Modifications of the Northern Aryl Fragment<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00245&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) triethylamine, anhydrous DCM, rt, 2â48 h; (b) potassium carbonate, anhydrous DMF, rt, 3â96 h; (c) potassium hydroxide, MeOH or EtOH, reflux, 1.5â3.5 h; (d) thionyl chloride, anhydrous DCM, 20 to 40 Â°C, 24â48 h; (e) anhydrous DCM, rt to reflux, 18â48 h.</p></p></figure><div class="NLM_p">The target compounds <b>70</b>â<b>81</b> were obtained by an alternative route (method B) shown in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. According to this, quinolinol <b>5a</b> was alkylated with ethyl 2-bromoacetate, followed by hydrolysis of ester <b>67</b> under basic conditions and conversion of the corresponding carboxylic acid <b>68</b> to acyl chloride <b>69</b> using thionyl chloride (SOCl<sub>2</sub>). Subsequently, reaction with a number of commercially available heterocyclic amines afforded the final compounds (<b>70</b>â<b>78</b>).</div><div class="NLM_p last">Lastly, the same methodology (method B) was used to synthesize three âhybridâ compounds, in which the quinoloxyacetamide core was covalently linked to known anti-TB drugs with available free amines: cycloserine (<b>79</b>), sulfamethoxazole (<b>80</b>), and isoniazid (<b>81</b>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div></div><div id="sec2_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Amide Bond Replacements</h4><div class="NLM_p">Lastly, three compounds (<b>82</b>â<b>84</b>) which could avoid amide bond hydrolysis were prepared. Deprotonation of compound <b>1</b> using sodium hydride (NaH) and subsequent methylation with methyl iodide (MeI) afforded the target compound <b>82</b>. Preparation of compounds <b>83</b> and <b>84</b> was similar to the general alkylation method described previously (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds with Amide Bond Replacements<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00245&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) methyl iodide, sodium hydride, anhydrous THF, 0â20 Â°C, overnight; (b) potassium carbonate, anhydrous DMF, rt, overnight; (c) sodium hydride, anhydrous DMF, rt, overnight.</p></p></figure></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Biological Evaluation</h3><div class="NLM_p">The hit compound <b>1</b> obtained from high throughput screening (HTS) was resynthesized to confirm activity and evaluated together with 62 novel derivatives. All synthesized compounds were evaluated for their ability to inhibit the growth of <i>Mtb</i> H<sub>37</sub>Rv strain and for cytotoxicity in HepG<sub>2</sub> cells. In addition, three physicochemical properties were measured: artificial membrane permeability, kinetic aqueous solubility (CLND, chemiluminescent nitrogen detection), and chromlogD.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a></div><div class="NLM_p"><a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> presents the results for the reference compound <b>1</b> and the first set of compounds possessing variations to the substitution pattern of the quinoline system (<b>8</b>â<b>24</b>). The main goal was to investigate the contribution to antimycobacterial activity of the 6-methoxy and 2-methyl quinoline substituents. Therefore, the 6-methoxy substituent was removed or replaced with halides, methylthio, alkyl, or alkoxy substituents (<b>8</b>, <b>9</b>, <b>11</b>â<b>16</b>, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). In addition, a regioisomer of compound <b>1</b> with the methoxy group shifted from position 6 to 7 was prepared (<b>10</b>, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Because the 2-methyl substituent of hits <b>1</b> and <b>2</b> was suspected to be a metabolically labile site, a few analogues possessing a trifluoromethyl group were synthesized (<b>19</b>â<b>23</b>, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Additionally, the 2-methyl group was replaced by a propyl group in an attempt to explore the available space (<b>24</b>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Biological Profile of the Compounds with a Modified Quinoline Part</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0009.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">MIC against <i>Mycobacterium tuberculosis</i> (H37Rv).</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">HepG<sub>2</sub>, human caucasian hepatocyte carcinoma.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Artificial membrane permeability.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">In vitro profiling for kinetic aqueous solubility (CLND, chemiluminescent nitrogen detection).</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">chromlogD values at pH = 7.4.</p></div><div class="footnote" id="t2fn6"><sup>Table f</sup><p class="last">n.d. = not determined.</p></div></div><div></div></div><div class="NLM_p">As shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, SAR analysis of the quinoline part of the molecule showed that only a methyl can be considered an acceptable alternative for the original 6-methoxy group (<b>13</b>, MIC = 3.9 Î¼M). This compound showed slightly better solubility (CLND) and high permeability, although it displayed similar cytotoxicity to <b>1</b>. The presence of fluorine or no substituent (âH) at the same position led to decreased activity (<b>11</b> and <b>8</b>; MIC = 15.6 and 24 Î¼M, respectively). Chlorine resulted in a further drop of the potency (<b>12</b>, MIC = 40 Î¼M). All the other substituents in the series were inactive. Steric limitations might be involved here, although other factors most likely contribute, as reflected by the absence of activity for the 6-trifluoromethyl containing analogue <b>15</b>.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Regarding the methyl group at position 2, its replacement with a trifluoromethyl or a propyl group led to inactive compounds (<b>19</b> and <b>24</b>). For all the compounds (<b>19</b>â<b>24</b>) possessing a trifluoromethyl group in position 2, the extremely poor solubility and higher chromlogD values could play a role in the loss of potency.</div><div class="NLM_p"><a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> presents the results for the second set of compounds possessing modifications on the linker. The first area of exploration was around the acetyl methylene group. Monosubstitution at this prochiral position is the most straightforward way of introducing a chiral center in these compounds without affecting the quinoloxyacetamide basic framework. In addition, this site was also suspected of being a contributor to the fast (oxidative) metabolism observed for the hit compounds. In this initial proof-of-concept compound set, the substituent choice was limited to small aliphatic groups (methyl and ethyl) and a phenyl ring (<b>27</b>â<b>30</b>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Biological Profile of the Compounds with Linker Modifications</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0010.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">MIC against <i>Mycobacterium tuberculosis</i> (H37Rv).</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">HepG<sub>2</sub>, human caucasian hepatocyte carcinoma.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Artificial membrane permeability.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">In vitro profiling for kinetic aqueous solubility (CLND, chemiluminescent nitrogen detection).</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">chromlogD values at pH = 7.4.</p></div><div class="footnote" id="t3fn6"><sup>Table f</sup><p class="last">n.d. = not determined.</p></div></div><div></div></div><div class="NLM_p">Next, four conformationally constrained analogues were prepared (<b>31</b>, <b>32</b>, <b>37</b>, and <b>40</b>). In compounds <b>31</b>, <b>32</b>, and <b>37</b>, conformational locking was accomplished by an additional ring closure, while in the case of analogue <b>40</b>, the oxalyl diamide fragment was expected to rigidify the linker region into a constrained conformation.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a></div><div class="NLM_p">Subsequently, three more analogues (<b>42</b>, <b>45</b>, <b>47</b>) were prepared with linker modifications that were not covered in the aforementioned sets. Compound <b>42</b> contains a benzylamide function as a means to avoid potential toxicity and metabolic stability concerns that are associated with anilide groups. Compound <b>45</b> possesses a fully reduced linker, while in compound <b>47</b> the ether bridge between the linker region and the quinoline residue is replaced by an amine function.</div><div class="NLM_p">Antimycobacterial screening of the compounds with an Î±-substituted acetyl group (<b>27</b>â<b>30</b>) demonstrated that modifications of this type are detrimental to activity. Similarly, in the second group of compounds, the activity was lost or significantly reduced in all cases. In the same way, compounds belonging to the third group (<b>42</b>, <b>45</b>, and <b>47</b>) showed some moderate potency, giving MIC values of 31, 32, and 47 Î¼M, respectively.</div><div class="NLM_p">To investigate the role of the hydrophobic phenyl ring in the northern part of the molecule, 30 compounds (<b>49</b>â<b>66</b>, <b>70</b>â<b>78</b>, and <b>79</b>â<b>81</b>) possessing modifications on the northern aryl part were prepared, and data from their biological and physicochemical evalution is presented in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Biological Profile of the Compounds with Modifications on the Northern Aryl</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0011.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">MIC against <i>Mycobacterium tuberculosis</i> (H37Rv).</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">HepG<sub>2</sub>, human caucasian hepatocyte carcinoma.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Artificial membrane permeability.</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">In vitro profiling for kinetic aqueous solubility (CLND, chemiluminescent nitrogen detection).</p></div><div class="footnote" id="t4fn5"><sup>Table e</sup><p class="last">chromlogD values at pH = 7.4.</p></div><div class="footnote" id="t4fn6"><sup>Table f</sup><p class="last">n.d. = not determined.</p></div></div><div></div></div><div class="NLM_p">Analogues in this section are divided into three categories: (1) derivatives with modified phenyl substitution (<b>49</b>â<b>66</b>), (2) compounds with heteroaryl groups (<b>70</b>â<b>78</b>), and (3) hybrid molecules in which three known anti-TB drugs replace the aniline of the hits compounds (<b>79</b>â<b>81</b>). For the first category, the initial goal was to introduce a diverse set of commercially available anilines. These molecules allow a more thorough investigation of the role of the aryl substituents on the antimycobacterial properties of QOA-based molecules. Furthermore, the metabolic liability of the specific aryl residues present in <b>1</b> and <b>2</b> had also been proposed as a potential reason for the observed microsomal instability. Therefore, additional value for this series could come from its potential to deliver antimycobacterial products in which positions prone to CYP-mediated oxidation have been blocked or modified.</div><div class="NLM_p">Similar to the substitutions discussed above, replacement of the phenyl ring with a heteroaryl (<b>70</b>â<b>78</b>) offered the possibility of improving the microsomal stability, at least partially, by reducing the overall lipophilicity of the molecule. Commercially available heteroaromatic amines with an identical or similar dimethyl-substitution pattern as present in reference <b>1</b> were included in the series to allow direct comparisons.</div><div class="NLM_p">Regarding the hybrid compounds, we hypothesized that the full hybrid constructs could still possess antimycobacterial properties. In addition, if metabolic cleavage of the amide would take place, either inside bacteria or mediated by host metabolism, a second antimycobacterial compound could be released.</div><div class="NLM_p">Modification of the substitution pattern on the phenyl ring resulted in a number of active compounds with MIC values in the low micromolar range. Elimination of one or both methyl groups (<b>50</b>, <b>49</b>) did not affect the activity (MIC = 2 Î¼M), indicating that the methyl groups are not critical for potency. Moreover, solubity and chromlogD values were improved, although cytotoxicity remained at similar levels as <b>1</b>. It is worth noting that shifting one methyl group from position 3 to 2 led to decreased activity (<b>51</b>, MIC = 8 Î¼M), while shifting both methyls from 3,5 to 2,6 positions led to the practically inactive compound <b>52</b> (MIC = 125 Î¼M).</div><div class="NLM_p">Exploration of the position of the methoxy group of the hit compound <b>2</b> indicated that the <i>para</i>-position (compound <b>54</b>, MIC = 0.6 Î¼M) is more favorable than the <i>ortho</i>- (hit compound <b>2</b>, 1.4 Î¼M) or <i>meta</i>- substitution (compound <b>53</b>, MIC = 6.4 Î¼M). Compound <b>54</b>, apart from excellent activity, also possessed an improved profile in comparison with the reference compound <b>1</b>. More specifically, it did not exhibit cytotoxic effects (IC<sub>50</sub> > 100 Î¼M), had good permeability (420 nm/s), improved kinetic aqueous solubility (CLND) (108 Î¼M), and chromlogD values (4.22). Compound <b>55</b>, where we preserved both methyl groups at positions 3 and 5 (as the reference compound <b>1</b>) and a methoxy group at position 4 (as compound <b>54</b>) showed very good activity (MIC = 1 Î¼M) but high cytotoxicity (IC<sub>50</sub> 7.94 Î¼M) and low solubility (17 Î¼M). Several compounds possessing mono-, di-, or tri- substituted phenyl rings (<b>56</b>â<b>60</b>, <b>66</b>) exhibited very good potencies, although they were less active than the reference compounds. Most of them did not show cytotoxic effects (<b>56</b>, <b>57</b>, <b>59</b>, <b>60</b>, <b>66</b>), but chromlogD values were generally high (>5) and solubility low (>32).</div><div class="NLM_p">Introduction of more hydrophilic rings such as pyridine, pyrimidine, thiazole, isoxazolidinone, or dimethylisoxazole did not provide the desired solubility improvement although the chromlogD values (2.46â4.24) were lower than the phenyl derivatives and the antitubercular activity was lost for most of them. Comparison among compounds <b>70</b>â<b>72</b> revealed that 2-pyridine (<b>70</b>) is the most favorable, however, still less active than the hit compounds (<b>1</b> and <b>2</b>). The last subset of compounds which includes three hybrid molecules (<b>79</b>â<b>81</b>), unfortunately, led to loss of activity too.</div><div class="NLM_p">Additionally, the intracellular activity for the hit compounds <b>1</b> and <b>2</b> and the most active, noncytotoxic synthesized compounds (<b>54</b>, <b>56</b>, <b>57</b>, <b>59</b>, <b>60</b>, <b>66</b>) was evaluated. This assay determines the effect of the compounds on mycobacteria growing inside macrophages. Activity in this assay is considered highly desirable, as many of the bacteria during an active <i>Mtb</i>-infection are found intracellularly in phagocytotic cell types. The obtained results are shown in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Intracellular IC<sub>50</sub> and IC<sub>90</sub> Values for Selected Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0012.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> and IC<sub>90</sub> against infected Human THP-1 macrophages with <i>Mycobacterium tuberculosis</i> (H37Rv).</p></div></div><div></div></div><div class="NLM_p last">It is worth noting that 7 out of 8 tested compounds showed excellent intracellular IC<sub>90</sub> values, ranging from 0.20 to 2.51 Î¼M. More specifically, compound <b>54</b>, which had also shown the highest MIC value, and compounds <b>1</b> and <b>57</b> exhibited the highest intracellular potencies, with IC<sub>90</sub> values of 0.20â0.25 Î¼M. They were followed by compounds <b>56</b> and <b>66</b>, with IC<sub>90</sub> values 0.50 and 0.63 Î¼M, respectively. Less active but still very potent compounds were the hit compound <b>2</b> and compound <b>59</b> (IC<sub>90</sub> 1.58 and 2.51 Î¼M, respectively). Lastly, compound <b>60</b>, although possessing a good MIC value, did not reach 90% inhibition at 50 Î¼M (IC<sub>90</sub> > 50 Î¼M) in the intracellular assay. This could be due to poor permeability of the compounds through the cell membrane or due to bacterial efflux pumps activated by the macrophage or inactivation of the compounds by host cell derived metabolites such as reactive species or acidic pH.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Metabolic Stability Studies</h3><div class="NLM_p">In view of the fact that microsomal instabillity was identified as a possible liability of the hits, six compounds were selected and the stability in mouse and human microsomal fractions was evaluated before continuing with further synthetic efforts. The selection of compounds was driven by structural criteria in an attempt to identify the metabolic liabilities of the series. Three possible metabolic sites were explored: the methoxy group, the amide bond, and the phenyl ring of the reference compound <b>1</b>. Therefore, compound <b>13</b>, which possesses a methyl group instead of methoxy group, was selected in order to evaluate its stability. Similarly, compounds <b>28</b> and <b>45</b>, which have a sterically hindered amide and an amine, respectively, were also chosen. Lastly, compounds <b>50</b>, <b>75</b>, and <b>57</b> were selected because they contain substituents in different positions of the phenyl ring.</div><div class="NLM_p">The six selected compounds together with the reference compound <b>1</b> were evaluated for their stability in mouse and human microsomal fractions, and the obtained data are presented in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>. All the tested compounds proved to be highly unstable, especially when incubated with mouse microsomal fractions. Comparison of the obtained data with the control without cofactor data indicated that cytochrome P-450 metabolism was not determinant for all the tested compounds apart from compound <b>45</b>, signifying that the amide bond is the most susceptible group of the series and that the esterase hydrolysis might be involved.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Stability of Selected Compounds in Mouse/Human Microsomal Fractions and Blood</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0013.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">In vitro microsomal fraction stability (mouse and human) results: intrinsic clearance (Cl<sub>int</sub>) and half-life time (<i>t</i><sub>1/2</sub>) are reported; imidazolam was used as control with Cl<sub>int</sub> = 27.5 Â± 0.4 and 6.4 mL min<sup>â1</sup>g<sup>â1</sup> in mouse and human, respectively, and <i>t</i><sub>1/2</sub> = <5 and 9 min in mouse and human, respectively.</p></div><div class="footnote" id="t6fn2"><sup>Table b</sup><p class="last">Blood stability results: half-life time (<i>t</i><sub>1/2</sub>) and effect in the presence of NaF are reported.</p></div></div><div></div></div><div class="NLM_p">To confirm that esterases are responsible for the rapid metabolism of the compounds, the selected compounds were incubated in fresh whole CD1 mouse blood. A parallel run, after pretreatment of the blood with pan-esterase inhibitor sodium fluoride (NaF), was performed and the obtained results are depicted in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>. As expected and in accordance with the no cofactor control in the microsomal stability experiment, nearly all the compounds possessing an amide bond were highly unstable. On the other hand, compounds <b>45</b> and <b>28</b>, which possess an amine or a sterically hindered amide, were stable. In addition, the instability is mitigated after NaF pretreatment, suggesting that it is mainly due to the hydrolysis of the amide. Microsomal stability in human fractions was better, which is in agreement with the hypothesis of esterase hydrolysis because esterases in rodents are more active.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">In the light of this evidence, further medicinal chemistry effort led to methylation of the amide (<b>82</b>) and replacement of the <i>N</i>-phenyl amide with benzoxazole (<b>83</b>) or benzimidazole (<b>84</b>) rings in an effort to overcome the rapid clearance observed in mice microsomal fractions. The ring closure or the methylated amide bond could potentially stabilize the metabolic liability of the series, in theory rendering an improved profile over the previous scaffold. <a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a> presents the obtained data for compounds <b>82</b>, <b>83</b>, and <b>84</b>. Lastly, <i>N</i>-methylation of the reference compound <b>1</b> was explored as a classic approach to reduce amide hydrolysis.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Biological Profile of Compounds <b>82</b>, <b>83</b>, and <b>84</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0014.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>Table a</sup><p class="last">MIC against <i>Mycobacterium tuberculosis</i> (H37Rv).</p></div><div class="footnote" id="t7fn2"><sup>Table b</sup><p class="last">IC<sub>90</sub> against infected human THP-1 macrophages with <i>Mycobacterium tuberculosis</i> (H37Rv).</p></div><div class="footnote" id="t7fn3"><sup>Table c</sup><p class="last">n.d. = not determined.</p></div><div class="footnote" id="t7fn4"><sup>Table d</sup><p class="last">HepG<sub>2</sub>, human caucasian hepatocyte carcinoma.</p></div><div class="footnote" id="t7fn5"><sup>Table e</sup><p class="last">Artificial membrane permeability.</p></div><div class="footnote" id="t7fn6"><sup>Table f</sup><p class="last">In vitro profiling for kinetic aqueous solubility (CLND, chemiluminescent nitrogen detection).</p></div><div class="footnote" id="t7fn7"><sup>Table g</sup><p class="last">chromlogD values at pH = 7.4.</p></div><div class="footnote" id="t7fn8"><sup>Table h</sup><p class="last">In vitro microsomal fraction stability results; clearance (Cl<sub>int</sub>) and half-life time (<i>t</i><sub>1/2</sub>) is reported; imidazolam was used as control with Cl<sub>int</sub> = 27.5 Â± 0.4 and 6.4 mL min<sup>â1</sup> g<sup>â1</sup> in mouse and human, respectively and <i>t</i><sub>1/2</sub> = <5 and 9 min in mouse and human, respectively (h) = human, (m) = mouse.</p></div><div class="footnote" id="t7fn9"><sup>Table i</sup><p class="last">Blood stability results: half-life time (<i>t</i><sub>1/2</sub>) is reported.</p></div></div><div></div></div><div class="NLM_p">Compound <b>83</b>, which possesses a benzoxazole ring instead of anilide, showed significant antitubercular activity with an MIC value of 5.5 Î¼M and intracellular IC<sub>90</sub> of 5 Î¼M. Subsequent testing for blood and microsomal stability revealed the expected improvement in blood stability due to the removal of the labile amide bond. However, solubility of compound <b>83</b> was very poor and in vitro microsomal clearance was high, suggesting that further medicinal chemistry effort is required in order to overcome these problems.</div><div class="NLM_p">Lastly, a preliminary evaluation of the cardiosafety of the series was performed by measuring the human ether-a-go-go-related gene (hERG) inhibition of selected compounds. Obtained results are presented in <a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Results of hERG Binding of Selected Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0015.gif" alt="" id="fx8" /></img><div></div></div><div class="NLM_p last">The data in <a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a> indicate that four out of eight tested compounds displayed a hERG inhibitory potency that was higher than the threshold value used for safety assessment (pIC<sub>50</sub>= 4.3). Interestingly, three of these (<b>2</b>, <b>54</b>, and <b>56</b>) possess a methoxyaniline substituent. The rest of the evaluated compounds did not display potent hERG inhibition (pIC<sub>50</sub> < 4.3). Compound <b>83</b>, which was found to be of particular interest due to its blood stability, did not show interaction with hERG.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63148" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63148" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In the presented work, the synthesis of more than 60 novel quinoloxyacetamide derivatives and their biological evaluation against <i>Mycobacterium tuberculosis</i> (H37Rv) is reported. Apart from the SAR exploration around the initial hits, the optimization processes focused on the improvement of the physicochemical properties, cytotoxicity, and metabolic stability of the hit compounds. Several compounds showed potent antitubercular activities with MICs in the low micromolar range, with the best compound (<b>54</b>) exhibiting a MIC value of 0.6 Î¼M and no measurable cytotoxicity. This compound and other potent, noncytotoxic analogues also showed excellent intracellular IC<sub>90</sub> values ranging from 0.20 to 2.51 Î¼M. Furthermore, the metabolic stability of the series was investigated, and it was shown that the amide bond is the most labile group. Thus, synthetic efforts were focused on amide replacement and compound <b>83</b>, which possessed a benzoxazole, was identified as a good alternative to improve blood stability (half-life time >240 min). Evaluation of hERG binding indicated that mainly compounds possessing a methoxyaniline substituent showed appreciable hERG inhibition, while the optimized compound <b>83</b> displayed no activity in the assay. Further medicinal chemistry effort is ongoing to increase solubility and microsomal stability of the series in order to provide a strong lead for a new antitubercular drug discovery program.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70748" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70748" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Information</h3><div class="NLM_p">Unless otherwise stated, laboratory reagent grade solvents were used. Reagents were purchased from Sigma-Aldrich, Acros Organics, TCI, or Enamine and were used without further purification unless otherwise mentioned. Reactions were monitored by TLC on silica gel with detection by UV light (254 nm). TLC analysis was performed using Polygram precoated silica gel TLC sheets SIL G/UV254.</div><div class="NLM_p">Characterization of all compounds was done using <sup>1</sup>H NMR and <sup>13</sup>C NMR spectroscopy and mass spectrometry. <sup>1</sup>H NMR (400 MHz) and <sup>13</sup>C NMR (100 MHz) spectra were recorded on a Bruker Avance III Nanobay Ultrashield 400 or a Bruker DPX 400 spectrometer. The chemical shift (Î´) values are expressed in parts per million (ppm), and coupling constants are in hertz (Hz). Minor rotamers of the amide bond, which were less than 10% of the major rotamer, are not reported in the NMR data. CDCl<sub>3</sub>, CD<sub>3</sub>OD, or DMSO-<i>d</i><sub>6</sub> were used as the standard NMR solvents. Legend: s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet, m = multiplet, dd = doublet of doublets, ddd = doublets of doublets of doublets, br = broad signal. For the measurement of melting points, a Technoterm 7300 (Reichert-Jung Optische Werke) microscope was used.</div><div class="NLM_p">Purity and mass were verified using a UPLC-MS system, and purities of all final products were found to be >95%. UPLC-MS involved the following: Waters Acquity UPLC system coupled to a Waters TQD ESI mass spectrometer and Waters TUV detector. A Waters Acquity UPLC BEH C18 1.7 Î¼m, 2.1 mm Ã 50 mm column was used. Solvent A consisted of water with 0.1% formic acid. Solvent B consisted of acetonitrile with 0.1% formic acid. Method A involved the following: flow 0.4 mL/min, 0.15 min isocratic elution (95% A, 5% B), followed by gradient elution during 1.85 min (from 95% A, 5% B to 95% B, 5% A), then 0.25 min (0.350 mL/min) isocratic elution (95% B, 5% A). The wavelength for UV detection was 254 nm. Method B: flow 0.4 mL/min, 0.25 min isocratic elution (95% A, 5% B), followed by gradient elution during 4.75 min (95% B, 5% A, then isocratic 0.25 min of isocratic elution (95% B, 5% A), followed by 0.75 min isocratic elution (95% A, 5% B). The wavelength for UV detection was 214 nm. For method C, a Waters Acquity UPLC system was coupled to a Waters SQ detector and an Acquity UPLC BEH C18 1.7 Î¼m, 3 mm Ã 50 mm column was used. The concentration of the measured samples was 0.1 mg/mL and flow 0.8 mL/min. The method involved the following: acetate NH<sub>4</sub> 25 mM + 10% ACN at pH 6.6/ACN, 0.0â0.2 min 99.9:0.1, 0.2â1.0 min 10:90, 1.0â1.8 min 10:90, 1.9â2.0 min 99.9:0.1 at temperature 40 Â°C. The UV detection was an averaged signal from wavelength of 210â400 nm. The quasimolecular ions [M + H]<sup>+</sup> or [M â H]<sup>â</sup> were detected. Retention time (RT) was indicated for the described method.</div><div class="NLM_p">For the high resolution mass spectrometry (HRMS) measurements: positive ion mass spectra were acquired using a QSTAR Elite (AB Sciex Instruments) mass spectrometer, equipped with a turbospray source, over a mass range of 250â700.</div><div class="NLM_p">When necessary, flash purification was performed on a Biotage ISOLERA One flash system equipped with an internal variable dual-wavelength diode array detector (200â400 nm). For normal phase purifications, SNAP cartridges (10â100 g, flow rate of 10â100 mL/min) were used, and reverse-phase purifications were done making use of KP-C18 containing cartridges. Dry sample loading was done by self-packing samplet cartridges using silica or Celite 545, respectively, for normal and reversed phase purifications. Gradients used varied for each purification. However, typical gradients used for normal phase were gradients of 0â100% ethyl acetate in <i>n</i>-heptane or 0â15% methanol in ethyl acetate. For reverse phase, a gradient of 5% MeCN in water to 50% MeCN in water was used.</div><div class="NLM_p">The following section comprises the synthetic procedures and analytical data for all final compounds and some representative intermediates reported in this publication. Complementary data for the rest of intermediates can be found in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00245/suppl_file/jm6b00245_si_001.pdf" class="ext-link">Supporting Information</a>. Synthetic procedures that were used in the preparation of several products are summarized here as âgeneral proceduresâ.</div><div class="NLM_p">For the synthesis of the quinolin-4-ols, three related methods were used (general procedures A, B, and C).</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> General Procedure A: Formation of 2-Methyl-quinolin-4-ols (<b>5a</b>, <b>5l</b>) and 2-Trifluoromethyl-quinolin-4-ols (<b>5m</b>, <b>5o</b>, <b>5p</b>)</h4><div class="NLM_p last">According to Brouet et al., the appropriate substituted aniline (1 equiv) and ethyl acetoacetate or ethyl 4,4,4-trifluoroacetoacetate (1.25â2.5 equiv) were dissolved in Dowtherm A (molarity: 0.5 M) and concentrated sulfuric acid (1â3 drops) was added to the stirred mixture.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The reaction vessel was equipped with a short distillation apparatus. The reaction mixture was heated gradually to 240â250 Â°C for 35â60 min, and the produced water/ethanol was removed by distillation as the reaction progressed. Subsequently, the reaction mixture was cooled down to room temperature and poured into <i>n</i>-heptane to give a precipitate. The precipitate was collected by filtration and washed with <i>n</i>-heptane and EtOAc. If necessary, the product was further purified by recrystallization or silica gel flash chromatography.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> General Procedure B: Formation of 2-Methyl-quinolin-4-ols (<b>5a</b>, <b>5c</b>, <b>5f</b>, <b>5h</b>â<b>k</b>)</h4><div class="NLM_p last">In accordance with the second method described by Tantrizos et al., the appropriate aniline (1 equiv) and ethylacetoacetate (1 equiv) were stirred at 130 Â°C for 90 min to form the corresponding imine.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Then, Dowtherm A (molarity: 0.7â2.3 M) was added to the reaction mixture and it was heated for 1 h at 250 Â°C. Then, the reaction mixture was cooled down to room temperature and poured into <i>n</i>-heptane to give a (sticky) precipitate. The precipitate was collected by filtration and washed with <i>n</i>-heptane and EtOAc. If necessary, the product was further purified by recrystallization or silica gel flash chromatography.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> General Procedure C: Formation of 2-Methyl-quinolin-4-ols (<b>5a</b>, <b>5b</b>)</h4><div class="NLM_p last">In line with Escribiano et al., AcOH (1.3 equiv) was added to a solution of the appropriate aniline (1 equiv) and ethylacetoacetate (1.2 equiv) in toluene (molarity: 0.5 M).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The reaction mixture was held at reflux for 2 h with azeotropic removal of water by means of a DeanâStark apparatus. The solvent was evaporated under reduced pressure, and the liquid residue was dissolved in Dowtherm A (molarity: 0.1M) and heated at 240 Â°C for 1 h. A DeanâStark apparatus was used to remove the ethanol produced during the reaction. The reaction mixture was cooled down to room temperature and poured into <i>n</i>-heptane to give a (sticky) precipitate. The precipitate was collected by filtration and washed with <i>n</i>-heptane and EtOAc. If necessary, the product was further purified by recrystallization or silica gel flash chromatography.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> General Procedure D: Preparation of 2-Bromo-<i>N</i>-Substituted Acetamides (<b>7</b>, <b>26a</b>â<b>d</b>, <b>41</b>, <b>48a</b>â<b>r</b>)</h4><div class="NLM_p last">2-Bromoacetyl bromide (1.2 equiv) was slowly added dropwise to a mixture of R-NH<sub>2</sub> (1 equiv) and triethylamine (1.2 mmol) in anhydrous DCM (molarity: 1 M) at 0 Â°C. The reaction mixture was warmed to room temperature and stirred for an additional 2â48 h. After the solvent was removed under reduced pressure, the residue was washed with iceâwater and separated by filtration. If necessary, the product was purified by recrystallization or silica gel column chromatography.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> General Procedure E: <i>O</i>-Alkylation of 4-hydroxy Quinolines (<b>1</b>, <b>8</b>â<b>24</b>, <b>31</b>, <b>32</b>, <b>42</b>, <b>49</b>â<b>67</b>, <b>83</b>, <b>84</b>)</h4><div class="NLM_p last">To a solution of substituted 4-hydroxyquinoline (1 equiv) in anhydrous DMF under nitrogen atmosphere was added K<sub>2</sub>CO<sub>3</sub> (3 equiv) and a solution of the suitable halide (1â1.2 equiv) in anhydrous DMF. The reaction mixture was stirred for 3 h to 4 days at room temperature before being poured into water (50 mL) and extracted with ethyl acetate (3 Ã 50 mL) or filtered in case of precipitation. The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, concentrated in vacuo, and purified by silica gel flash chromatography, if necessary.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> General Procedure F: <i>O</i>-Alkylation of Deprotonated 4-Hydroxy Quinolines (<b>27</b>â<b>30</b>)</h4><div class="NLM_p last">Sodium hydride (NaH) 60% suspended in mineral oil (1 equiv) was added to a solution of intermediate <b>7a</b> in anhydrous DMF under nitrogen atmosphere, and the resulting suspension was stirred for 30 min. Subsequently, a solution of the suitable halide (1 equiv) and in some cases potassium iodide (KI) (1 equiv) in anhydrous DMF was added to the reaction mixture and left stirring for 3 h to 4 days at room temperature. Afterward, the reaction mixture was poured into water (50 mL) and extracted with ethyl acetate (3 Ã 50 mL) or filtered in the case of precipitation. The combined organic extracts were dried over MgSO<sub>4</sub>, concentrated under reduced pressure, and purified by flash chromatography, if necessary.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> General Procedure G: Formation of the Acyl Chlorides (<b>46c</b>, <b>69</b>)</h4><div class="NLM_p last">The appropriate carboxylic acid/carboxylate (1 equiv) was dissolved in anhydrous DCM (molarity: 0.04â0.3 M), and thionyl chloride was added (1.2â45 equiv) dropwise. The reaction mixture was left stirring for 1â3 days at room temperature or under reflux. The volatiles of the reaction mixture were evaporated under reduced pressure, and the obtained acyl chlorides were directly used for the next step.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> General Procedure H: Formation of the Amide Bond (<b>47</b>, <b>70</b>â<b>81</b>)</h4><div class="NLM_p last">The acyl chlorides (<b>46c</b>, <b>69</b>) were dissolved in anhydrous DCM (molarity: 0.04â0.5 M) and the suitable amine (1â2.5 equiv) was added to the solution. In some cases, triethylamine (1â1.2 equiv) was also added to the reaction mixture. Then the reaction mixture was stirred at room temperature for 7â72 h. If triethylamine was not used, the volatiles were evaporated under reduced pressure and the residue was dissolved in water. The solution was basified to pH 8â9 using an aqueous solution of NaOH (2 N), and the obtained crystals were collected by filtration, washed with water, and dried to obtain in most cases the pure product. If necessary, the crude product was recrystallized from EtOAc or purified by column chromatography. If triethylamine was used, DCM was evaporated and the obtained residue was purified by column chromatography.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-(3,5-Dimethylphenyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>1</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 85% (237 mg, 0.68 mmol), mp 189â191 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.16 (s, 1H), 7.91 (d, <i>J</i> = 9.0 Hz, 1H), 7.42â7.32 (m, 2H), 7.18 (s, 2H), 6.80 (s, 1H), 6.60 (s, 1H), 4.80 (s, 2H), 3.96 (s, 3H), 2.64 (s, 3H), 2.29 (s, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 165.3, 159.0, 157.6, 157.3, 145.0, 139.1, 136.6, 130.1, 127.0, 122.2, 119.9, 118.0, 102.3, 99.6, 67.9, 55.7, 25.7, 21.5. UPLC-MS (A) (ESI) RT 1.58 min, <i>m</i>/<i>z</i> 351.5 [M + H]<sup>+</sup> (>95%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 351.1703; found, 351.1694.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 6-Methoxy-2-methylquinolin-4-ol (<b>5a</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedures A, B, and C. Off-white solid; yield 7% (100 mg, 0.53 mmol, procedure A), 20% (153 mg, 0.809 mmol, procedure B), 41% (6.237 g, 33.0 mmol, procedure C). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 11.53 (br s, 1H), 7.45 (dd, <i>J</i> = 5.9, 2.9 Hz, 2H), 7.24 (dd, <i>J</i> = 9.0, 2.9 Hz, 1H), 5.86 (s, 1H), 3.81 (s, 3H), 2.32 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 176.1, 155.2, 148.5, 134.7, 125.5, 121.7, 119.4, 107.4, 104.2, 55.3, 19.3. UPLC-MS (A) (ESI) RT 1.06 min, <i>m</i>/<i>z</i> = 190.1 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-Bromo-<i>N</i>-(3,5-dimethylphenyl)acetamide (<b>7</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure D. Brown solid; yield 97% (3.890 g, 16.07 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.20 (br s, 1H), 7.20 (s, 2H), 6.73 (s, 1H), 4.00 (s, 2H), 2.24 (d, <i>J</i> = 0.4 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) (major cis/trans amide rotamers) Î´ 170.6, 138.3, 137.6, 125.0, 117.3, 61.8, 21.1; (minor cis/trans amide rotamers) Î´ 164.7, 138.5, 137.9, 125.4, 117.0, 30.5, 21.1. UPLC-MS (A) (ESI) RT 1.73 min, <i>m</i>/<i>z</i> 242.3:244.3 (1:1) [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-(3,5-Dimethylphenyl)-2-((2-methylquinolin-4-yl)oxy)acetamide (<b>8</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 63% (318 mg, 0.99 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.10 (s, 1H), 8.24 (dd, <i>J</i> = 8.3, 1.0 Hz, 1H), 7.87 (dd, <i>J</i> = 8.4, 0.5 Hz, 1H), 7.72 (ddd, <i>J</i> = 8.4, 6.9, 1.5 Hz, 1H), 7.53 (ddd, <i>J</i> = 8.2, 6.9, 1.2 Hz, 1H), 7.27 (s, 2H), 6.89 (s, 1H), 6.75 (s, 1H), 4.99 (s, 2H), 2.60 (s, 3H), 2.25 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.4, 160.2, 159.7, 148.4, 138.2, 137.8, 129.8, 127.9, 125.3, 124.8, 121.8, 119.2, 117.5, 102.0, 67.2, 25.4, 21.1. UPLC-MS (A) (ESI) RT 1.49 min, <i>m</i>/<i>z</i> 321.4 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-(3,5-Dimethylphenyl)-2-((2-methyl-6-(methylthio)quinolin-4-yl)oxy)acetamide (<b>9</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 48% (171 mg, 0.47 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.10 (s, 1H), 7.94 (d, <i>J</i> = 2.1 Hz, 1H), 7.79 (d, <i>J</i> = 8.8 Hz, 1H), 7.61 (dd, <i>J</i> = 8.8, 2.3 Hz, 1H), 7.26 (s, 2H), 6.87 (s, 1H), 6.74 (s, 1H), 4.99 (s, 2H), 2.60 (s, 3H), 2.56 (s, 3H), 2.24 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.4, 159.3, 158.8, 146.4, 138.2, 137.8, 134.9, 128.8, 128.4, 125.3, 119.6, 117.4, 116.7, 102.6, 67.1, 25.3, 21.1, 14.9. UPLC-MS (A) (ESI) RT 1.65 min, <i>m</i>/<i>z</i> 367.1 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-(3,5-Dimethylphenyl)-2-((7-methoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>10</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 34% (93 mg, 0.27 mmol). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.12 (br s, 1H), 8.03 (d, <i>J</i> = 9.1 Hz, 1H), 7.38 (d, <i>J</i> = 2.5 Hz, 1H), 7.22â7.15 (m, 3H), 6.81 (s, 1H), 6.55 (s, 1H), 4.80 (s, 2H), 3.94 (s, 3H), 2.68 (s, 3H), 2.31 (s, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 165.1, 161.7, 160.6, 160.2, 150.7, 139.1, 136.5, 127.1, 122.2, 118.5, 118.1, 113.8, 106.8, 100.5, 67.7, 55.7, 25.8, 21.5. UPLC-MS (A) (ESI) RT 1.63 min, <i>m</i>/<i>z</i> 351.5 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-(3,5-Dimethylphenyl)-2-(6-fluoro-2-methylquinolin-4-yloxy)acetamide (<b>11</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 84% (643 mg, 1.90 mmol). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.07â7.97 (m, 2H), 7.75 (dd, <i>J</i> = 9.2, 2.8 Hz, 1H), 7.48 (ddd, <i>J</i> = 9.2, 8.2, 2.9 Hz, 1H), 7.20 (s, 2H), 6.82 (s, 1H), 6.69 (s, 1H), 4.82 (s, 2H), 2.70 (s, 3H), 2.31 (s, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 164.8, 160.2 (d, <sup>1</sup><i>J</i><sub>CâF</sub> = 246.8 Hz), 159.6 (d, <sup>4</sup><i>J</i><sub>CâF</sub> = 2.6 Hz), 146.0, 139.2, 136.4, 131.0 (d, <sup>3</sup><i>J</i><sub>CâF</sub> = 8.7 Hz), 127.2, 120.4 (d, <sup>2</sup><i>J</i><sub>CâF</sub> = 25.3 Hz), 119.9 (d, <sup>3</sup><i>J</i><sub>CâF</sub> = 9.5 Hz), 118.2, 118.0, 105.2 (d, <sup>2</sup><i>J</i><sub>CâF</sub> = 23.6 Hz), 102.6, 67.9, 25.8, 21.5. UPLC-MS (A) (ESI) RT 1.58 min, <i>m</i>/<i>z</i> 339.4 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-((6-Chloro-2-methylquinolin-4-yl)oxy)-<i>N</i>-(3,5-dimethylphenyl)acetamide (<b>12</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 31% (113 mg, 0.32 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.10 (s, 1H), 8.22 (d, <i>J</i> = 2.3 Hz, 1H), 7.88 (d, <i>J</i> = 9.0 Hz, 1H), 7.72 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H), 7.25 (s, 2H), 6.97 (s, 1H), 6.74 (s, 1H), 5.00 (s, 2H), 2.59 (s, 3H), 2.24 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.3, 160.6, 159.5, 146.8, 138.1, 137.8, 130.2, 130.1, 129.4, 125.4, 120.8, 120.0, 117.7, 103.0, 67.3, 25.4, 21.1. UPLC-MS (A) (ESI) RT 1.67 min, <i>m</i>/<i>z</i> 355.1, 357.1 (3:1) [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-(3,5-Dimethylphenyl)-2-((2,6-dimethylquinolin-4-yl)oxy)acetamide (<b>13</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 95% (365 mg, 1.09 mmol), mp 208â210 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.10 (s, 1H), 7.99 (s, 1H), 7.76 (d, <i>J</i> = 8.5 Hz, 1H), 7.55 (dd, <i>J</i> = 8.6, 2.0 Hz, 1H), 7.27 (s, 2H), 6.83 (s, 1H), 6.75 (s, 1H), 4.97 (s, 2H), 2.57 (s, 3H), 2.50 (s, 3H, overlaps with solventâs peak), 2.25 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.4, 159.9, 158.6, 146.9, 138.2, 137.8, 134.1, 131.7, 127.7, 125.3, 120.5, 119.0, 117.4, 101.9, 67.1, 25.3, 21.2, 21.1. UPLC-MS (A) (ESI) RT 1.64 min, <i>m</i>/<i>z</i> 335.5 [M + H]<sup>+</sup> (>95%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 335.1754; found, 335.1739.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-(3,5-Dimethylphenyl)-2-((2-methyl-6-(trifluoromethyl)quinolin-4-yl)oxy)acetamide (<b>14</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 66% (226 mg, 0.58 mmol), mp >210 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.14 (s, 1H), 8.54 (s, 1H), 8.07 (d, <i>J</i> = 8.8 Hz, 1H), 7.98 (dd, <i>J</i> = 8.9, 2.1 Hz, 1H), 7.24 (s, 2H), 7.06 (s, 1H), 6.74 (s, 1H), 5.06 (s, 2H), 2.64 (s, 3H), 2.24 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.2, 163.0, 160.8, 149.5, 138.1, 137.8, 125.3, 125.2 (q, <sup>3</sup><i>J</i><sub>CâF</sub> = 3.1 Hz), 125.0 (q, <sup>2</sup><i>J</i><sub>CâF</sub> = 32.1 Hz), 124.3 (q, <sup>1</sup><i>J</i><sub>CâF</sub> = 272.2 Hz), 120.0 (q, <sup>3</sup><i>J</i><sub>CâF</sub> = 4.5 Hz), 118.5, 117.5, 103.4, 67.3, 25.6, 21.1. UPLC-MS (A) (ESI) RT 2.08 min, <i>m</i>/<i>z</i> 389.2 [M + H]<sup>+</sup> (>95%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>20</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 389.1471; found, 389.1478.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-(3,5-Dimethylphenyl)-2-((2-methyl-6-(trifluoromethoxy)quinolin-4-yl)oxy)acetamide (<b>15</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 47% (157 mg, 0.39 mmol), mp 241 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.12 (s, 1H), 8.09 (d, <i>J</i> = 1.4 Hz, 1H), 8.00 (d, <i>J</i> = 9.1 Hz, 1H), 7.71 (dd, <i>J</i> = 9.1, 2.1 Hz, 1H), 7.24 (s, 2H), 7.00 (s, 1H), 6.74 (s, 1H), 5.03 (s, 2H), 2.61 (s, 3H), 2.24 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.2, 161.0, 160.2, 146.8, 144.9, 138.1, 137.8, 130.6, 125.3, 123.7, 120.2 (q, <sup>1</sup><i>J</i><sub>CâF</sub> = 256.9 Hz), 119.4, 117.5, 112.8, 103.1, 67.2, 25.4, 21.1. UPLC-MS (A) (ESI) RT 2.08 min, <i>m</i>/<i>z</i> 405.2 [M + H]<sup>+</sup> (>95%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>20</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 405.1421; found, 405.1418.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-(3,5-Dimethylphenyl)-2-((6-ethoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>16</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 9% (32 mg, 0.09 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.10 (s, 1H), 7.77 (d, <i>J</i> = 9.1 Hz, 1H), 7.48 (d, <i>J</i> = 2.8 Hz, 1H), 7.34 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 7.25 (s, 2H), 6.82 (s, 1H), 6.74 (s, 1H), 4.97 (s, 2H), 4.15 (q, <i>J</i> = 7.0 Hz, 2H), 2.54 (s, 3H), 2.24 (s, 6H), 1.40 (t, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.5, 159.4, 156.8, 155.5, 144.1, 138.2, 137.8, 129.5, 125.3, 121.8, 119.8, 117.4, 102.1, 100.7, 67.1, 63.4, 25.1, 21.1, 14.6. UPLC-MS (B) (ESI) RT 4.08 min, <i>m</i>/<i>z</i> 365.2 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-((6,7-Dimethoxy-2-methylquinolin-4-yl)oxy)-<i>N</i>-(3,5-dimethylphenyl)acetamide (<b>17</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 70% (244 mg, 0.64 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.09 (s, 1H), 7.44 (s, 1H), 7.26 (s, 1H), 7.26 (s, 2H), 6.73 (s, 1H), 6.72 (s, 1H), 4.96 (s, 2H), 3.90 (s, 6H), 2.52 (s, 3H), 2.24 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.6, 159.3, 157.0, 152.1, 148.1, 145.3, 138.2, 137.8, 125.2, 117.3, 113.2, 107.4, 100.6, 99.9, 67.0, 55.6, 55.5, 25.1, 21.1. UPLC-MS (A) (ESI) RT 1.94 min, <i>m</i>/<i>z</i> 381.3 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-(6-(Benzyloxy)-2-methylquinolin-4-yloxy)-<i>N</i>-(3,5-dimethylphenyl)acetamide (<b>18</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 48% (100 mg, 0.23 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.09 (s, 1H), 7.80 (d, <i>J</i> = 9.1 Hz, 1H), 7.63 (d, <i>J</i> = 2.8 Hz, 1H), 7.54â7.49 (m, 2H), 7.45â7.31 (m, 4H), 7.27 (s, 2H), 6.84 (s, 1H), 6.74 (s, 1H), 5.24 (s, 2H), 4.98 (s, 2H), 2.55 (s, 3H), 2.24 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.5, 159.5, 157.0, 155.3, 144.3, 138.2, 137.8, 136.8, 129.6, 128.4, 127.9, 127.8, 125.3, 121.9, 119.7, 117.4, 102.2, 101.6, 69.6, 67.1, 25.1, 21.1. UPLC-MS (A) (ESI) RT 1.82 min, <i>m</i>/<i>z</i> 427.5 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-(3,5-Dimethylphenyl)-2-(6-methoxy-2-(trifluoromethyl)quinolin-4-yloxy)acetamide (<b>19</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. Off-white solid; yield 72% (597 mg, 1.48 mmol), mp 201â202 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.18 (s, 1H), 8.05 (d, <i>J</i> = 9.2 Hz, 1H), 7.61 (d, <i>J</i> = 2.8 Hz, 1H), 7.57 (dd, <i>J</i> = 9.2, 2.9 Hz, 1H), 7.36 (s, 1H), 7.24 (s, 2H), 6.75 (s, 1H), 5.20 (s, 2H), 3.97 (s, 3H), 2.24 (s, 6H). <sup>13</sup>C NMR <b>(</b>101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.1, 161.3, 158.6, 145.1 (q, <sup>2</sup><i>J</i><sub>CâF</sub> = 33.5 Hz), 143.4, 138.1, 137.9, 130.8, 125.3, 123.8, 122.3, 121.7 (q, <sup>1</sup><i>J</i><sub>CâF</sub> = 275.4 Hz), 117.3, 99.9, 98.2, 67.6, 55.7, 21.1. UPLC-MS (B) (ESI) RT 4.60 min, <i>m</i>/<i>z</i> 405.6 [M + H]<sup>+</sup> (>95%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>20</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 405.1421; found, 405.1426.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-(3,5-Dimethylphenyl)-2-(6-(trifluoromethoxy)-2-(trifluoromethyl)quinolin-4-yloxy)acetamide (<b>20</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 39% (182 mg, 0.40 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.18 (s, 1H), 8.30 (d, <i>J</i> = 9.2 Hz, 1H), 8.24 (bs, 1H), 7.95 (dd, <i>J</i> = 8.8, 2.3 Hz, 1H), 7.54 (s, 1H), 7.23 (s, 2H), 6.75 (s, 1H), 5.25 (s, 2H), 2.24 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.8, 162.7, 148.5 (q, <sup>2</sup><i>J</i><sub>CâF</sub> = 33.9 Hz), 147.1, 145.9, 138.1, 137.9, 132.1, 125.5, 125.4, 121.6, 121.3 (q, <sup>1</sup><i>J</i><sub>CâF</sub> = 275.9 Hz), 120.1 (q, <sup>1</sup><i>J</i><sub>CâF</sub> = 258.5 Hz), 117.4, 112.8, 99.1, 67.9, 21.1. UPLC-MS (A) (ESI) RT 2.51 min, <i>m</i>/<i>z</i> 459.4 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-(3,5-Dimethylphenyl)-2-(6-ethoxy-2-(trifluoromethyl)quinolin-4-yloxy)acetamide (<b>21</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 77% (189 mg, 0.45 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.16 (s, 1H), 8.03 (d, <i>J</i> = 9.2 Hz, 1H), 7.59 (d, <i>J</i> = 2.8 Hz, 1H), 7.54 (dd, <i>J</i> = 9.2, 2.9 Hz, 1H), 7.35 (s, 1H), 7.24 (s, 2H), 6.74 (s, 1H), 5.18 (s, 2H), 4.23 (q, <i>J</i> = 7.0 Hz, 2H), 2.24 (s, 6H), 1.43 (t, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.1, 161.2, 157.8, 145.0 (q, <sup>2</sup><i>J</i><sub>CâF</sub> = 33.8 Hz), 143.3, 138.1, 137.8, 130.8, 125.3, 124.0, 122.3, 121.7 (q,<sup>1</sup><i>J</i><sub>CâF</sub> = 274.7 Hz), 117.3, 100.5, 98.1, 67.6, 63.8, 21.0, 14.5. UPLC-MS (A) (ESI) RT 2.28 min, <i>m</i>/<i>z</i> 419.4 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-(3,5-Dimethylphenyl)-2-((6-(trifluoromethyl)-[1,3]dioxolo[4,5-g]quinolin-8-yl)oxy)acetamide (<b>22</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 43% (217 mg, 0.52 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.11 (s, 1H), 7.63 (s, 1H), 7.47 (s, 1H), 7.29 (s, 1H), 7.23 (s, 2H), 6.74 (s, 1H), 6.29 (s, 2H), 5.12 (s, 2H), 2.24 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.2, 161.3, 152.0, 149.0, 146.2, 145.4 (q, <sup>2</sup><i>J</i><sub>CâF</sub> = 33.8 Hz), 138.1, 137.8, 125.4, 121.7 (q, <sup>1</sup><i>J</i><sub>CâF</sub> = 274.9 Hz), 117.7, 117.6, 105.2, 102.8, 97.5 (q, <sup>3</sup><i>J</i><sub>CâF</sub> = 2.4 Hz), 97.4, 67.6, 21.1. UPLC-MS (A) (ESI) RT 2.17 min, <i>m</i>/<i>z</i> 419.4 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-((2,8-Bis(trifluoromethyl)quinolin-4-yl)oxy)-<i>N</i>-(3,5-dimethylphenyl)acetamide (<b>23</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 50% (118 mg, 0.27 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.17 (s, 1H), 8.67 (d, <i>J</i> = 7.9 Hz, 1H), 8.35 (d, <i>J</i> = 7.2 Hz, 1H), 7.90 (t, <i>J</i> = 7.9 Hz, 1H), 7.61 (s, 1H), 7.24 (s, 2H), 6.74 (s, 1H), 5.27 (s, 2H), 2.24 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.8, 163.1, 148.4 (q, <sup>2</sup><i>J</i><sub>CâF</sub> = 33.8 Hz), 143.7, 138.1, 137.8, 130.2 (q, <sup>3</sup><i>J</i><sub>CâF</sub> = 5.2 Hz), 127.3, 127.1, 126.3 (q, <sup>2</sup><i>J</i><sub>CâF</sub> = 29.7 Hz), 125.4, 123.7 (q, <sup>1</sup><i>J</i><sub>CâF</sub> = 273.5 Hz), 121.8, 121.1 (q, <sup>1</sup><i>J</i><sub>CâF</sub> = 276.6 Hz), 117.4, 99.4, 67.9, 21.0. UPLC-MS (A) (ESI) RT 2.35 min, <i>m</i>/<i>z</i> 443.4 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-(3,5-Dimethylphenyl)-2-((6-methoxy-2-propylquinolin-4-yl)oxy)acetamide (<b>24</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 57% (197 mg, 0.52 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.10 (s, 1H), 7.80 (d, <i>J</i> = 9.1 Hz, 1H), 7.50 (d, <i>J</i> = 2.8 Hz, 1H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 7.24 (s, 2H), 6.84 (s, 1H), 6.73 (s, 1H), 4.99 (s, 2H), 3.89 (s, 3H), 2.81â2.72 (m, 2H), 2.23 (s, 6H), 1.80â1.66 (m, 2H), 0.91 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.6, 160.6, 159.5, 156.3, 144.2, 138.2, 137.8, 129.7, 125.3, 121.5, 120.0, 117.4, 101.7, 100.0, 67.2, 55.4, 40.5, 22.3, 21.1, 13.8. UPLC-MS (A) (ESI) RT 2.01 min, <i>m</i>/<i>z</i> 379.3 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-Bromo-2-phenylacetyl Chloride (<b>25d</b>)</h4><div class="NLM_p last">The title compound was prepared according to the literature.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Phenylacetyl chloride (0.428 mL, 3.23 mmol), <i>N</i>-bromosuccinimide (576 mg, 3.23 mmol), and (<i>E</i>)-azobis(isobutyronitrile) (31.9 mg, 0.194 mmol) were taken up in CCl<sub>4</sub> (volume: 3.7 mL), and the resulting mixture was heated at 80 Â°C for 6 h. The reaction mixture was then cooled to ambient temperature, followed by addition of <i>n</i>-heptane. The solid that precipitated was removed by filtration, and the filtrate was concentrated under reduced pressure to yield the target compound as a yellow oil. The yellow oil was used directly for the next step without further purification.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-(3,5-Dimethylphenyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)propanamide (<b>27</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure F. White solid; yield 49% (140 mg, 0.38 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.09 (s, 1H), 7.77 (d, <i>J</i> = 9.1 Hz, 1H), 7.49 (d, <i>J</i> = 2.9 Hz, 1H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 7.24 (s, 2H), 6.74 (s, 1H), 6.73 (s, 1H), 5.16 (q, <i>J</i> = 6.5 Hz, 1H), 3.90 (s, 3H), 2.51 (s, 3H), 2.22 (s, 6H), 1.69 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 168.8, 158.9, 156.7, 156.2, 144.3, 138.2, 137.8, 129.5, 125.3, 121.5, 119.9, 117.5, 102.3, 100.3, 73.9, 55.4, 25.2, 21.0, 18.4. UPLC-MS (A) (ESI) RT 1.83 min, <i>m</i>/<i>z</i> 365.3 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-(3,5-Dimethylphenyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)-2-methylpropanamide (<b>28</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure F. White solid; yield 25% (99 mg, 0.26 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.82 (s, 1H), 7.76 (d, <i>J</i> = 9.1 Hz, 1H), 7.51 (d, <i>J</i> = 2.7 Hz, 1H), 7.36 (dd, <i>J</i> = 9.1, 2.8 Hz, 1H), 7.21 (s, 2H), 6.72 (s, 1H), 6.54 (s, 1H), 3.91 (s, 3H), 2.47 (s, 3H), 2.21 (s, 6H), 1.74 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 171.3, 156.8, 156.2, 156.2, 144.5, 138.1, 137.5, 129.5, 125.5, 121.3, 121.2, 118.5, 105.5, 100.9, 81.3, 55.3, 25.1, 24.5, 21.0. UPLC-MS (A) (ESI) RT 1.62 min, <i>m</i>/<i>z</i> 379.2 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i>-(3,5-Dimethylphenyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)butanamide (<b>29</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure F. White solid; yield 15% (60 mg, 0.16 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.09 (s, 1H), 7.77 (d, <i>J</i> = 9.1 Hz, 1H), 7.51 (d, <i>J</i> = 2.9 Hz, 1H), 7.36 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 7.23 (s, 2H), 6.73 (s, 1H), 6.72 (s, 1H), 4.96 (t, <i>J</i> = 6.3 Hz, 1H), 3.90 (s, 3H), 2.51 (s, 3H, overlaps with solventâs peak), 2.22 (s, 6H), 2.10 (tt, <i>J</i> = 8.6, 4.9 Hz, 2H), 1.10 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 168.2, 159.2, 156.7, 156.3, 144.3, 138.1, 137.8, 129.5, 125.4, 121.5, 120.0, 117.6, 102.3, 100.3, 78.8, 55.4, 25.9, 25.2, 21.0, 9.6. UPLC-MS (A) (ESI) RT 2.15 min, <i>m</i>/<i>z</i> 379.3 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-(3,5-Dimethylphenyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)-2-phenylacetamide (<b>30</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure F. White solid; yield 14% (63 mg, 0.15 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.37 (s, 1H), 7.78 (t, <i>J</i> = 8.4 Hz, 3H), 7.60 (d, <i>J</i> = 2.9 Hz, 1H), 7.53â7.45 (m, 2H), 7.45â7.36 (m, 2H), 7.21 (s, 2H), 6.81 (s, 1H), 6.72 (s, 1H), 6.18 (s, 1H), 3.92 (s, 3H), 2.52 (s, 3H), 2.21 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.6, 158.6, 156.7, 156.4, 144.3, 138.0, 137.9, 136.1, 129.6, 128.9, 128.8, 126.9, 125.6, 121.5, 120.0, 117.5, 102.7, 100.5, 78.8, 55.4, 25.2, 21.0. UPLC-MS (A) (ESI) RT 1.79 min, <i>m</i>/<i>z</i> 427.2 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 6-Methoxy-2-methyl-4-(quinolin-2-ylmethoxy)quinoline (<b>31</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. Off-white solid; yield 81% (349 mg, 0.86 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.46 (d, <i>J</i> = 8.5 Hz, 1H), 8.05 (d, <i>J</i> = 8.5 Hz, 1H), 8.02 (dd, <i>J</i> = 8.2, 1.0 Hz, 1H), 7.86â7.75 (m, 3H), 7.64 (ddd, <i>J</i> = 8.1, 6.9, 1.2 Hz, 1H), 7.50 (d, <i>J</i> = 2.9 Hz, 1H), 7.36 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 7.03 (s, 1H), 5.65 (s, 2H), 3.89 (s, 3H), 2.53 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 159.5, 157.0, 156.7, 156.4, 147.0, 144.2, 137.3, 130.0, 129.6, 128.6, 128.0, 127.3, 126.7, 121.4, 119.8, 119.4, 102.7, 99.8, 71.1, 55.4, 25.1. UPLC-MS (A) (ESI) RT 1.44 min, <i>m</i>/<i>z</i> 331.4 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 3-((6-Methoxy-2-methylquinolin-4-yl)oxy)-1-phenylpyrrolidin-2-one (<b>32</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. Light-brown solid; yield 20% (75 mg, 0.22 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.83â7.73 (m, 3H), 7.46â7.41 (m, 2H), 7.39 (d, <i>J</i> = 2.8 Hz, 1H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 7.25â7.17 (m, 1H), 7.12 (s, 1H), 5.60 (t, <i>J</i> = 8.4 Hz, 1H), 4.06â3.88 (m, 2H), 3.87 (s, 3H), 2.94â2.81 (m, 1H), 2.58 (s, 3H), 2.36â2.22 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 169.4, 159.0, 156.9, 156.3, 144.3, 139.1, 129.6, 128.8, 124.7, 121.6, 119.8, 119.5, 103.4, 99.7, 75.8, 55.4, 44.1, 25.4, 25.1. UPLC-MS (A) (ESI) RT 1.43 min, <i>m</i>/<i>z</i> 349.4 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 6-Methoxy-2-methyl-3-nitroquinolin-4-ol (<b>33</b>)</h4><div class="NLM_p last">A suspension of <b>5a</b> (1 g, 5.29 mmol) in propionic acid (12 mL) was heated at 110 Â°C. Nitric acid (0.236 mL, 5.29 mmol) was then added dropwise, and the reaction mixture was heated for 2 h at 110 Â°C with vigorous stirring. The resulting suspension was cooled to room temperature, and the solid was collected by filtration, washed with cold ethanol, and dried. It was used in the next step without purification. Yield 76% (942 mg, 4.02 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 12.42 (s, 1H), 7.58 (d, <i>J</i> = 9.0 Hz, 1H), 7.53 (d, <i>J</i> = 2.9 Hz, 1H), 7.40 (dd, <i>J</i> = 9.0, 3.0 Hz, 1H), 3.86 (s, 3H), 2.50 (s, 3H, ovelaps with solventâs peak). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.7, 156.6, 145.4, 135.0, 132.9, 126.6, 123.3, 120.4, 105.0, 55.6, 16.8. UPLC-MS (A) (ESI) RT 1.24 min, <i>m</i>/<i>z</i> 234.9 [M + H]<sup>+</sup> (95%).</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 3-Amino-6-methoxy-2-methylquinolin-4-ol (<b>34</b>)</h4><div class="NLM_p last">Zinc (Zn) was purified by stirring 1 g of commercial zinc dust with 5 mL of 2% hydrochloric acid (HCl) for 1 min. The acid was removed by filtration, and the zinc was washed with one 5 mL portion of 2% hydrochloric acid, three 5 mL portions of distilled water, two 5 mL portions of 95% ethanol, and finally with one 5 mL portion of absolute ether, the wash solutions being removed each time by filtration. Then the material was quickly dried on air. 6-Methoxy-2-methyl-3-nitroquinolin-4-ol (1612 mg, 6.88 mmol) was dissolved in a 2:1 mixture of THF and saturated aqueous NH<sub>4</sub>Cl (60 mL). The mixture was treated with the zinc at vigorous stirring to keep the Zn dust in a suspension and to prevent it from caking on the bottom of flask. The reaction mixture was stirred at room temperature for 1 h. The reaction mixture was filtered through GF/F paper while rinsing with THF. The filtrate was evaporated under reduced pressure, and the residue was purified by column chromatography reverse phase using MeOH/H<sub>2</sub>O 50:50. Yellow solid; yield 16% (227 mg, 1.11 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 11.34 (s, 1H), 7.45â7.37 (m, 2H), 7.12 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 4.16 (s, 2H), 3.79 (s, 3H), 2.33 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 167.7, 154.1, 132.0, 129.3, 127.7, 121.6, 120.6, 119.3, 103.0, 55.1, 15.7. UPLC-MS (A) (ESI) RT 0.39 min, <i>m</i>/<i>z</i> 205.3 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 2-((3,5-Dimethylphenyl)amino)-2-oxoacetyl chloride (<b>35</b>)</h4><div class="NLM_p last">3,5-Xylidine (5.14 mL, 41.3 mmol) was added dropwise to oxalyl chloride (34.9 mL, 41.3 mmol) at 0 Â°C, and the resulting mixture was stirred for 1 h. The excess oxalyl chloride was removed under vacuum. Diethyl ether was added to the residue, and the solids were filtered off. The filtrate was evaporated under reduced pressure, and hexane was added to the residue. After vigorous stirring for 30 min, the insoluble material was filtered, washed with pentane, and dried under vacuum to give the target compound. Yield 38% (3.305 g, 15.6 mmol). It was used directly for next step without further purification.</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>N</i>1-(3,5-Dimethylphenyl)-<i>N</i>2-(4-hydroxy-6-methoxy-2-methylquinolin-3-yl)oxalamide (<b>36</b>)</h4><div class="NLM_p last">The title compound was prepared according to the procedure described by H. Kokatla et al.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Compound <b>34</b> (200 mg, 0.98 mmol) was dissolved in a mixture of anhydrous DCM/anhydrous DMF 10/1 (volume: 22 mL) and stirred at room temperature for 5 min. Compound <b>35</b> (435 mg, 1.44 mmol) was added to the stirring solution at 0 Â°C, and the reaction mixture was allowed to react for 1 h at 0 Â°C. Solvents were removed, and the residue was purified by silica gel column chromatography. Off-white solid; 54% (201 mg, 0.53 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.52 (s, 1H), 9.69 (s, 1H), 7.53 (d, <i>J</i> = 9.0 Hz, 1H), 7.50â7.46 (m, 3H), 7.31 (dd, <i>J</i> = 9.0, 3.0 Hz, 1H), 6.81 (s, 1H), 3.84 (s, 3H), 2.32 (s, 3H), 2.27 (s, 6H). UPLC-MS (A) (ESI) RT 1.61 min, <i>m</i>/<i>z</i> 380.4 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>N</i>-(3,5-Dimethylphenyl)-8-methoxy-4-methylthiazolo[4,5-<i>c</i>]quinoline-2-carbothioamide (<b>37</b>)</h4><div class="NLM_p last">The title compound was prepared using the procedure described by H. Kokatla et al.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> according to which compound <b>36</b> (100 mg, 0.26 mmol) was suspended in anhydrous pyridine (10 mL) and phosphorus pentasulfide (586 mg, 1.31 mmol) was added, and the reaction mixture was left stirring under reflux overnight. Pyridine was evaporated, and the obtained residue was dissolved in water. The pH was adjusted to 8 using saturated aqueous solution of potasium carbonate, and the target compound was extracted with EtOAc. It was purified by silica gel and reverse phase column chromatography. Off-white solid; 19% (20 mg, 0.05 mmol). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 10.82 (s, 1H), 8.06 (d, <i>J</i> = 9.1 Hz, 1H), 7.67 (s, 2H), 7.37 (dd, <i>J</i> = 9.2, 2.8 Hz, 1H), 7.25 (d, <i>J</i> = 2.7 Hz, 1H), 6.97 (s, 1H), 3.97 (s, 3H), 3.08 (s, 3H), 2.40 (s, 6H). UPLC-MS (A) (ESI) RT 2.54 min, <i>m</i>/<i>z</i> 394.4 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>N</i>1-(3,5-Dimethylphenyl)-<i>N</i>2-(6-methoxy-2-methylquinolin-4-yl)oxalamide (<b>40</b>)</h4><div class="NLM_p last">6-Methoxy-2methyl-4-quinolinamine (200 mg, 1.06 mmol) was allowed to react with sodium hydride (NaH) and 60% mineral oil (85 mg, 1.28 mmol) in anhydrous DMF (10 mL) for 20 min at room temperature. Subsequently, 2-((3,5-dimethylphenyl)amino)-2-oxoacetyl chloride (<b>36</b>) (321 mg, 1.06 mmol) was added to the mixture and left stirring overnight at room temperature. The reaction mixture was poured into water (80 mL), and the formed precipitate was filtered and washed with water (10 mL Ã 3). It was further purified by silica gel column chromatography. White solid; yield 12% (45 mg, 0.12 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.94 (br s, 1H), 10.72 (s, 1H), 7.87 (d, <i>J</i> = 9.1 Hz, 1H), 7.73 (s, 1H), 7.51 (s, 2H), 7.40 (dd, <i>J</i> = 9.1, 2.7 Hz, 1H), 7.35 (d, <i>J</i> = 2.7 Hz, 1H), 6.83 (s, 1H), 3.91 (s, 3H), 2.63 (s, 3H), 2.28 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 159.8, 158.2, 156.6, 155.9, 144.3, 139.4, 137.8, 137.4, 130.2, 126.3, 121.7, 121.3, 118.2, 115.4, 101.1, 55.5, 24.7, 21.1. UPLC-MS (A) (ESI) RT 1.66 min, <i>m</i>/<i>z</i> 364.4 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> <i>N</i>-(3,5-Dimethylbenzyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>42</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. Off-white solid; yield 64% (117 mg, 0.32 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.72 (t, <i>J</i> = 6.0 Hz, 1H), 7.79 (d, <i>J</i> = 9.1 Hz, 1H), 7.54 (d, <i>J</i> = 2.8 Hz, 1H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 6.85 (s, 3H), 6.80 (s, 1H), 4.86 (s, 2H), 4.32 (d, <i>J</i> = 6.0 Hz, 2H), 3.89 (s, 3H), 2.54 (s, 3H), 2.22 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.9, 159.3, 156.8, 156.2, 144.2, 139.1, 137.2, 129.5, 128.2, 124.9, 121.4, 119.7, 102.3, 100.5, 67.2, 55.4, 41.8, 25.1, 20.9. UPLC-MS (A) (ESI) RT 1.60 min, <i>m</i>/<i>z</i> 365.5 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 4-Bromo-6-methoxy-2-methylquinoline (<b>43</b>)</h4><div class="NLM_p last">Phosphorus tribromide (1.994 mL, 21.14 mmol) was added slowly to a suspension of 6-methoxy-4-hydroxy-2-methyl-quinoline (<b>5a</b>) (1 g, 5.29 mmol) in DMF (20 mL) at ambient temperature. The reaction mixture was stirred under nitrogen at 50 Â°C for 4 days. The mixture was quenched with water and stirred for 30 min. The reaction mixture was made basic by addition of KHCO<sub>3</sub>, and the formed precipitate was filtered and dried. Yellow solid; yield 86% (1.141 g, 4.53 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.89 (d, <i>J</i> = 9.1 Hz, 1H), 7.82 (s, 1H), 7.45 (dd, <i>J</i> = 9.1, 2.8 Hz, 1H), 7.34 (d, <i>J</i> = 2.8 Hz, 1H), 3.93 (s, 3H), 2.60 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 157.9, 156.3, 143.8, 131.4, 130.6, 126.3, 126.0, 122.7, 104.1, 55.6, 24.0. UPLC-MS (A) (ESI) RT 1.43 min, <i>m</i>/<i>z</i> 251.8, 253.8 (1:1) [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 2-((3,5-Dimethylphenyl)amino)ethanol (<b>44</b>)</h4><div class="NLM_p last">Glycolbromohydrin (681 mg, 5.45 mmol) was added to 3,5-xylidine (1 g, 8.25 mmol), and the reaction mixture was heated at 90 Â°C for 4 h. The resulting solid was dissolved in ethyl acetate and washed with 2 M aqueous NaOH, followed by brine and dried over MgSO<sub>4</sub>. The solvent was removed under reduced pressure, and the residue was purified through a silica gel flash column using <i>n</i>-heptane/EtOAc gradient from 20 to 40% to yield the desired compound. Brown liquid; yield 43% (587 mg, 3.55 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 6.18 (s, 2H), 6.17 (s, 1H), 5.23 (t, <i>J</i> = 5.7 Hz, 1H), 4.63 (t, <i>J</i> = 5.5 Hz, 1H), 3.52 (q, <i>J</i> = 6.1 Hz, 2H), 3.04 (q, <i>J</i> = 6.1 Hz, 2H), 2.12 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 148.9, 137.6, 117.6, 110.0, 59.6, 45.6, 21.3. UPLC-MS (A) (ESI) RT 0.97 min, <i>m</i>/<i>z</i> 166.0 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> <i>N</i>-(2-((6-Methoxy-2-methylquinolin-4-yl)oxy)ethyl)-3,5-dimethylaniline (<b>45</b>)</h4><div class="NLM_p last">4-Bromo-6-methoxy-2-methylquinoline (<b>43</b>) (200 mg, 0.793 mmol) and 2-((3,5-dimethylphenyl) amino) ethanol (<b>44</b>) (131 mg, 0.793 mmol), TMEDA (9.22 mg, 0.079 mmol), copper(I)iodide (15.11 mg, 0.079 mmol), and cesium carbonate (517 mg, 1.587 mmol) were placed in anhydrous DMF (4 mL) in a high pressure tube under nitrogen atmosphere. The reaction mixture was stirred at 95 Â°C for 2 d, cooled down, and filtered. The filtrate was evaporated, and the residue was dissolved in DCM (50 mL) and washed with brine (30 mL Ã 3). The organic layer was dried over MgSO<sub>4</sub> and evaporated under reduced pressure. The residue was purified by silica gel column chromatography. Light-yellow solid; yield 17% (45 mg, 0.13 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.74 (d, <i>J</i> = 9.1 Hz, 1H), 7.40 (d, <i>J</i> = 2.9 Hz, 1H), 7.31 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 6.89 (s, 1H), 6.30 (s, 2H), 6.19 (s, 1H), 5.72 (t, <i>J</i> = 6.2 Hz, 1H), 4.31 (t, <i>J</i> = 5.4 Hz, 2H), 3.83 (s, 3H), 3.57 (q, <i>J</i> = 5.6 Hz, 2H), 2.54 (s, 3H), 2.13 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 159.9, 157.1, 156.5, 148.5, 144.0, 137.7, 129.4, 121.2, 119.9, 117.9, 110.1, 102.0, 100.3, 67.3, 55.4, 41.8, 25.0, 21.3. UPLC-MS (A) (ESI) RT 1.63 min, <i>m</i>/<i>z</i> 337.4 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Ethyl 2-((6-Methoxy-2-methylquinolin-4-yl)amino)acetate (<b>46a</b>)</h4><div class="NLM_p last">4-Bromo-6-methoxy-2-methyl quinoline (<b>43</b>) (250 mg, 0.992 mmol), glycine ethyl ester hydrochloride (277 mg, 1.983 mmol), and phenol (900 mg, 9.56 mmol) were placed in a round-bottom flask and heated at 120 Â°C under magnetic stirring overnight. The reaction mixture was cooled at room temperature and diluted with EtOAc. The formed precipitate was filtered off and washed with EtOAc. The target compound was purified by column chromatography using as eluent EtOAc/<i>n</i>-heptane gradient from 50 to 100%. Off-white solid; yield 55% (150 mg, 0.55 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.63 (d, <i>J</i> = 9.1 Hz, 1H), 7.50 (d, <i>J</i> = 2.7 Hz, 1H), 7.33 (t, <i>J</i> = 6.3 Hz, 1H), 7.23 (dd, <i>J</i> = 9.1, 2.7 Hz, 1H), 6.17 (s, 1H), 4.22â4.10 (m, 4H), 3.87 (s, 3H), 2.40 (s, 3H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 170.5, 155.9, 155.5, 149.1, 143.5, 129.8, 120.3, 117.8, 100.7, 98.7, 60.5, 55.5, 44.1, 24.9, 14.2. UPLC-MS (A) (ESI) RT 1.27 min, <i>m</i>/<i>z</i> 275.4 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Potassium 2-((6-Methoxy-2-methylquinolin-4-yl)amino)acetate (<b>46b</b>)</h4><div class="NLM_p last">In a round-bottom flask, ethyl 2-((6-methoxy-2-methylquinolin-4-yl)amino)acetate (<b>46a</b>) (150 mg, 0.547 mmol) was dissolved in methanol (volume: 10 mL). Potassium hydroxide (92 mg, 1.640 mmol) was added to the reaction mixture and left stirring under reflux for 1.5 h. Then methanol was evaporated under reduced pressure to yield 250 mg of the crude, which was directly used for the next step. Off-white solid. <sup>1</sup>H NMR (400 MHz, MeOD) Î´ 7.68 (d, <i>J</i> = 9.2 Hz, 1H), 7.37 (d, <i>J</i> = 2.7 Hz, 1H), 7.24 (dd, <i>J</i> = 10.3, 3.8 Hz, 1H), 6.28 (s, 1H), 3.94 (s, 3H), 3.84 (s, 2H), 2.50 (s, 3H). UPLC-MS (A) (ESI) RT 0.89, <i>m</i>/<i>z</i> 247.3 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> <i>N</i>-(3,5-Dimethylphenyl)-2-((6-methoxy-2-methylquinolin-4-yl)amino)acetamide (<b>47</b>)</h4><div class="NLM_p last">The title compound was prepared according to general procedure H. Off-white solid; yield 65% (125 mg, 0.36 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.96 (s, 1H), 7.64 (d, <i>J</i> = 9.1 Hz, 1H), 7.54 (d, <i>J</i> = 2.7 Hz, 1H), 7.33 (t, <i>J</i> = 6.0 Hz, 1H), 7.28â7.20 (m, 3H), 6.70 (s, 1H), 6.23 (s, 1H), 4.10 (d, <i>J</i> = 6.1 Hz, 2H), 3.89 (s, 3H), 2.40 (s, 3H), 2.22 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 168.1, 155.9, 155.5, 149.5, 143.5, 138.7, 137.7, 129.7, 124.9, 120.3, 117.9, 117.1, 100.9, 98.7, 55.6, 46.3, 25.0, 21.1. UPLC-MS (A) (ESI) RT 1.53 min, <i>m</i>/<i>z</i> 350.4 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 2-((6-Methoxy-2-methylquinolin-4-yl)oxy)-<i>N</i>-phenylacetamide (<b>49</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. Off-white solid; yield 29% (75 mg, 0.23 mmol), mp 221â222 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.26 (s, 1H), 7.78 (d, <i>J</i> = 9.1 Hz, 1H), 7.64 (dd, <i>J</i> = 8.5, 1.0 Hz, 2H), 7.51 (d, <i>J</i> = 2.8 Hz, 1H), 7.39â7.29 (m, 3H), 7.14â7.05 (m, 1H), 6.86 (s, 1H), 5.01 (s, 2H), 3.90 (s, 3H), 2.55 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.7, 159.5, 156.9, 156.2, 144.2, 138.4, 129.5, 128.8, 123.8, 121.6, 119.7, 119.6, 102.2, 100.1, 67.1, 55.4, 25.1. UPLC-MS (A) (ESI) RT 1.66 min, <i>m</i>/<i>z</i> 323.2 [M + H]<sup>+</sup> (>95%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 323.1390; found, 323.1380.</div></div><div id="sec4_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 2-((6-Methoxy-2-methylquinolin-4-yl)oxy)-<i>N</i>-(<i>m</i>-tolyl)acetamide (<b>50</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. Off-white solid; yield 58% (155 mg, 0.46 mmol), mp 142â144 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.19 (s, 1H), 7.78 (d, <i>J</i> = 9.1 Hz, 1H), 7.57â7.46 (m, 2H), 7.41 (d, <i>J</i> = 8.0 Hz, 1H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 7.21 (t, <i>J</i> = 7.8 Hz, 1H), 6.91 (d, <i>J</i> = 7.5 Hz, 1H), 6.84 (s, 1H), 5.00 (s, 2H), 3.89 (s, 3H), 2.54 (s, 3H), 2.28 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.58, 159.47, 156.85, 156.25, 144.22, 138.30, 138.02, 129.51, 128.65, 124.44, 121.59, 120.15, 119.75, 116.82, 102.19, 100.08, 67.07, 55.40, 25.10, 21.17. UPLC-MS (A) (ESI) RT 1.55 min, <i>m</i>/<i>z</i> 337.2 [M + H]<sup>+</sup> (>95%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 337.1547; found, 337.1533.</div></div><div id="sec4_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> <i>N</i>-(2,5-Dimethylphenyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>51</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 35% (97 mg, 0.28 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.57 (s, 1H), 7.79 (d, <i>J</i> = 9.1 Hz, 1H), 7.55 (d, <i>J</i> = 2.9 Hz, 1H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 7.30 (s, 1H), 7.11 (d, <i>J</i> = 7.7 Hz, 1H), 6.94 (d, <i>J</i> = 7.6 Hz, 1H), 6.90 (s, 1H), 5.01 (s, 2H), 3.90 (s, 3H), 2.57 (s, 3H), 2.26 (s, 3H), 2.18 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.9, 159.5, 157.1, 156.5, 144.4, 135.5, 135.3, 130.4, 129.7, 129.0, 126.5, 125.9, 121.9, 119.9, 102.6, 100.4, 67.5, 55.6, 25.3, 20.8, 17.5. UPLC-MS (A) (ESI) RT 1.66 min, <i>m</i>/<i>z</i> 351.2 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> <i>N</i>-(2,6-Dimethylphenyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>52</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. Off-white solid; yield 73% (204 mg, 0.58 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.67 (s, 1H), 7.79 (d, <i>J</i> = 9.1 Hz, 1H), 7.58 (d, <i>J</i> = 2.8 Hz, 1H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 7.12â7.06 (m, 3H), 6.90 (s, 1H), 5.03 (s, 2H), 3.89 (s, 3H), 2.57 (s, 3H), 2.17 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.6, 159.3, 156.8, 156.3, 144.2, 135.4, 134.3, 129.5, 127.8, 126.8, 121.7, 119.8, 102.4, 100.4, 67.3, 55.4, 25.0, 18.1. UPLC-MS (A) (ESI) RT 1.45 min, <i>m</i>/<i>z</i> 351.5 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 2-((6-Methoxy-2-methylquinolin-4-yl)oxy)-<i>N</i>-(3-methoxyphenyl)acetamide (<b>53</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 28% (77 mg, 0.22 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.27 (s, 1H), 7.78 (d, <i>J</i> = 9.1 Hz, 1H), 7.50 (d, <i>J</i> = 2.8 Hz, 1H), 7.38â7.32 (m, 2H), 7.24 (t, <i>J</i> = 8.1 Hz, 1H), 7.20â7.15 (m, 1H), 6.85 (s, 1H), 6.68 (ddd, <i>J</i> = 8.1, 2.5, 1.0 Hz, 1H), 5.01 (s, 2H), 3.89 (s, 3H), 3.73 (s, 3H), 2.54 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.7, 159.5, 159.5, 156.9, 156.3, 144.2, 139.6, 129.6, 129.5, 121.6, 119.7, 111.8, 109.2, 105.4, 102.2, 100.1, 67.0, 55.4, 55.0, 25.1. UPLC-MS (A) (ESI) RT 1.48 min, <i>m</i>/<i>z</i> 353.5 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 2-((6-Methoxy-2-methylquinolin-4-yl)oxy)-<i>N</i>-(4-methoxyphenyl)acetamide (<b>54</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 85% (238 mg, 0.68 mmol), mp 205â207 Â°C. <sup>1</sup>H NMR (400 MHz, MeOD) Î´ 7.79 (d, <i>J</i> = 9.2 Hz, 1H), 7.65 (d, <i>J</i> = 2.8 Hz, 1H), 7.55â7.46 (m, 2H), 7.36 (dd, <i>J</i> = 9.2, 2.9 Hz, 1H), 6.95â6.87 (m, 2H), 6.84 (s, 1H), 4.95 (s, 2H), 3.95 (s, 3H), 3.78 (s, 3H), 2.62 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 167.8, 161.9, 158.8, 158.7, 158.4, 145.2, 131.9, 129.3, 123.6, 123.5, 121.7, 115.1, 103.3, 101.4, 68.7, 56.1, 55.9, 24.8. UPLC-MS (A) (ESI) RT 1.40 min, <i>m</i>/<i>z</i> 353.5 [M + H]<sup>+</sup> (>95%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>21</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 353.1496; found, 353.1494.</div></div><div id="sec4_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 2-((6-Methoxy-2-methylquinolin-4-yl)oxy)-<i>N</i>-(4-methoxy-3,5-dimethylphenyl)acetamide (<b>55</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 60% (180 mg, 0.47 mmol), mp 202â204 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.05 (s, 1H), 7.78 (d, <i>J</i> = 9.1 Hz, 1H), 7.50 (d, <i>J</i> = 2.8 Hz, 1H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 7.28 (s, 2H), 6.83 (s, 1H), 4.97 (s, 2H), 3.89 (s, 3H), 3.61 (s, 3H), 2.54 (s, 3H), 2.19 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.3, 159.5, 156.8, 156.2, 152.7, 144.2, 133.8, 130.4, 129.5, 121.6, 120.1, 119.8, 102.2, 100.1, 67.1, 59.4, 55.4, 25.1, 16.0. UPLC-MS (A) (ESI) RT 1.79 min, <i>m</i>/<i>z</i> 381.3 [M + H]<sup>+</sup> (>95%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>25</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 381.1809; found, 381.1798.</div></div><div id="sec4_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 2-((6-Methoxy-2-methylquinolin-4-yl)oxy)-<i>N</i>-(2-methoxy-5-methylphenyl)acetamide (<b>56</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. Off-white solid; yield 32% (94 mg, 0.26 mmol), mp 193â194 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.32 (s, 1H), 7.93 (s, 1H), 7.81 (d, <i>J</i> = 9.1 Hz, 1H), 7.50 (d, <i>J</i> = 2.3 Hz, 1H), 7.39 (dd, <i>J</i> = 9.1, 2.8 Hz, 1H), 7.00â6.87 (m, 3H), 5.04 (s, 2H), 3.91 (s, 3H), 3.80 (s, 3H), 2.56 (s, 3H), 2.23 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.4, 158.9, 157.0, 156.4, 147.1, 144.2, 129.7, 129.3, 126.2, 124.9, 121.5, 121.3, 119.6, 111.1, 102.5, 100.1, 67.0, 55.9, 55.5, 25.1, 20.5. UPLC-MS (A) (ESI) RT 1.61 min, <i>m</i>/<i>z</i> 367.3 [M + H] <sup>+</sup> (>95%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 367.1652; found, 367.1653.</div></div><div id="sec4_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> <i>N</i>-(4-Fluoro-3,5-dimethylphenyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>57</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 68% (198 mg, 0.54 mmol), mp 207â210 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.14 (s, 1H), 7.78 (d, <i>J</i> = 9.1 Hz, 1H), 7.50 (d, <i>J</i> = 2.8 Hz, 1H), 7.39â7.31 (m, 3H), 6.84 (s, 1H), 4.98 (s, 2H), 3.89 (s, 3H), 2.54 (s, 3H), 2.19 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.5, 159.5, 156.9, 156.2, 155.5 (d, <sup>1</sup><i>J</i><sub>CâF</sub> = 238.3 Hz), 144.2, 133.7 (d, <sup>4</sup><i>J</i><sub>CâF</sub> = 3.2 Hz), 129.5, 123.9 (d, <sup>2</sup><i>J</i><sub>CâF</sub> = 18.8 Hz), 121.6, 120.3 (d, <sup>3</sup><i>J</i><sub>CâF</sub> = 4.4 Hz), 119.8, 102.2, 100.1, 67.0, 55.4, 25.1, 14.5 (d, <sup>3</sup><i>J</i><sub>CâF</sub> = 3.6 Hz). UPLC-MS (A) (ESI) RT 1.84 min, <i>m</i>/<i>z</i> 369.2 [M + H]<sup>+</sup> (>95%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>22</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 369.1609; found, 369.1610.</div></div><div id="sec4_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> <i>N</i>-(4-Bromo-3-methylphenyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>58</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. Yellowish solid; yield 54% (178 mg, 0.43 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.33 (s, 1H), 7.78 (d, <i>J</i> = 9.1 Hz, 1H), 7.66 (d, <i>J</i> = 2.3 Hz, 1H), 7.53 (d, <i>J</i> = 8.7 Hz, 1H), 7.50 (d, <i>J</i> = 2.9 Hz, 1H), 7.41 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 6.85 (s, 1H), 5.01 (s, 2H), 3.89 (s, 3H), 2.54 (s, 3H), 2.32 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.8, 159.4, 156.8, 156.2, 144.2, 137.9, 137.5, 132.3, 129.5, 121.9, 122.0, 119.7, 119.1, 117.9, 102.2, 100.1, 67.0, 55.4, 25.1, 22.7. UPLC-MS (A) (ESI) RT 1.75 min, <i>m</i>/<i>z</i> 415.4, 417.4 (1:1) [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> <i>N</i>-(3,5-Difluorophenyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>59</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 53% (151 mg, 0.42 mmol), mp 175â176 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.64 (s, 1H), 7.78 (d, <i>J</i> = 9.1 Hz, 1H), 7.50 (d, <i>J</i> = 2.9 Hz, 1H), 7.44â7.31 (m, 3H), 6.97 (tt, <i>J</i> = 9.4, 2.4 Hz, 1H), 6.86 (s, 1H), 5.04 (s, 2H), 3.89 (s, 3H), 2.55 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.5, 162.4 (dd, <sup>1</sup><i>J</i><sub>CâF</sub> = 243.5 Hz, <sup>3</sup><i>J</i><sub>CâF</sub> = 15.3 Hz), 159.3, 156.9, 156.3, 144.2, 140.9 (t, <sup>3</sup><i>J</i><sub>CâF</sub> = 13.8 Hz), 129.5, 121.6, 119.7, 102.5 (d, <sup>2</sup><i>J</i><sub>CâF</sub> = 29.7 Hz), 102.3, 100.1, 98.9 (t, <sup>2</sup><i>J</i><sub>CâF</sub> = 26.0 Hz), 66.9, 55.4, 25.1. UPLC-MS (A) (ESI) RT 1.93 min, <i>m</i>/<i>z</i> 359.2 [M + H]<sup>+</sup> (>95%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>17</sub>F<sub>2</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 359.1202; found, 359.1209.</div></div><div id="sec4_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> <i>N</i>-(2,4-Dichlorophenyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>60</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. Off-white solid; yield 2% (9 mg, 0.02 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.86 (s, 1H), 7.88 (d, <i>J</i> = 8.7 Hz, 1H), 7.79 (d, <i>J</i> = 9.1 Hz, 1H), 7.73 (d, <i>J</i> = 2.4 Hz, 1H), 7.54 (d, <i>J</i> = 2.8 Hz, 1H), 7.47 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 7.36 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 6.92 (s, 1H), 5.07 (s, 2H), 3.90 (s, 3H), 2.56 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.2, 159.0, 156.9, 156.3, 144.2, 133.3, 129.9, 129.6, 129.0, 127.8, 127.4, 126.8, 121.7, 119.6, 102.5, 100.0, 67.1, 55.4, 25.1. UPLC-MS (A) (ESI) RT 1.57 min, <i>m</i>/<i>z</i> 391.1, 393.1 (1:1) [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> <i>N</i>-(4-Chloro-3-(trifluoromethyl)phenyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>61</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 43% (194 mg, 0.46 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.69 (br s, 1H), 8.24 (d, <i>J</i> = 2.5 Hz, 1H), 7.91 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 7.79 (d, <i>J</i> = 9.1 Hz, 1H), 7.70 (d, <i>J</i> = 8.8 Hz, 1H), 7.52 (d, <i>J</i> = 2.9 Hz, 1H), 7.35 (dd, <i>J</i> = 11.4, 5.2 Hz, 1H), 6.88 (s, 1H), 5.05 (s, 2H), 3.89 (s, 3H), 2.55 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.5, 159.3, 156.9, 156.3, 144.2, 137.9, 132.2, 129.5, 126.8 (q, <sup>2</sup><i>J</i><sub>CâF</sub> = 30.6 Hz), 124.49, 122.69 (q, <sup>1</sup><i>J</i><sub>CâF</sub> = 272.8 Hz), 121.62, 119.70, 118.32 (m, 2C), 102.30, 100.12, 66.95, 55.40, 25.07. UPLC-MS (A) (ESI) RT 1.67 min, <i>m</i>/<i>z</i> 425.4, 427.4 (3:1) [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> <i>N</i>-(4-Chloro-3-methoxyphenyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>62</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 68% (278 mg, 0.72 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.38 (s, 1H), 7.78 (d, <i>J</i> = 9.2 Hz, 1H), 7.56 (d, <i>J</i> = 2.3 Hz, 1H), 7.51 (d, <i>J</i> = 2.9 Hz, 1H), 7.40â7.31 (m, 2H), 7.22 (dd, <i>J</i> = 8.6, 2.3 Hz, 1H), 6.86 (s, 1H), 5.02 (s, 2H), 3.90 (s, 3H), 3.82 (s, 3H), 2.55 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.9, 159.4, 156.9, 156.3, 154.5, 144.2, 138.6, 129.8, 129.5, 121.6, 119.7, 115.4, 112.2, 104.2, 102.2, 100.1, 67.0, 55.9, 55.4, 25.1. UPLC-MS (A) (ESI) RT 1.54 min, <i>m</i>/<i>z</i> 387.4, 389.4 (3:1) [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> <i>N</i>-(4-Chloro-2,5-dimethoxyphenyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>63</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 27% (117 mg, 0.28 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.49 (s, 1H), 8.04 (s, 1H), 7.81 (d, <i>J</i> = 9.1 Hz, 1H), 7.48 (d, <i>J</i> = 2.7 Hz, 1H), 7.39 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 7.21 (s, 1H), 6.93 (s, 1H), 5.08 (s, 2H), 3.91 (s, 3H), 3.83 (s, 3H), 3.77 (s, 3H), 2.56 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.8, 158.9, 157.0, 156.4, 148.2, 144.2, 143.2, 129.6, 126.3, 121.3, 119.6, 115.4, 113.3, 106.0, 102.4, 100.1, 66.9, 56.7, 56.4, 55.4, 25.1. UPLC-MS (A) (ESI) RT 1.56 min, <i>m</i>/<i>z</i> 417.4, 419.4 (3:1) [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 2-((6-Methoxy-2-methylquinolin-4-yl)oxy)-<i>N</i>-(3,4,5-trimethoxyphenyl)acetamide (<b>64</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. Off-white solid; yield 75% (328 mg, 0.80 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.18 (s, 1H), 7.78 (d, <i>J</i> = 9.1 Hz, 1H), 7.51 (d, <i>J</i> = 2.8 Hz, 1H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 7.04 (s, 2H), 6.85 (s, 1H), 4.99 (s, 2H), 3.90 (s, 3H), 3.74 (s, 6H), 3.63 (s, 3H), 2.55 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.5, 159.4, 156.9, 156.3, 152.8, 144.2, 134.5, 133.7, 129.5, 121.6, 119.7, 102.2, 100.1, 97.3, 67.0, 60.1, 55.7, 55.4, 25.1. UPLC-MS (A) (ESI) RT 1.36 min, <i>m</i>/<i>z</i> 413.5 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> <i>N</i>-(4-Fluorophenyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>65</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 52% (230 mg, 0.68 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.32 (br s, 1H), 7.78 (d, <i>J</i> = 9.1 Hz, 1H), 7.70â7.62 (m, 2H), 7.52 (d, <i>J</i> = 2.8 Hz, 1H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 7.23â7.14 (m, 2H), 6.86 (s, 1H), 5.00 (s, 2H), 3.89 (s, 3H), 2.55 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.6, 159.4, 15.3 (d, <sup>1</sup><i>J</i><sub>CâF</sub> = 240.4 Hz), 156.9, 156.2, 144.2, 134.7 (d, <sup>4</sup><i>J</i><sub>CâF</sub> = 2.5 Hz), 129.5, 121.6, 121.6 (d, <sup>3</sup><i>J</i><sub>CâF</sub> = 8.1 Hz), 119.7, 115.4 (d, <sup>2</sup><i>J</i><sub>CâF</sub> = 22.4 Hz), 102.2, 100.1, 67.1, 55.4, 25.1. UPLC-MS (A) (ESI) RT 1.42 min, <i>m</i>/<i>z</i> 341.4 [M + H] <sup>+</sup> (>95%).</div></div><div id="sec4_1_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> <i>N</i>-(4-Chlorophenyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>66</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 75% (353 mg, 0.99 mmol), mp 224â225 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.41 (br s, 1H), 7.78 (d, <i>J</i> = 9.1 Hz, 1H), 7.70â7.64 (m, 2H), 7.51 (d, <i>J</i> = 2.9 Hz, 1H), 7.43â7.37 (m, 2H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 6.86 (s, 1H), 5.02 (s, 2H), 3.89 (s, 3H), 2.54 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.9, 159.4, 156.9, 156.3, 144.2, 137.3, 129.5, 128.7, 127.3, 121.6, 121.2, 119.7, 102.2, 100.1, 67.1, 55.4, 25.1. UPLC-MS (A) (ESI) RT 1.51 min, <i>m</i>/<i>z</i> 357.3, 359.3 (3:1) [M + H]<sup>+</sup> (>95%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>18</sub>ClN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 357.1000; found, 357.1001.</div></div><div id="sec4_1_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 2-((6-Methoxy-2-methylquinolin-4-yl)oxy)acetic Acid (<b>68</b>)</h4><div class="NLM_p last">Ethyl 2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetate (<b>67</b>) (1 equiv) was dissolved in methanol or ethanol (molarity: 0.1â0.3 M), and potassium hydroxide (2 equiv) was added to the solution. The reaction mixture was stirred under reflux for 2.5â3.5 h, and then the solvent was removed under reduced pressure. The obtained residue was dissolved in H<sub>2</sub>O, and the pH was acidified using CH<sub>3</sub>COOH until pH 5â6. The crystallized solid was collected by filtration, washed with H<sub>2</sub>O, and dried to give the pure target compound. White solid; yield (over 2 steps) 92% (1.252 g, 5.06 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.77 (d, <i>J</i> = 9.1 Hz, 1H), 7.40 (d, <i>J</i> = 2.9 Hz, 1H), 7.33 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 6.80 (s, 1H), 4.93 (s, 2H), 3.87 (s, 3H), 2.53 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 169.4, 159.3, 156.8, 156.3, 144.1, 129.5, 121.6, 119.7, 102.2, 99.6, 64.7, 55.4, 25.0. UPLC-MS (A) ESI RT 0.43 min, <i>m</i>/<i>z</i> 248.1 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 2-((6-Methoxy-2-methylquinolin-4-yl)oxy)acetyl Chloride (<b>69</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure G. Off-white solid; yield 100% (1.275 g, 4.80 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 16.10 (s, 1H), 8.25 (d, <i>J</i> = 9.3 Hz, 1H), 7.74 (dd, <i>J</i> = 9.3, 2.8 Hz, 1H), 7.56 (d, <i>J</i> = 2.8 Hz, 1H), 7.51 (s, 1H), 5.28 (s, 2H), 3.95 (s, 3H), 2.84 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 168.2, 164.9, 158.5, 155.8, 134.1, 126.1, 121.6, 120.2, 104.2, 100.9, 66.3, 56.0, 20.1.</div></div><div id="sec4_1_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 2-((6-Methoxy-2-methylquinolin-4-yl)oxy)-<i>N</i>-(pyridin-2-yl)acetamide (<b>70</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure H. Off-white solid; yield 51% (61 mg, 0.19 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 2.54 (s, 3 H), 3.34 (s, 3 H), 5.12 (s, 2 H), 6.83 (s, 1 H), 7.15 (ddd, <i>J</i> = 7.33, 4.93, 0.88 Hz, 1 H), 7.35 (dd, <i>J</i> = 9.09, 2.78 Hz, 1 H), 7.46 (d, <i>J</i> = 3.03 Hz, 1 H), 7.74â7.86 (m, 2 H), 8.06 (d, <i>J</i> = 8.34 Hz, 1 H), 8.34â8.38 (m, 1 H), 10.76 (s, 1 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 25.1, 55.4, 66.6, 99.8, 102.0, 113.6, 119.7, 119.8, 121.6, 129.5, 138.4, 144.2, 148.1, 151.4, 156.3, 156.8, 159.4, 166.5. UPLC-MS (C) RT 1.06 min, <i>m</i>/<i>z</i> 324 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 2-((6-Methoxy-2-methylquinolin-4-yl)oxy)-<i>N</i>-(pyridin-3-yl)acetamide (<b>71</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure H. Off-white solid; yield 58% (70 mg, 0.22 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 2.55 (s, 3 H), 3.90 (s, 3 H), 5.05 (s, 2 H), 6.88 (s, 1 H), 7.30â7.43 (m, 2 H), 7.53 (d, <i>J</i> = 2.8 Hz, 1 H), 7.79 (d, <i>J</i> = 9.1 Hz, 1 H), 8.03â8.14 (m, 1 H), 8.31 (dd, <i>J</i> = 4.7, 1.4 Hz, 1 H), 8.80 (d, <i>J</i> = 2.5 Hz, 1 H), 10.48 (s, 1 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 25.0, 55.4, 66.9, 100.1, 102.2, 119.7, 121.3, 123.7, 126.7, 129.6, 135.0, 141.3, 144.1, 144.7, 156.2, 156.8, 159.3, 166.3. UPLC-MS (C) RT 0.97 min, <i>m</i>/<i>z</i> 324 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 2-((6-Methoxy-2-methylquinolin-4-yl)oxy)-<i>N</i>-(pyridin-4-yl)acetamide (<b>72</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure H. White solid; yield 31% (81 mg, 0.25 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.66 (s, 1H), 8.46 (dd, <i>J</i> = 4.8, 1.7 Hz, 2H), 7.78 (d, <i>J</i> = 9.1 Hz, 1H), 7.62 (dd, <i>J</i> = 4.8, 1.7 Hz, 2H), 7.50 (d, <i>J</i> = 2.9 Hz, 1H), 7.35 (dd, <i>J</i> = 9.2, 2.9 Hz, 1H), 6.86 (s, 1H), 5.07 (s, 2H), 3.89 (s, 3H), 2.54 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.9, 159.3, 156.9, 156.3, 150.5, 145.1, 144.2, 129.5, 121.6, 119.7, 113.5, 102.2, 100.0, 66.9, 55.4, 25.1. UPLC-MS (A) (ESI) RT 0.43 min, <i>m</i>/<i>z</i> 324.1 [M + H] <sup>+</sup> (>95%).</div></div><div id="sec4_1_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> <i>N</i>-(2,6-Dimethylpyridin-4-yl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>73</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure H. White solid; yield 36% (51 mg, 0.15 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.77 (s, 1H), 7.81 (d, <i>J</i> = 9.1 Hz, 1H), 7.49 (d, <i>J</i> = 2.8 Hz, 1H), 7.42â7.34 (m, 3H), 6.89 (s, 1H), 5.11 (s, 2H), 3.89 (s, 3H), 2.56 (s, 3H), 2.42 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 167.0, 159.8, 157.1, 156.8, 156.4, 146.9, 143.6, 129.0, 122.0, 119.7, 110.2, 102.4, 100.0, 67.0, 55.4, 24.7, 23.3. UPLC-MS (A) (ESI) RT 1.01 min, <i>m</i>/<i>z</i> 352.2 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 2-((6-Methoxy-2-methylquinolin-4-yl)oxy)-<i>N</i>-(pyrimidin-4-yl)acetamide (<b>74</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure H. White solid; yield 40% (105 mg, 0.32 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 11.22 (s, 1H), 8.93 (d, <i>J</i> = 0.9 Hz, 1H), 8.68 (d, <i>J</i> = 5.8 Hz, 1H), 8.03 (dd, <i>J</i> = 5.8, 1.2 Hz, 1H), 7.78 (d, <i>J</i> = 9.1 Hz, 1H), 7.45 (d, <i>J</i> = 2.8 Hz, 1H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 6.83 (s, 1H), 5.16 (s, 2H), 3.88 (s, 3H), 2.53 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 167.9, 159.4, 158.5, 158.4, 157.2, 156.9, 156.3, 144.2, 129.5, 121.6, 119.7, 110.0, 102.1, 99.8, 66.6, 55.4, 25.1. UPLC-MS (A) (ESI) RT 1.36 min, <i>m</i>/<i>z</i> 325.2 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> <i>N</i>-(2,6-Dimethylpyrimidin-4-yl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>75</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure H. White solid; yield 40% (115 mg, 0.33 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 11.06 (s, 1H), 7.78 (d, <i>J</i> = 9.1 Hz, 1H), 7.73 (s, 1H), 7.44 (d, <i>J</i> = 2.9 Hz, 1H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 6.80 (s, 1H), 5.12 (s, 2H), 3.88 (s, 3H), 2.53 (s, 3H), 2.50 (s, 3H, overlaps with solventâs peak) 2.37 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 168.2, 167.7, 166.6, 159.4, 157.4, 156.8, 156.3, 144.2, 129.5, 121.6, 119.7, 105.6, 102.1, 99.8, 66.5, 55.4, 25.2, 25.1, 23.9. UPLC-MS (A) (ESI) RT 1.13 min, <i>m</i>/<i>z</i> 353.2 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 2-((6-Methoxy-2-methylquinolin-4-yl)oxy)-<i>N</i>-(thiazol-2-yl)acetamide (<b>76</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure H. White solid; yield 59% (266 mg, 0.48 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 12.51 (s, 1H), 7.79 (d, <i>J</i> = 9.1 Hz, 1H), 7.51 (d, <i>J</i> = 3.6 Hz, 1H), 7.47 (d, <i>J</i> = 2.8 Hz, 1H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 7.27 (d, <i>J</i> = 3.6 Hz, 1H), 6.84 (s, 1H), 5.17 (s, 2H), 3.89 (s, 3H), 2.54 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.0, 159.4, 157.5, 156.9, 156.3, 144.2, 137.7, 129.5, 121.7, 119.7, 113.9, 102.1, 99.9, 66.1, 55.4, 25.1. UPLC-MS (A) (ESI) RT 1.65 min, <i>m</i>/<i>z</i> 330.2 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> <i>N</i>-(4,5-Dimethylthiazol-2-yl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>77</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure H. White solid; yield 6% (18 mg, 0.05 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 12.26 (s, 1H), 7.78 (d, <i>J</i> = 9.1 Hz, 1H), 7.47 (d, <i>J</i> = 2.9 Hz, 1H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 6.80 (s, 1H), 5.11 (s, 2H), 3.89 (s, 3H), 2.53 (s, 3H), 2.24 (d, <i>J</i> = 0.7 Hz, 3H), 2.17 (d, <i>J</i> = 0.7 Hz, 3H). UPLC-MS (A) (ESI) RT 1.70 min, <i>m</i>/<i>z</i> 358.2 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> <i>N</i>-(4,5-Dimethylisoxazol-3-yl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetamide (<b>78</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure H. White solid; yield 61% (169 mg, 0.50 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.56 (br s, 1H), 7.78 (d, <i>J</i> = 9.1 Hz, 1H), 7.51 (d, <i>J</i> = 2.8 Hz, 1H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 6.82 (s, 1H), 5.08 (s, 2H), 3.89 (s, 3H), 2.55 (s, 3H), 2.31 (s, 3H), 1.81 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.5, 166.2, 159.3, 157.6, 156.8, 156.3, 144.2, 129.5, 121.6, 119.7, 106.4, 102.2, 100.2, 66.7, 55.4, 25.1, 10.8, 6.8. UPLC-MS (A) (ESI) RT 1.54 min, <i>m</i>/<i>z</i> 342.2 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> 2-((6-Methoxy-2-methylquinolin-4-yl)oxy)-<i>N</i>-(3-oxoisoxazolidin-4-yl)acetamide (<b>79</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure H. Off-white solid; yield 5% (17 mg, 0.05 mmol), mp decomposition >150 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 8.31 (s, 1 H), 7.95 (d, <i>J</i> = 4.5 Hz, 1 H), 7.76 (d, <i>J</i> = 9.0 Hz, 1 H), 7.47 (d, <i>J</i> = 3.0 Hz, 1 H), 7.33 (dd, <i>J</i> = 9.2, 2.9 Hz, 1 H), 6.85 (s, 1 H), 4.80 (ABq, ÎÎ´<sub>AB</sub> = 0.004, <i>J</i> = 14.6 Hz, 2 H), 4.30 (t, <i>J</i> = 7.8 Hz, 1 H), 4.08â4.17 (m, 1 H), 3.92 (s, 3 H), 3.36â3.39 (m, 1 H, overlaps with water peak), 2.54 (s, 3 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 171.9, 166.9, 159.0, 156.9, 156.4, 144.1, 129.5, 121.7, 119.6, 102.4, 99.7, 73.0, 66.8, 55.5, 55.3, 25.0. UPLC-MS (A) (ESI) RT 0.97 min, <i>m</i>/<i>z</i> 332.1 [M + H]<sup>+</sup> (>95%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>18</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 332.1241; found, 332.1241.</div></div><div id="sec4_1_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> 2-((6-Methoxy-2-methylquinolin-4-yl)oxy)-<i>N</i>-(4-(<i>N</i>-(5-methylisoxazol-3-yl)sulfamoyl)phenyl)acetamide (<b>80</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure H. Off-white solid; yield 44% (165 mg, 0.34 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 11.38 (br s, 1H), 10.68 (s, 1H), 7.83 (s, 4H), 7.78 (d, <i>J</i> = 9.1 Hz, 1H), 7.49 (d, <i>J</i> = 2.8 Hz, 1H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 6.85 (s, 1H), 6.12 (s, 1H), 5.06 (s, 2H), 3.89 (s, 3H), 2.54 (s, 3H), 2.29 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 170.2, 166.4, 159.4, 157.6, 156.9, 156.3, 144.1, 142.6, 133.8, 129.4, 128.1, 121.7, 119.7, 119.4, 102.2, 100.0, 95.4, 66.9, 55.4, 25.0, 12.0. UPLC-MS (A) (ESI) RT 1.40 min, <i>m</i>/<i>z</i> 483.4 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> <i>N</i>â²-(2-((6-Methoxy-2-methylquinolin-4-yl)oxy)acetyl)isonicotinohydrazide (<b>81</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure H. Off-white solid; yield 19% (55 mg, 0.15 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.83 (br s, 1H), 10.54 (s, 1H), 8.78 (dd, <i>J</i> = 4.4, 1.6 Hz, 2H), 7.81â7.75 (m, 3H), 7.57 (d, <i>J</i> = 2.8 Hz, 1H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1H), 6.94 (s, 1H), 4.99 (s, 2H), 3.90 (s, 3H), 2.58 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.5, 164.1, 159.1, 156.9, 156.3, 150.5, 144.2, 139.3, 129.5, 121.5, 121.3, 119.7, 102.6, 100.4, 66.2, 55.5, 25.1. UPLC-MS (A) (ESI) RT 0.29 min, <i>m</i>/<i>z</i> 367.4 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> <i>N</i>-(3,5-Dimethylphenyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)-<i>N</i>-methylacetamide (<b>82</b>)</h4><div class="NLM_p last">Iodomethane (MeI) (0.021 mL, 0.342 mmol) was added to a solution of <i>N</i>-(3,5-dimethylphenyl)-2-((6-methoxy-2-methylquinolin-4-yl)oxy)acetamide (100 mg, 0.285 mmol) and sodium hydride (NaH) 60% suspended in mineral oil (13.70 mg, 0.342 mmol) in anhydrous tetrahydrofuran (THF) (2 mL) which was maintained below 5 Â°C. There reaction mixture was left stirring overnight at room temperature. THF was evaporated, the obtained residue was dissolved in water (50 mL), and the target compound was extracted with ethyl acetate (50 mL Ã 3). The combined organic layers were dried over MgSO<sub>4</sub> and evaporated under reduced pressure. The residue was purified by flash chromatography using a Merck prepacked column (18 + 2 g) and eluent ethyl acetate/cyclohexane 80/20. Yellowish solid; yield 83% (86 mg, 0.237 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 7.74 (d, <i>J</i> = 9.1 Hz, 1 H), 7.31 (dd, <i>J</i> = 9.1, 3.0 Hz, 1 H), 7.22 (br s, 1 H), 7.07 (br s, 2 H), 7.00 (br s, 1 H), 6.59 (br s, 1 H), 4.79 (br s, 2 H), 3.84 (s, 3 H), 3.19 (br s, 3 H), 2.53 (s, 3 H), 2.25 (s, 6 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 166.4 (br s), 159.8, 157.1, 156.6, 144.5, 142.3 (br s), 139.5(br s), 129.8 (2 peaks overlap, proven by HSQC), 124.8 (br s), 121.9, 120.2, 102.3 (br s), 100.2, 66.2, 55.8, 37.5, 25.5, 21.2. UPLC-MS (C) RT 1.23 min, <i>m</i>/<i>z</i> 365 [M + H]<sup>+</sup> (>95%).</div></div><div id="sec4_1_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> 2-(((6-Methoxy-2-methylquinolin-4-yl)oxy)methyl)-5-methylbenzo[<i>d</i>]oxazole (<b>83</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. White solid; yield 19% (8.5 mg, 0.025 mmol), mp 231â233 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 7.79 (d, <i>J</i> = 9.1 Hz, 1 H), 7.66 (d, <i>J</i> = 8.3 Hz, 1 H), 7.61 (s, 1 H), 7.39 (d, <i>J</i> = 2.8 Hz, 1 H), 7.33â7.38 (m, 1 H), 7.26 (dd, <i>J</i> = 8.2, 1.1 Hz, 1 H), 7.10 (s, 1 H), 5.74 (s, 2 H), 3.86 (s, 3 H), 2.55 (s, 3 H), 2.43 (s, 3 H). UPLC-MS (C) RT 1.25 min, <i>m</i>/<i>z</i> 335 [M + H]<sup>+</sup> (>95%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 335.1390; found, 335.1376.</div></div><div id="sec4_1_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> 4-((1<i>H</i>-Benzo[<i>d</i>]imidazol-2-yl)methoxy)-6-methoxy-2-methylquinoline (<b>84</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure E. Off-white solid; yield 3% (5 mg, 0.016 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 12.80 (br s, 1 H), 7.79 (d, <i>J</i> = 9.1 Hz, 1 H), 7.66 (d, <i>J</i> = 7.8 Hz, 1 H), 7.53 (d, <i>J</i> = 7.1 Hz, 1 H), 7.48 (d, <i>J</i> = 2.8 Hz, 1 H), 7.35 (dd, <i>J</i> = 9.1, 3.0 Hz, 1 H), 7.17â7.28 (m, 2 H), 7.12 (s, 1 H), 5.59 (s, 2 H), 3.87 (s, 3 H), 2.57 (s, 3 H). UPLC-MS (C) RT 1.05 min, <i>m</i>/<i>z</i> 320 [M + H]<sup>+</sup> (>95%).</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> Strain and Growth Conditions</h3><div class="NLM_p last"><i>M. tuberculosis</i> H37Rv (ATC25618) wild-type was grown in Middlebrook 7H9-ADC broth (Difco) supplemented with 0.05% Tween 80 and on 7H10-OADC or 7H11-OADC agar (Difco) at 37 Â°C. Isoniazid and hygromycin were purchased from Sigma-Aldrich. When required, hygromycin (50 Î¼g/mL) was added to the culture medium.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> MIC Determination</h3><div class="NLM_p last">The measurement of the minimum inhibitory concentration (MIC) against <i>M. tuberculosis</i> H37Rv for each tested compound was performed in 96-well flat-bottom, polystyrene microtiter plates in a final volume of 200 Î¼L. Ten 2-fold drug dilutions in neat DMSO were performed. Middlebrook 7H9 (Difco) was used as medium. Isoniazid (INH) (Sigma-Aldrich) was used as a positive control with 2-fold dilutions of INH starting at 4 Î¼g/mL placed at row 11 of the plate layout, and rifampicin (Sigma-Aldrich) was used as no-growth control at concentration of 1 Î¼M, placed at G-12 and H-12 wells. The inoculum (200 Î¼L) was added to the entire plate. All plates were placed in a sealed box to prevent drying out of the peripheral wells and incubated at 37 Â°C without shaking for 6 days. A Resazurin solution was prepared by dissolving one tablet of resazurin (Resazurin Tablets for Milk Testing; ref 330884Y, VWR International Ltd.) in 30 mL of sterile PBS (phosphate buffered saline). Of this solution, 25 Î¼L were added to each well. Fluorescence was measured (Spectramax M5, Molecular Devices, excitation 530 nm, emission 590 nm) after 48 h to determine the MIC value.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> Intracellular IC<sub>50</sub> and IC<sub>90</sub> Determination</h3><div class="NLM_p">Human THP-1 macrophages differentiated with PMA was used as a model to study the intracellular stages of <i>Mycobacterium tuberculosis</i> (Mtb). The assay determines the effect of the compounds on mycobacteria growing inside phagocytes by determining luciferase activity per well, which is related to the number of living bacteria.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> Protocol Steps</h4><div id="sec4_4_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i114" class="anchor-spacer"></div><h5 class="article-section__title" id="_i114">a Bacterial Culture and Single Cell Suspension Protocol</h5><div class="NLM_p last">A single cell suspension of Mtb H37Rv pATB45luc was prepared prior to infection. Then 25 mL of bacterial culture grown to log phase was centrifuged at 2800<i>g</i> for 10 min. After removal of the supernatant, cell clumps were dispersed by vigorously shaking with sterile glass 3 mm beads (Sigma) for 2 min. Dispersed cells were then resuspended in 10 mL of RPMI medium and left to decant for 5 min at room temperature. Cells were then centrifuged at 400<i>g</i> for 5 min. Supernatant was collected, and its OD600 was measured. OD mL<sup>â1</sup> was converted to CFU mL<sup>â1</sup> considering that 0.125 OD is equal to 10<sup>7</sup> CFU mL<sup>â1</sup>.</div></div><div id="sec4_4_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i115" class="anchor-spacer"></div><h5 class="article-section__title" id="_i115">b THP1 Cell Preparation and Infection with <i>Mtb</i></h5><div class="NLM_p last">THP1 cells (Human acute monocytic leukemia cell line, ATCC no. TIB-202) were maintained in suspension with RPMI-1640 media (Sigma) containing 10% fetal bovine serum (Gibco), 1 mM of pyruvate (Sigma), 2 mM of <span class="smallcaps smallerCapital">l</span>-glutamine (Sigma), and incubated at 37 Â°C with 5% CO<sub>2</sub>. THP1 cells were routinely subcultured every 3 days at a cell density of 10<sup>5</sup> cells/mL. THP-1 cells were simultaneously differentiated with phorbol myristate acetate (PMA, 40 ng mL<sup>â1</sup>, Sigma) and infected with a single cell suspension of Mtb H37Rv-pATB45luc in a roller bottle at a MOI of 1:1. Cells were put in a roller bottle apparatus for 4 h at 37 Â°C at 1.5 rpm. After this step of incubation, infected cells were washed four times by centrifugation at 400<i>g</i> for 5 min and resuspended in fresh RPMI medium to remove extracellular bacilli. In the last wash, infected cells were resuspended in RPMI medium supplemented with 10% fetal bovine serum (Gibco), 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, and pyruvate at a concentration of 2 Ã 10<sup>5</sup> cells/mL. Then 50 Î¼L of this cell suspension (typically 10000 cells per well) were dispensed into the wells of 384-well plates (white, flat bottom, Greiner).</div></div><div id="sec4_4_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i116" class="anchor-spacer"></div><h5 class="article-section__title" id="_i116">c Incubation of Infected THP-1 Cells with Tested Compounds</h5><div class="NLM_p last">Prior to addition of the infected cell suspension, the compounds (250 nL/well) were dispensed into the plates with an Echo liquid handler. The maximum DMSO concentration is 0.5%. Plates were allowed to incubate at 37 Â°C at 80% relative humidity for 4 days. Luciferase activity, proportional to bacterial load, was determined by using BrightGlo luciferase assay system (Promega, Madison, WI) according to the manufacturerâs protocol. Resultant luminescence was measured in an Envision multilabel plate reader (PerkinElmer) using the 384-plate Ultra Sensitive luminescence mode, with a measurement time of 200 ms per well. Results were processed by using an Excel spreadsheet and Grafit software. IC<sub>50</sub> and IC<sub>90</sub> values were calculated from the doseâresponse curves by nonlinear regression analysis.</div></div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> HepG<sub>2</sub> Cytotoxicity Assay</h3><div class="NLM_p">HepG<sub>2</sub> cells were cultured using Eagleâs MEM supplemented with 10% heat-inactivated FBS, 1% NEAA, and 1% penicillin/streptomycin. Prior to addition of the cell suspension, 250 nL of test compounds per well were predispensed in TC-treated black clear-bottomed 384-well plates (Greiner, cat. no. 781091) with an Echo 555 instrument. After that, 25 Î¼L of HepG<sub>2</sub> (ATCC HB-8065) cells (â¼3000 cells/well) grown to confluency in Eagleâs MEM supplemented with 10% heat-inactivated FBS, 1% NEAA, and 1% pencillin/streptomycin were added to each well with the reagent dispenser. Plates were allowed to incubate at 37 Â°C with 20% O<sub>2</sub> and 5% CO<sub>2</sub> for 48 h.</div><div class="NLM_p last">After the incubation period (48 h), the plates were equilibrated to room temperature before proceeding to develop the luminescent signal. ATP levels measured with CellTiter Glo kit (Promega) were used as cell viability read-out. Then 25 Î¼L of CellTiter Glo substrate dissolved in the buffer was added to each well. Plates were incubated at room temperature for 10 min for stabilization of luminescence signal and read on View Lux with excitation and emission filters of 613 and 655 nm, respectively.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> Microsomal Fraction Stability Experimental Procedure</h3><div class="NLM_p last">Pooled mouse liver microsomes were purchased from Xenotech. Microsomes (final protein concentration 0.5 mg/mL, MgCl<sub>2</sub> (final concentration 5 mM), and test compound (final substrate concentration 0.5 Î¼M; final DMSO concentration 0.5%) in 0.1 M phosphate buffer pH 7.4 were preincubated at 37 Â°C prior to the addition of NADPH (final concentration 1 mM) to initiate the reaction. The final incubation volume was 600 Î¼L. All incubations were performed singularly for each test compound. Each compound was incubated for 30 min, and samples (90 Î¼L) of incubate were taken at 0, 5, 10, 20, and 30 min. The reactions were stopped by the addition of sample to 200 Î¼L of acetonitrile:methanol (3:1) containing an internal standard. The terminated samples were centrifuged at 3700 rpm for 15 min at 4 Â°C to precipitate the protein. Quantitative analysis: following protein precipitation, the samples were analyzed using specific LC-MS/MS conditions. Data analysis: from a plot of ln peak area ratio (compound peak area/internal standard peak area) against time, the gradient of the line was determined. Subsequently, half-life and intrinsic clearance were calculated using the equations below:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/jm-2016-00245t_m001.gif" alt="" /></img></span><span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/jm-2016-00245t_m002.gif" alt="" /></img></span><span class="NLM_disp-formula" id="ueq3"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/jm-2016-00245t_m003.gif" alt="" /></img></span></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i119" class="anchor-spacer"></div><h3 class="article-section__title" id="_i119"> Blood Stability Assay</h3><div class="NLM_p">The stability of each compound was assessed in CD1 mouse whole blood collected on the day of the experiment in EDTA tubes. Typically, 1 mL of blood was spiked with 2 Î¼L of a 0.5 mM of each test compound solution to produce a 1 Î¼M incubation.</div><div class="NLM_p">Three separate 300 Î¼L aliquots were then taken from each tube and incubated at 37 Â°C. At each time point (0, 5, 10, 20, 30, 60, 120, (240) min), 50 Î¼L of blood were collected from each sample over 50 Î¼L of Milli-Q water. Samples were extracted by protein precipitation with 350 Î¼L of 0.1% AcOH acetonitrile methanol 3â1 (v:v) containing 1 Î¼M internal standard and centrifuged for 10 min. Supernatants were collected prior the injection onto an LC-MS/MS system. Analyte/internal standard peak area ratios were referenced to the zero time-point samples as 100% in order to determine the percentage of compound remaining for each time-point. ln plots of the % remaining for each compound were used to determine the half-life for the blood incubations.</div><div class="NLM_p last">The human biological samples were sourced ethically, and their research use was in accord with the terms of the informed consents.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i120" class="anchor-spacer"></div><h3 class="article-section__title" id="_i120"> Artificial Membrane Permeability, Kinetic Aqueous Solubility (CLND), and Hydrophobicity (chromlogD<sub>pH7.4</sub>) Assays</h3><div class="NLM_p last">These assays were performed analogously to those previously described.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i121"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00245">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82857" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82857" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00245" class="ext-link">10.1021/acs.jmedchem.6b00245</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional data (yield, <sup>1</sup>H NMR, <sup>13</sup>C NMR, and UPLC-MS) for the intermediate compounds <b>5b</b>,<b>c</b>, <b>5f</b>, <b>5h</b>â<b>m</b>, <b>5o</b>,<b>p</b>, <b>26a</b>â<b>d</b>, <b>41</b>, <b>48a</b>â<b>r</b> and <b>67</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00245/suppl_file/jm6b00245_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00245/suppl_file/jm6b00245_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00245/suppl_file/jm6b00245_si_001.pdf">jm6b00245_si_001.pdf (188.7 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00245/suppl_file/jm6b00245_si_002.csv">jm6b00245_si_002.csv (5.98 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00245" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03220" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03220" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert H. Bates</span> - <span class="hlFld-Affiliation affiliation">Diseases
of the Developing World (DDW), Tres Cantos Medicines Development Campus
(TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos Madrid, Spain</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7d0f121f180f095315531f1c09180e3d1a0e16531e1210"><span class="__cf_email__" data-cfemail="12607d707760663c7a3c7073667761527561793c717d7f">[emailÂ protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pieter Van der Veken</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universitieitsplein 1, B-2610 Wilrijk, Belgium</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a7d7cec2d3c2d589d1c6c9c3c2d5d1c2ccc2c9e7d2c6c9d3d0c2d5d7c2c989c5c2"><span class="__cf_email__" data-cfemail="b4c4ddd1c0d1c69ac2d5dad0d1c6c2d1dfd1daf4c1d5dac0c3d1c6c4d1da9ad6d1">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eleni Pitta</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universitieitsplein 1, B-2610 Wilrijk, Belgium</span>;Â 
    <span class="hlFld-Affiliation affiliation">Diseases
of the Developing World (DDW), Tres Cantos Medicines Development Campus
(TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maciej K. Rogacki</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universitieitsplein 1, B-2610 Wilrijk, Belgium</span>;Â 
    <span class="hlFld-Affiliation affiliation">Diseases
of the Developing World (DDW), Tres Cantos Medicines Development Campus
(TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olga Balabon</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universitieitsplein 1, B-2610 Wilrijk, Belgium</span>;Â 
    <span class="hlFld-Affiliation affiliation">Diseases
of the Developing World (DDW), Tres Cantos Medicines Development Campus
(TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sophie Huss</span> - <span class="hlFld-Affiliation affiliation">Diseases
of the Developing World (DDW), Tres Cantos Medicines Development Campus
(TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fraser Cunningham</span> - <span class="hlFld-Affiliation affiliation">Diseases
of the Developing World (DDW), Tres Cantos Medicines Development Campus
(TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eva Maria Lopez-Roman</span> - <span class="hlFld-Affiliation affiliation">Diseases
of the Developing World (DDW), Tres Cantos Medicines Development Campus
(TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jurgen Joossens</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universitieitsplein 1, B-2610 Wilrijk, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Koen Augustyns</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universitieitsplein 1, B-2610 Wilrijk, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lluis Ballell</span> - <span class="hlFld-Affiliation affiliation">Diseases
of the Developing World (DDW), Tres Cantos Medicines Development Campus
(TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos Madrid, Spain</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d52e6653-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i122">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38482" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38482" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was funded by a Marie Curie Intra-European Grant within the Seventh European Community Framework Programme (FP7-PEOPLE-2012-ITN) under the European Industrial Doctorates Scheme of the Marie Curie Initial Training Networks actions with grant agreement no. 316773, and it is part of the OpenMedChem project. We gratefully acknowledge the many scientists from GSK DDW involved in the research.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i123" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i123"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i124" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i124"> Abbreviations Used</h2><tr><td class="NLM_term">ACN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">CFU</td><td class="NLM_def"><p class="first last">colony-forming unit</p></td></tr><tr><td class="NLM_term">Cl<sub>int</sub></td><td class="NLM_def"><p class="first last">hepatic intrinsic clearance</p></td></tr><tr><td class="NLM_term">CLND</td><td class="NLM_def"><p class="first last">chemiluminescent nitrogen detection</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">HepG<sub>2</sub></td><td class="NLM_def"><p class="first last">hepatocellular carcinoma human</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">LC-MS</td><td class="NLM_def"><p class="first last">liquid chromatographyâmass spectrometry</p></td></tr><tr><td class="NLM_term"><i>Mtb</i></td><td class="NLM_def"><p class="first last"><i>Mycobacterium tuberculosis</i></p></td></tr><tr><td class="NLM_term">MDR-TB</td><td class="NLM_def"><p class="first last">multidrug-resistant tuberculosis</p></td></tr><tr><td class="NLM_term">MEM</td><td class="NLM_def"><p class="first last">minimum essential medium</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">minimun inhibitory concentration</p></td></tr><tr><td class="NLM_term">NADPH</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide phosphate</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structureâactivity relationship</p></td></tr><tr><td class="NLM_term">TB</td><td class="NLM_def"><p class="first last">tuberculosis</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">UPLC-MS</td><td class="NLM_def"><p class="first last">ultra performance liquid chromatographyâmass spectrometry</p></td></tr><tr><td class="NLM_term">XDR-TB</td><td class="NLM_def"><p class="first last">extensively drug-resistant tuberculosis</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i125">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85287" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85287" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 28 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>Global Tuberculosis Report 2015; <span class="NLM_publisher-name">World Health Organisation</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Global+Tuberculosis+Report+2015%3B+World+Health+Organisation%3A+Geneva%2C+Switzerland%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DGlobal%2520Tuberculosis%2520Report%25202015%26pub%3DWorld%2520Health%2520Organisation%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Onyebujoh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zumla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustomjee, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mwaba, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grange, J. M.</span><span> </span><span class="NLM_article-title">Treatment of Tuberculosis: Present Status and Future Prospects</span> <span class="citation_source-journal">Bull. World Health Organ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">â</span> <span class="NLM_lpage">865</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=16302043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A280%3ADC%252BD2Mnlt1Ortg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2005&pages=857-865&author=P.+Onyebujohauthor=A.+Zumlaauthor=I.+Ribeiroauthor=R.+Rustomjeeauthor=P.+Mwabaauthor=M.+Gomesauthor=J.+M.+Grange&title=Treatment+of+Tuberculosis%3A+Present+Status+and+Future+Prospects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of tuberculosis: present status and future prospects</span></div><div class="casAuthors">Onyebujoh Philip; Zumla Alimuddin; Ribeiro Isabella; Rustomjee Roxana; Mwaba Peter; Gomes Melba; Grange John M</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the World Health Organization</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">857-65</span>
        ISSN:<span class="NLM_cas:issn">0042-9686</span>.
    </div><div class="casAbstract">Over recent years, tuberculosis (TB) and disease caused by human immunodeficiency virus (HIV) have merged in a synergistic pandemic.  The number of new cases of TB is stabilizing and declining, except in countries with a high prevalence of HIV infection.  In these countries, where HIV is driving an increase in the TB burden, the capacity of the current tools and strategies to reduce the burden has been exceeded.  This paper summarizes the current status of TB management and describes recent thinking and strategy adjustments required for the control of TB in settings of high HIV prevalence.  We review the information on anti-TB drugs that is available in the public domain and highlight the need for continued and concerted efforts (including financial, human and infrastructural investments) for the development of new strategies and anti-TB agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTbrBb1cyB6hGx8TEN9K18QfW6udTcc2ebk9JMB835nt7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mnlt1Ortg%253D%253D&md5=8bd8724e9cd19376124113b2e6bf73c4</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOnyebujoh%26aufirst%3DP.%26aulast%3DZumla%26aufirst%3DA.%26aulast%3DRibeiro%26aufirst%3DI.%26aulast%3DRustomjee%26aufirst%3DR.%26aulast%3DMwaba%26aufirst%3DP.%26aulast%3DGomes%26aufirst%3DM.%26aulast%3DGrange%26aufirst%3DJ.%2BM.%26atitle%3DTreatment%2520of%2520Tuberculosis%253A%2520Present%2520Status%2520and%2520Future%2520Prospects%26jtitle%3DBull.%2520World%2520Health%2520Organ.%26date%3D2005%26volume%3D83%26spage%3D857%26epage%3D865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Ducati, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruffino-Netto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, D. S.</span><span> </span><span class="NLM_article-title">The Resumption of Consumption-A Review on Tuberculosis</span> <span class="citation_source-journal">Mem. Inst. Oswaldo Cruz</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">â</span> <span class="NLM_lpage">714</span><span class="refDoi">Â DOI: 10.1590/S0074-02762006000700001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1590%2FS0074-02762006000700001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=17160276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCisr7F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2006&pages=697-714&author=R.+G.+Ducatiauthor=A.+Ruffino-Nettoauthor=L.+A.+Bassoauthor=D.+S.+Santos&title=The+Resumption+of+Consumption-A+Review+on+Tuberculosis&doi=10.1590%2FS0074-02762006000700001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The resumption of consumption-a review on tuberculosis</span></div><div class="casAuthors">Ducati, Rodrigo Gay; Ruffino-Netto, Antonio; Basso, Luiz Augusto; Santos, Diogenes Santiago</div><div class="citationInfo"><span class="NLM_cas:title">Memorias do Instituto Oswaldo Cruz</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">697-714</span>CODEN:
                <span class="NLM_cas:coden">MIOCAS</span>;
        ISSN:<span class="NLM_cas:issn">0074-0276</span>.
    
            (<span class="NLM_cas:orgname">Instituto Oswaldo Cruz</span>)
        </div><div class="casAbstract">A review.  Among all infectious diseases that afflict humans, tuberculosis (TB) remains the deadliest.  At present, epidemiologists est. that one-third of the world population is infected with tubercle bacilli, which is responsible for 8 to 10 million new cases of TB and 3 million deaths annually throughout the world.  Approx. 95% of new cases and 98% of deaths occur in developing nations, generally due to the few resources available to ensure proper treatment and where human immunodeficiency virus (HIV) infections are common.  In 1882, Dr Robert Koch identified an acid-fast bacterium, Mycobacterium tuberculosis, as the causative agent of TB.  Thirty-nine years later, BCG vaccine was introduced for human use, and became the most widely used prophylactic strategy to fight TB in the world.  The discovery of the properties of first-line antimycobacterial drugs in the past century yielded effective chemotherapies, which considerably decreased TB mortality rates worldwide.  The later introduction of some addnl. drugs to the arsenal used to treat TB seemed to provide an adequate no. of effective antimicrobial agents.  The modern, std. short-course therapy for TB recommended by the World Health Organization is based on a four-drug regimen that must be strictly followed to prevent drug resistance acquisition, and relies on direct observation of patient compliance to ensure effective treatment.  Mycobacteria show a high degree of intrinsic resistance to most antibiotics and chemotherapeutic agents due to the low permeability of its cell wall.  Nevertheless, the cell wall barrier alone cannot produce significant levels of drug resistance.  M. tuberculosis mutants resistant to any single drug are naturally present in any large bacterial population, irresp. of exposure to drugs.  The frequency of mutants resistant to rifampicin and isoniazid, the two principal antimycobacterial drugs currently in use, is relatively high and, therefore, the large extra-cellular population of actively metabolizing and rapidly growing tubercle bacilli in cavitary lesions will contain organisms which are resistant to a single drug.  Consequently, monotherapy or improperly administered two-drug therapies will select for drug-resistant mutants that may lead to drug resistance in the entire bacterial population.  Thereby, despite the availability of effective chemotherapy and the moderately protective vaccine, new anti-TB agents are urgently needed to decrease the global incidence of TB.  The resumption of TB, mainly caused by the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains and HIV epidemics, led to an increased need to understand the mol. mechanisms of drug action and drug resistance, which should provide significant insight into the development of newer compds.  The latter should be effective to combat both drug-susceptible and MDR/XDR-TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvwbi-EwlccbVg90H21EOLACvtfcHk0lgbOFfnDdh1vg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCisr7F&md5=55605c48ab6941766140be6c65c5acdf</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1590%2FS0074-02762006000700001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS0074-02762006000700001%26sid%3Dliteratum%253Aachs%26aulast%3DDucati%26aufirst%3DR.%2BG.%26aulast%3DRuffino-Netto%26aufirst%3DA.%26aulast%3DBasso%26aufirst%3DL.%2BA.%26aulast%3DSantos%26aufirst%3DD.%2BS.%26atitle%3DThe%2520Resumption%2520of%2520Consumption-A%2520Review%2520on%2520Tuberculosis%26jtitle%3DMem.%2520Inst.%2520Oswaldo%2520Cruz%26date%3D2006%26volume%3D101%26spage%3D697%26epage%3D714%26doi%3D10.1590%2FS0074-02762006000700001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Nachega, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaisson, R. E.</span><span> </span><span class="NLM_article-title">Tuberculosis Drug Resistance: A Global Threat</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">S24</span><span class="NLM_x">â</span> <span class="NLM_lpage">S30</span><span class="refDoi">Â DOI: 10.1086/344657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1086%2F344657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=12516027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1ynu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2003&pages=S24-S30&author=J.+B.+Nachegaauthor=R.+E.+Chaisson&title=Tuberculosis+Drug+Resistance%3A+A+Global+Threat&doi=10.1086%2F344657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Tuberculosis drug resistance: a global threat</span></div><div class="casAuthors">Nachega, Jean B.; Chaisson, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S24-S30</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">A review.  Resistance to antituberculosis drugs has been a problem since the era of chemotherapy began.  After dramatic outbreaks of multidrug-resistant tuberculosis (MDR-TB) in the early 1990s, resistance became recognized as a global problem.  MDR-TB now threatens the inhabitants of countries in Europe, Asia, Africa, and the Americas.  An understanding of the mol. basis of drug resistance may contribute to the development of new drugs.  Management of MDR-TB relies on prompt recognition and treatment with at least 3 drugs to which an isolate is susceptible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7eHIIuICjYbVg90H21EOLACvtfcHk0lh_ndh0xkP_mA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1ynu78%253D&md5=188fae134e67ffc38090126897ab0432</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1086%2F344657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F344657%26sid%3Dliteratum%253Aachs%26aulast%3DNachega%26aufirst%3DJ.%2BB.%26aulast%3DChaisson%26aufirst%3DR.%2BE.%26atitle%3DTuberculosis%2520Drug%2520Resistance%253A%2520A%2520Global%2520Threat%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2003%26volume%3D36%26spage%3DS24%26epage%3DS30%26doi%3D10.1086%2F344657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Orenstein, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedland, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moll, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvani, A. P.</span><span> </span><span class="NLM_article-title">Treatment Outcomes among Patients with Multidrug-Resistant Tuberculosis: Systematic Review and Meta-Analysis</span> <span class="citation_source-journal">Lancet Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">â</span> <span class="NLM_lpage">161</span><span class="refDoi">Â DOI: 10.1016/S1473-3099(09)70041-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1016%2FS1473-3099%2809%2970041-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=19246019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ntVGitw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=153-161&author=E.+W.+Orensteinauthor=S.+Basuauthor=N.+S.+Shahauthor=J.+R.+Andrewsauthor=G.+H.+Friedlandauthor=A.+P.+Mollauthor=N.+R.+Gandhiauthor=A.+P.+Galvani&title=Treatment+Outcomes+among+Patients+with+Multidrug-Resistant+Tuberculosis%3A+Systematic+Review+and+Meta-Analysis&doi=10.1016%2FS1473-3099%2809%2970041-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis</span></div><div class="casAuthors">Orenstein Evan W; Basu Sanjay; Shah N Sarita; Andrews Jason R; Friedland Gerald H; Moll Anthony P; Gandhi Neel R; Galvani Alison P</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Infectious diseases</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-61</span>
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    </div><div class="casAbstract">Multidrug-resistant (MDR) tuberculosis is a growing clinical and public-health concern.  To evaluate existing evidence regarding treatment regimens for MDR tuberculosis, we used a Bayesian random-effects meta-analysis of the available therapeutic studies to assess how the reported proportion of patients treated successfully is influenced by differences in treatment regimen design, study methodology, and patient population.  Successful treatment outcome was defined as cure or treatment completion. 34 clinical reports with a mean of 250 patients per report met the inclusion criteria.  Our analysis shows that the proportion of patients treated successfully improved when treatment duration was at least 18 months, and if patients received directly observed therapy throughout treatment.  Studies that combined both factors had significantly higher pooled success proportions (69%, 95% credible interval [CI] 64-73%) than other studies of treatment outcomes (58%, 95% CI 52-64%).  Individualised treatment regimens had higher treatment success (64%, 95% CI 59-68%) than standardised regimens (54%, 95% CI 43-68%), although the difference was not significant.  Treatment approaches and study methodologies were heterogeneous across studies.  Many important variables, including patients' HIV status, were inconsistently reported between studies.  These results underscore the importance of strong patient support and treatment follow-up systems to develop successful MDR tuberculosis treatment programmes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRpKfOIwjMB0zDnmmyUf5qOfW6udTcc2ebYnNYvieB0obntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ntVGitw%253D%253D&md5=c7a4824bfc7702a80c98ebfc29beb4fa</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2809%2970041-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252809%252970041-6%26sid%3Dliteratum%253Aachs%26aulast%3DOrenstein%26aufirst%3DE.%2BW.%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DN.%2BS.%26aulast%3DAndrews%26aufirst%3DJ.%2BR.%26aulast%3DFriedland%26aufirst%3DG.%2BH.%26aulast%3DMoll%26aufirst%3DA.%2BP.%26aulast%3DGandhi%26aufirst%3DN.%2BR.%26aulast%3DGalvani%26aufirst%3DA.%2BP.%26atitle%3DTreatment%2520Outcomes%2520among%2520Patients%2520with%2520Multidrug-Resistant%2520Tuberculosis%253A%2520Systematic%2520Review%2520and%2520Meta-Analysis%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2009%26volume%3D9%26spage%3D153%26epage%3D161%26doi%3D10.1016%2FS1473-3099%2809%2970041-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Ballell, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-Gomez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-Ruiz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barroso, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escribano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos-Villarejo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Plaza, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rebollo-Lopez, M. J. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remuinan-Blanco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavandera, J. L. J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Herran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo-Benito, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Bustos, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GonzÃ¡lez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos-Villarejo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MartÃ­n-Plaza, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rebollo-Lopez, M. J. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">RemuiÃ±an-Blanco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavandera, J. L. J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">PÃ©rez-Herran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo-Benito, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GarcÃ­a-Bustos, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span> </span><span class="NLM_article-title">Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">â</span> <span class="NLM_lpage">321</span><span class="refDoi">Â DOI: 10.1002/cmdc.201200428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1002%2Fcmdc.201200428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=23307663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BC3sXls1Omug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=313-321&author=L.+L.+Ballellauthor=R.+H.+Batesauthor=R.+J.+Youngauthor=D.+Alvarez-Gomezauthor=E.+Alvarez-Ruizauthor=V.+Barrosoauthor=D.+Blancoauthor=B.+Crespoauthor=J.+Escribanoauthor=R.+Gonzalezauthor=S.+Lozanoauthor=S.+Hussauthor=A.+Santos-Villarejoauthor=J.+J.+Martin-Plazaauthor=A.+Mendozaauthor=M.+J.+M.+J.+Rebollo-Lopezauthor=M.+Remuinan-Blancoauthor=J.+L.+J.+L.+Lavanderaauthor=E.+Perez-Herranauthor=F.+J.+Gamo-Benitoauthor=J.+F.+Garcia-Bustosauthor=D.+Barrosauthor=J.+P.+Castroauthor=N.+Cammackauthor=R.+Gonz%C3%A1lezauthor=S.+Lozanoauthor=S.+Hussauthor=A.+Santos-Villarejoauthor=J.+J.+Mart%C3%ADn-Plazaauthor=A.+Mendozaauthor=M.+J.+M.+J.+Rebollo-Lopezauthor=M.+Remui%C3%B1an-Blancoauthor=J.+L.+J.+L.+Lavanderaauthor=E.+P%C3%A9rez-Herranauthor=F.+J.+Gamo-Benitoauthor=J.+F.+Garc%C3%ADa-Bustosauthor=D.+Barrosauthor=J.+P.+Castroauthor=N.+Cammack&title=Fueling+Open-Source+Drug+Discovery%3A+177+Small-Molecule+Leads+against+Tuberculosis&doi=10.1002%2Fcmdc.201200428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis</span></div><div class="casAuthors">Ballell, Lluis; Bates, Robert H.; Young, Rob J.; Alvarez-Gomez, Daniel; Alvarez-Ruiz, Emilio; Barroso, Vanessa; Blanco, Delia; Crespo, Benigno; Escribano, Jaime; Gonzalez, Ruben; Lozano, Sonia; Huss, Sophie; Santos-Villarejo, Angel; Martin-Plaza, Jose Julio; Mendoza, Alfonso; Rebollo-Lopez, Maria Jose; Remuinan-Blanco, Modesto; Lavandera, Jose Luis; Perez-Herran, Esther; Gamo-Benito, Francisco Javier; Garcia-Bustos, Jose Francisco; Barros, David; Castro, Julia P.; Cammack, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">313-321</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">With the aim of fuelling open-source, translational, early-stage drug discovery activities, the results of the recently completed antimycobacterial phenotypic screening campaign against Mycobacterium bovis BCG with hit confirmation in M. tuberculosis H37Rv were made publicly accessible.  A set of 177 potent non-cytotoxic H37Rv hits was identified and will be made available to maximize the potential impact of the compds. toward a chem. genetics/proteomics exercise, while at the same time providing a plethora of potential starting points for new synthetic lead-generation activities.  Two addnl. drug-discovery-relevant datasets are included: (a) a drug-like property anal. reflecting the latest lead-like guidelines and (b) an early lead-generation package of the most promising hits within the clusters identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUJ2sVPWfPALVg90H21EOLACvtfcHk0li-SO_88mioOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXls1Omug%253D%253D&md5=32c975dbe183849358c701ca697681d3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200428%26sid%3Dliteratum%253Aachs%26aulast%3DBallell%26aufirst%3DL.%2BL.%26aulast%3DBates%26aufirst%3DR.%2BH.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DAlvarez-Gomez%26aufirst%3DD.%26aulast%3DAlvarez-Ruiz%26aufirst%3DE.%26aulast%3DBarroso%26aufirst%3DV.%26aulast%3DBlanco%26aufirst%3DD.%26aulast%3DCrespo%26aufirst%3DB.%26aulast%3DEscribano%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DR.%26aulast%3DLozano%26aufirst%3DS.%26aulast%3DHuss%26aufirst%3DS.%26aulast%3DSantos-Villarejo%26aufirst%3DA.%26aulast%3DMartin-Plaza%26aufirst%3DJ.%2BJ.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DRebollo-Lopez%26aufirst%3DM.%2BJ.%2BM.%2BJ.%26aulast%3DRemuinan-Blanco%26aufirst%3DM.%26aulast%3DLavandera%26aufirst%3DJ.%2BL.%2BJ.%2BL.%26aulast%3DPerez-Herran%26aufirst%3DE.%26aulast%3DGamo-Benito%26aufirst%3DF.%2BJ.%26aulast%3DGarcia-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DCastro%26aufirst%3DJ.%2BP.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DR.%26aulast%3DLozano%26aufirst%3DS.%26aulast%3DHuss%26aufirst%3DS.%26aulast%3DSantos-Villarejo%26aufirst%3DA.%26aulast%3DMart%25C3%25ADn-Plaza%26aufirst%3DJ.%2BJ.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DRebollo-Lopez%26aufirst%3DM.%2BJ.%2BM.%2BJ.%26aulast%3DRemui%25C3%25B1an-Blanco%26aufirst%3DM.%26aulast%3DLavandera%26aufirst%3DJ.%2BL.%2BJ.%2BL.%26aulast%3DP%25C3%25A9rez-Herran%26aufirst%3DE.%26aulast%3DGamo-Benito%26aufirst%3DF.%2BJ.%26aulast%3DGarc%25C3%25ADa-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DCastro%26aufirst%3DJ.%2BP.%26aulast%3DCammack%26aufirst%3DN.%26atitle%3DFueling%2520Open-Source%2520Drug%2520Discovery%253A%2520177%2520Small-Molecule%2520Leads%2520against%2520Tuberculosis%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D313%26epage%3D321%26doi%3D10.1002%2Fcmdc.201200428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Maddry, J. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ananthan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobrath, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secrist, J. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosa, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span> </span><span class="NLM_article-title">Antituberculosis Activity of the Molecular Libraries Screening Center Network Library</span> <span class="citation_source-journal">Tuberculosis (Oxford, U. K.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">354</span><span class="NLM_x">â</span> <span class="NLM_lpage">363</span><span class="refDoi">Â DOI: 10.1016/j.tube.2009.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1016%2Fj.tube.2009.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=19783214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlaktbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2009&pages=354-363&author=J.+a+Maddryauthor=S.+Ananthanauthor=R.+C.+Goldmanauthor=J.+V.+Hobrathauthor=C.+D.+Kwongauthor=C.+Maddoxauthor=L.+Rasmussenauthor=R.+C.+Reynoldsauthor=J.+a+Secristauthor=M.+I.+Sosaauthor=E.+L.+Whiteauthor=W.+Zhang&title=Antituberculosis+Activity+of+the+Molecular+Libraries+Screening+Center+Network+Library&doi=10.1016%2Fj.tube.2009.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Antituberculosis activity of the Molecular Libraries Screening Center Network library</span></div><div class="casAuthors">Maddry, Joseph A.; Ananthan, Subramaniam; Goldman, Robert C.; Hobrath, Judith V.; Kwong, Cecil D.; Maddox, Clinton; Rasmussen, Lynn; Reynolds, Robert C.; Secrist, John A., III; Sosa, Melinda I.; White, E. Lucile; Zhang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Tuberculosis (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">354-363</span>CODEN:
                <span class="NLM_cas:coden">TUBECU</span>;
        ISSN:<span class="NLM_cas:issn">1472-9792</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">There is an urgent need for the discovery and development of new antitubercular agents that target novel biochem. pathways and treat drug-resistant forms of the disease.  One approach to addressing this need is through high-throughput screening of drug-like small mol. libraries against the whole bacterium in order to identify a variety of new, active scaffolds that will stimulate addnl. biol. research and drug discovery.  Through the Mol. Libraries Screening Center Network, the NIAID Tuberculosis Antimicrobial Acquisition and Coordinating Facility tested a 215,110-compd. library against Mycobacterium tuberculosis strain H37Rv.  A medicinal chem. survey of the results from the screening campaign is reported herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH1oCyettJJLVg90H21EOLACvtfcHk0li-SO_88mioOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlaktbY%253D&md5=2b8d1ea9ef392231534d6eb020771da9</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.tube.2009.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tube.2009.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DMaddry%26aufirst%3DJ.%2Ba%26aulast%3DAnanthan%26aufirst%3DS.%26aulast%3DGoldman%26aufirst%3DR.%2BC.%26aulast%3DHobrath%26aufirst%3DJ.%2BV.%26aulast%3DKwong%26aufirst%3DC.%2BD.%26aulast%3DMaddox%26aufirst%3DC.%26aulast%3DRasmussen%26aufirst%3DL.%26aulast%3DReynolds%26aufirst%3DR.%2BC.%26aulast%3DSecrist%26aufirst%3DJ.%2Ba%26aulast%3DSosa%26aufirst%3DM.%2BI.%26aulast%3DWhite%26aufirst%3DE.%2BL.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DAntituberculosis%2520Activity%2520of%2520the%2520Molecular%2520Libraries%2520Screening%2520Center%2520Network%2520Library%26jtitle%3DTuberculosis%2520%2528Oxford%252C%2520U.%2520K.%2529%26date%3D2009%26volume%3D89%26spage%3D354%26epage%3D363%26doi%3D10.1016%2Fj.tube.2009.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Lilienkampf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationships for a Series of Quinoline-Based Compounds Active against Replicating and Nonreplicating <i>Mycobacterium Tuberculosis</i></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2109</span><span class="NLM_x">â</span> <span class="NLM_lpage">2118</span><span class="refDoi">Â DOI: 10.1021/jm900003c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900003c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2109-2118&author=A.+Lilienkampfauthor=J.+Maoauthor=B.+Wanauthor=Y.+Wangauthor=S.+G.+Franzblauauthor=A.+P.+Kozikowski&title=Structure-Activity+Relationships+for+a+Series+of+Quinoline-Based+Compounds+Active+against+Replicating+and+Nonreplicating+Mycobacterium+Tuberculosis&doi=10.1021%2Fjm900003c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm900003c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900003c%26sid%3Dliteratum%253Aachs%26aulast%3DLilienkampf%26aufirst%3DA.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DStructure-Activity%2520Relationships%2520for%2520a%2520Series%2520of%2520Quinoline-Based%2520Compounds%2520Active%2520against%2520Replicating%2520and%2520Nonreplicating%2520Mycobacterium%2520Tuberculosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2109%26epage%3D2118%26doi%3D10.1021%2Fjm900003c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Eswaran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adhikari, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdhury, I. H.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Some New Quinoline-3-Carbohydrazone Derivatives as Potential Antimycobacterial Agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1040</span><span class="NLM_x">â</span> <span class="NLM_lpage">1044</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2009.12.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1016%2Fj.bmcl.2009.12.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=20056418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGrs7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1040-1044&author=S.+Eswaranauthor=A.+V.+Adhikariauthor=N.+K.+Palauthor=I.+H.+Chowdhury&title=Design+and+Synthesis+of+Some+New+Quinoline-3-Carbohydrazone+Derivatives+as+Potential+Antimycobacterial+Agents&doi=10.1016%2Fj.bmcl.2009.12.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents</span></div><div class="casAuthors">Eswaran, Sumesh; Adhikari, Airody Vasudeva; Pal, Nishith K.; Chowdhury, Imran H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1040-1044</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 26 new quinoline derivs. carrying active pharmacophores has been synthesized and evaluated for their in vitro antituberculosis activity against Mycobacterium tuberculosis H37Rv (MTB), Mycobacterium smegmatis (MC2), and Mycobacterium fortuitum following the broth micro diln. assay method.  Seven compds., e.g., I, exhibited significant min. inhibition concns., when compared with first line drugs isoniazid (INH) and rifampicin (RIF) and could be ideally suited for further modifications to obtain more efficacious compds. in the fight against multi-drug resistant tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpONAgbR5vNwbVg90H21EOLACvtfcHk0lg88Xk-t_p1aA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGrs7s%253D&md5=8b59c409c280db8a573c385c8b47eb85</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.12.045%26sid%3Dliteratum%253Aachs%26aulast%3DEswaran%26aufirst%3DS.%26aulast%3DAdhikari%26aufirst%3DA.%2BV.%26aulast%3DPal%26aufirst%3DN.%2BK.%26aulast%3DChowdhury%26aufirst%3DI.%2BH.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Some%2520New%2520Quinoline-3-Carbohydrazone%2520Derivatives%2520as%2520Potential%2520Antimycobacterial%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1040%26epage%3D1044%26doi%3D10.1016%2Fj.bmcl.2009.12.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Tukulula, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Little, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chibale, K.</span><span> </span><span class="NLM_article-title">The Design, Synthesis, in Silico ADME Profiling, Antiplasmodial and Antimycobacterial Evaluation of New Arylamino Quinoline Derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">â</span> <span class="NLM_lpage">267</span><span class="refDoi">Â DOI: 10.1016/j.ejmech.2012.08.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1016%2Fj.ejmech.2012.08.047" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2012&pages=259-267&author=M.+Tukululaauthor=S.+Littleauthor=J.+Gutauthor=P.+J.+Rosenthalauthor=B.+Wanauthor=S.+G.+Franzblauauthor=K.+Chibale&title=The+Design%2C+Synthesis%2C+in+Silico+ADME+Profiling%2C+Antiplasmodial+and+Antimycobacterial+Evaluation+of+New+Arylamino+Quinoline+Derivatives&doi=10.1016%2Fj.ejmech.2012.08.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.08.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.08.047%26sid%3Dliteratum%253Aachs%26aulast%3DTukulula%26aufirst%3DM.%26aulast%3DLittle%26aufirst%3DS.%26aulast%3DGut%26aufirst%3DJ.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DThe%2520Design%252C%2520Synthesis%252C%2520in%2520Silico%2520ADME%2520Profiling%252C%2520Antiplasmodial%2520and%2520Antimycobacterial%2520Evaluation%2520of%2520New%2520Arylamino%2520Quinoline%2520Derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D57%26spage%3D259%26epage%3D267%26doi%3D10.1016%2Fj.ejmech.2012.08.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Koul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dendouga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergauwen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molenberghs, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vranckx, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willebrords, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ristic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lill, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorange, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillemont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bald, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andries, K.</span><span> </span><span class="NLM_article-title">Diarylquinolines Target Subunit c of Mycobacterial ATP Synthase</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">â</span> <span class="NLM_lpage">324</span><span class="refDoi">Â DOI: 10.1038/nchembio884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1038%2Fnchembio884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=17496888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlOjurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=323-324&author=A.+Koulauthor=N.+Dendougaauthor=K.+Vergauwenauthor=B.+Molenberghsauthor=L.+Vranckxauthor=R.+Willebrordsauthor=Z.+Risticauthor=H.+Lillauthor=I.+Dorangeauthor=J.+Guillemontauthor=D.+Baldauthor=K.+Andries&title=Diarylquinolines+Target+Subunit+c+of+Mycobacterial+ATP+Synthase&doi=10.1038%2Fnchembio884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Diarylquinolines target subunit c of mycobacterial ATP synthase</span></div><div class="casAuthors">Koul, Anil; Dendouga, Najoua; Vergauwen, Karen; Molenberghs, Brenda; Vranckx, Luc; Willebrords, Rudy; Ristic, Zorica; Lill, Holger; Dorange, Ismet; Guillemont, Jerome; Bald, Dirk; Andries, Koen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">323-324</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The diarylquinoline R207910 (TMC207) is a promising candidate in clin. development for the treatment of tuberculosis.  Though R207910-resistant mycobacteria bear mutations in ATP synthase, the compd.'s precise target is not known.  Here we establish by genetic, biochem. and binding assays that the oligomeric subunit c (AtpE) of ATP synthase is the target of R207910.  Thus targeting energy metab. is a new, promising approach for antibacterial drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoo57k1zZdTLVg90H21EOLACvtfcHk0lhV7tFgOSqd0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlOjurc%253D&md5=f9ba04042bef448f5910cea0e89715f0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnchembio884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio884%26sid%3Dliteratum%253Aachs%26aulast%3DKoul%26aufirst%3DA.%26aulast%3DDendouga%26aufirst%3DN.%26aulast%3DVergauwen%26aufirst%3DK.%26aulast%3DMolenberghs%26aufirst%3DB.%26aulast%3DVranckx%26aufirst%3DL.%26aulast%3DWillebrords%26aufirst%3DR.%26aulast%3DRistic%26aufirst%3DZ.%26aulast%3DLill%26aufirst%3DH.%26aulast%3DDorange%26aufirst%3DI.%26aulast%3DGuillemont%26aufirst%3DJ.%26aulast%3DBald%26aufirst%3DD.%26aulast%3DAndries%26aufirst%3DK.%26atitle%3DDiarylquinolines%2520Target%2520Subunit%2520c%2520of%2520Mycobacterial%2520ATP%2520Synthase%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D3%26spage%3D323%26epage%3D324%26doi%3D10.1038%2Fnchembio884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Moadebi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harder, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elwood, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marra, F.</span><span> </span><span class="NLM_article-title">Fluoroquinolones for the Treatment of Pulmonary Tuberculosis</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2077</span><span class="NLM_x">â</span> <span class="NLM_lpage">2099</span><span class="refDoi">Â DOI: 10.2165/00003495-200767140-00007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.2165%2F00003495-200767140-00007" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=2077-2099&author=S.+Moadebiauthor=C.+K.+Harderauthor=M.+J.+Fitzgeraldauthor=K.+R.+Elwoodauthor=F.+Marra&title=Fluoroquinolones+for+the+Treatment+of+Pulmonary+Tuberculosis&doi=10.2165%2F00003495-200767140-00007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2165%2F00003495-200767140-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003495-200767140-00007%26sid%3Dliteratum%253Aachs%26aulast%3DMoadebi%26aufirst%3DS.%26aulast%3DHarder%26aufirst%3DC.%2BK.%26aulast%3DFitzgerald%26aufirst%3DM.%2BJ.%26aulast%3DElwood%26aufirst%3DK.%2BR.%26aulast%3DMarra%26aufirst%3DF.%26atitle%3DFluoroquinolones%2520for%2520the%2520Treatment%2520of%2520Pulmonary%2520Tuberculosis%26jtitle%3DDrugs%26date%3D2007%26volume%3D67%26spage%3D2077%26epage%3D2099%26doi%3D10.2165%2F00003495-200767140-00007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Brouet, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. D.</span><span> </span><span class="NLM_article-title">A Survey of Solvents for the Conrad-Limpach Synthesis of 4-Hydroxyquinolones</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1593</span><span class="NLM_x">â</span> <span class="NLM_lpage">1596</span><span class="refDoi">Â DOI: 10.1080/00397910802542044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1080%2F00397910802542044" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2009&pages=1593-1596&author=J.-C.+Brouetauthor=S.+Guauthor=N.+P.+Peetauthor=J.+D.+Williams&title=A+Survey+of+Solvents+for+the+Conrad-Limpach+Synthesis+of+4-Hydroxyquinolones&doi=10.1080%2F00397910802542044"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1080%2F00397910802542044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910802542044%26sid%3Dliteratum%253Aachs%26aulast%3DBrouet%26aufirst%3DJ.-C.%26aulast%3DGu%26aufirst%3DS.%26aulast%3DPeet%26aufirst%3DN.%2BP.%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26atitle%3DA%2520Survey%2520of%2520Solvents%2520for%2520the%2520Conrad-Limpach%2520Synthesis%2520of%25204-Hydroxyquinolones%26jtitle%3DSynth.%2520Commun.%26date%3D2009%26volume%3D39%26spage%3D1593%26epage%3D1596%26doi%3D10.1080%2F00397910802542044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Escribano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivero-HernÃ¡ndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Pichel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">PÃ©rez-HerrÃ¡n, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza-Losana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer-Bazaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">JimÃ©nez-Navarro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballell, L.</span><span> </span><span class="NLM_article-title">4-Substituted Thioquinolines and Thiazoloquinolines: Potent, Selective, and Tween-80 in Vitro Dependent Families of Antitubercular Agents with Moderate in Vivo Activity</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2252</span><span class="NLM_x">â</span> <span class="NLM_lpage">2263</span><span class="refDoi">Â DOI: 10.1002/cmdc.201100309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1002%2Fcmdc.201100309" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=2252-2263&author=J.+Escribanoauthor=C.+Rivero-Hern%C3%A1ndezauthor=H.+Riveraauthor=D.+Barrosauthor=J.+Castro-Pichelauthor=E.+P%C3%A9rez-Herr%C3%A1nauthor=A.+Mendoza-Losanaauthor=I.+Angulo-Barturenauthor=S.+Ferrer-Bazagaauthor=E.+Jim%C3%A9nez-Navarroauthor=L.+Ballell&title=4-Substituted+Thioquinolines+and+Thiazoloquinolines%3A+Potent%2C+Selective%2C+and+Tween-80+in+Vitro+Dependent+Families+of+Antitubercular+Agents+with+Moderate+in+Vivo+Activity&doi=10.1002%2Fcmdc.201100309"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100309%26sid%3Dliteratum%253Aachs%26aulast%3DEscribano%26aufirst%3DJ.%26aulast%3DRivero-Hern%25C3%25A1ndez%26aufirst%3DC.%26aulast%3DRivera%26aufirst%3DH.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DCastro-Pichel%26aufirst%3DJ.%26aulast%3DP%25C3%25A9rez-Herr%25C3%25A1n%26aufirst%3DE.%26aulast%3DMendoza-Losana%26aufirst%3DA.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DFerrer-Bazaga%26aufirst%3DS.%26aulast%3DJim%25C3%25A9nez-Navarro%26aufirst%3DE.%26aulast%3DBallell%26aufirst%3DL.%26atitle%3D4-Substituted%2520Thioquinolines%2520and%2520Thiazoloquinolines%253A%2520Potent%252C%2520Selective%252C%2520and%2520Tween-80%2520in%2520Vitro%2520Dependent%2520Families%2520of%2520Antitubercular%2520Agents%2520with%2520Moderate%2520in%2520Vivo%2520Activity%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D2252%26epage%3D2263%26doi%3D10.1002%2Fcmdc.201100309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Tsantrizos, Y.</span><span> </span><span class="NLM_article-title">Inhibitors of Human Immunodeficiency Virus Replication</span>. WO 2009/062285 A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Y.+Tsantrizos&title=Inhibitors+of+Human+Immunodeficiency+Virus+Replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%26atitle%3DInhibitors%2520of%2520Human%2520Immunodeficiency%2520Virus%2520Replication%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Activity of Novel Barbituric and Thiobarbituric Acid Derivatives against Non-Alcoholic Fatty Liver Disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2003</span><span class="NLM_x">â</span> <span class="NLM_lpage">2010</span><span class="refDoi">Â DOI: 10.1016/j.ejmech.2011.02.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1016%2Fj.ejmech.2011.02.033" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2003-2010&author=L.+Maauthor=S.+Liauthor=H.+Zhengauthor=J.+Chenauthor=L.+Linauthor=X.+Yeauthor=Z.+Chenauthor=Q.+Xuauthor=T.+Chenauthor=J.+Yangauthor=N.+Qiuauthor=G.+Wangauthor=A.+Pengauthor=Y.+Dingauthor=Y.+Weiauthor=L.+Chen&title=Synthesis+and+Biological+Activity+of+Novel+Barbituric+and+Thiobarbituric+Acid+Derivatives+against+Non-Alcoholic+Fatty+Liver+Disease&doi=10.1016%2Fj.ejmech.2011.02.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.02.033%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DPeng%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DSynthesis%2520and%2520Biological%2520Activity%2520of%2520Novel%2520Barbituric%2520and%2520Thiobarbituric%2520Acid%2520Derivatives%2520against%2520Non-Alcoholic%2520Fatty%2520Liver%2520Disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D2003%26epage%3D2010%26doi%3D10.1016%2Fj.ejmech.2011.02.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Dvorak, C. A.; Swanson, D. M.; Wong, V. D.</span><span> </span><span class="NLM_article-title">Piperazinyl Derivatives Useful as Modulators of Neuropeptide Y2 Receptor</span>. US 2011/0046151,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+A.+Dvorak&author=D.+M.+Swanson&author=V.+D.+Wong&title=Piperazinyl+Derivatives+Useful+as+Modulators+of+Neuropeptide+Y2+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26atitle%3DPiperazinyl%2520Derivatives%2520Useful%2520as%2520Modulators%2520of%2520Neuropeptide%2520Y2%2520Receptor%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span> </span><span class="NLM_article-title">Copper-Catalyzed Highly Regioselective 2-Aryloxylation of 2,x-Dihalopyridines</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">â</span> <span class="NLM_lpage">333</span><span class="refDoi">Â DOI: 10.1016/j.tet.2012.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1016%2Fj.tet.2012.10.025" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=327-333&author=Q.+Zhouauthor=B.+Zhangauthor=T.+Duauthor=H.+Guauthor=Y.+Yeauthor=H.+Jiangauthor=R.+Chen&title=Copper-Catalyzed+Highly+Regioselective+2-Aryloxylation+of+2%2Cx-Dihalopyridines&doi=10.1016%2Fj.tet.2012.10.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2012.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2012.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DDu%26aufirst%3DT.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DR.%26atitle%3DCopper-Catalyzed%2520Highly%2520Regioselective%25202-Aryloxylation%2520of%25202%252Cx-Dihalopyridines%26jtitle%3DTetrahedron%26date%3D2013%26volume%3D69%26spage%3D327%26epage%3D333%26doi%3D10.1016%2Fj.tet.2012.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">PeÅ¡iÄ, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">StarÄeviÄ, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toplak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herreros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almela, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">JeliÄ, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">AlihodÅ¾iÄ, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaventi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">PeriÄ, M.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and in Vitro Activity of Novel 2â²-O-Substituted 15-Membered Azalides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3216</span><span class="NLM_x">â</span> <span class="NLM_lpage">3227</span><span class="refDoi">Â DOI: 10.1021/jm201676t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201676t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3216-3227&author=D.+Pe%C5%A1i%C4%87author=K.+Star%C4%8Devi%C4%87author=A.+Toplakauthor=E.+Herrerosauthor=J.+Vidalauthor=M.+J.+Almelaauthor=D.+Jeli%C4%87author=S.+Alihod%C5%BEi%C4%87author=R.+Spaventiauthor=M.+Peri%C4%87&title=Design%2C+Synthesis%2C+and+in+Vitro+Activity+of+Novel+2%E2%80%B2-O-Substituted+15-Membered+Azalides&doi=10.1021%2Fjm201676t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm201676t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201676t%26sid%3Dliteratum%253Aachs%26aulast%3DPe%25C5%25A1i%25C4%2587%26aufirst%3DD.%26aulast%3DStar%25C4%258Devi%25C4%2587%26aufirst%3DK.%26aulast%3DToplak%26aufirst%3DA.%26aulast%3DHerreros%26aufirst%3DE.%26aulast%3DVidal%26aufirst%3DJ.%26aulast%3DAlmela%26aufirst%3DM.%2BJ.%26aulast%3DJeli%25C4%2587%26aufirst%3DD.%26aulast%3DAlihod%25C5%25BEi%25C4%2587%26aufirst%3DS.%26aulast%3DSpaventi%26aufirst%3DR.%26aulast%3DPeri%25C4%2587%26aufirst%3DM.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520in%2520Vitro%2520Activity%2520of%2520Novel%25202%25E2%2580%25B2-O-Substituted%252015-Membered%2520Azalides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3216%26epage%3D3227%26doi%3D10.1021%2Fjm201676t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Huang, T.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, B.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syu, W.</span><span> </span><span class="NLM_article-title">Susceptibility of <i>Mycobacterium Tuberculosis</i> to Sulfamethoxazole, Trimethoprim and Their Combination over a 12 Year Period in Taiwan</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">â</span> <span class="NLM_lpage">637</span><span class="refDoi">Â DOI: 10.1093/jac/dkr501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1093%2Fjac%2Fdkr501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=22127584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BC38Xit1Ogt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=633-637&author=T.-S.+Huangauthor=C.+M.+Kuninauthor=B.-S.+Yanauthor=Y.-S.+Chenauthor=S.+S.-J.+Leeauthor=W.+Syu&title=Susceptibility+of+Mycobacterium+Tuberculosis+to+Sulfamethoxazole%2C+Trimethoprim+and+Their+Combination+over+a+12+Year+Period+in+Taiwan&doi=10.1093%2Fjac%2Fdkr501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Susceptibility of Mycobacterium tuberculosis to sulfamethoxazole, trimethoprim and their combination over a 12 year period in Taiwan</span></div><div class="casAuthors">Huang, Tsi-Shu; Kunin, Calvin M.; Yan, Bo-Shiun; Chen, Yao-Shen; Lee, Susan Shin-Jung; Syu, Wan-Jr</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">633-637</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">This study was designed to det. the susceptibility of clin. isolates of multidrug-resistant (MDR) and non-MDR Mycobacterium tuberculosis to sulfamethoxazole, trimethoprim and trimethoprim/sulfamethoxazole over a 12 yr period in Taiwan.  Microbial examd. a total of 117 clin. isolates of M. tuberculosis collected from Southern Taiwan, 116 from 1995 to 2006 and an extensively drug-resistant (XDR) isolate in 2009.  These included 28 isolates susceptible to all four first-line agents, 52 MDR isolates and 36 isolates with a mixed combination of drug resistance patterns other than MDR and 1 XDR isolate.  Sulfamethoxazole inhibited 80% growth of all 117 isolates regardless of their susceptibility to the first-line agents at an MIC90 of 9.5 mg/L.  The concn. required to inhibit 99% growth was 38 mg/L.  There were no significant changes in the MIC50 or MIC90 of sulfamethoxazole over a 12 yr period.  All 117 isolates were resistant to trimethoprim at >8 mg/L.  The combination of trimethoprim/sulfamethoxazole at a ratio of 1 : 19 had no additive or synergistic effects.  Thus, sulfamethoxazole inhibited the growth of clin. isolates of M. tuberculosis at achievable concns. in plasma after oral administration.  Susceptibility to sulfamethoxazole remained const. over a 12 yr period.  Trimethoprim was inactive against M. tuberculosis and trimethoprim/sulfamethoxazole provided no addnl. activity.  Although the current and prior studies demonstrate that sulfamethoxazole is active against M. tuberculosis the search needs to continue for more active, lipid-sol. sulfonamides that are better absorbed into tissues and have improved therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWx43W1uVtUrVg90H21EOLACvtfcHk0lj6Do0F9LRp6A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xit1Ogt74%253D&md5=fff292ebc9c0a61a72b1c69a2f321460</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkr501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkr501%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DT.-S.%26aulast%3DKunin%26aufirst%3DC.%2BM.%26aulast%3DYan%26aufirst%3DB.-S.%26aulast%3DChen%26aufirst%3DY.-S.%26aulast%3DLee%26aufirst%3DS.%2BS.-J.%26aulast%3DSyu%26aufirst%3DW.%26atitle%3DSusceptibility%2520of%2520Mycobacterium%2520Tuberculosis%2520to%2520Sulfamethoxazole%252C%2520Trimethoprim%2520and%2520Their%2520Combination%2520over%2520a%252012%2520Year%2520Period%2520in%2520Taiwan%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2012%26volume%3D67%26spage%3D633%26epage%3D637%26doi%3D10.1093%2Fjac%2Fdkr501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Kestranek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chervenak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longenberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Placko, S.</span><span> </span><span class="NLM_article-title">Chemiluminescent Nitrogen Detection (CLND) to Measure Kinetic Aqueous Solubility</span> <span class="citation_source-journal">Curr. Protoc. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">â</span> <span class="NLM_lpage">280</span><span class="refDoi">Â DOI: 10.1002/9780470559277.ch130145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1002%2F9780470559277.ch130145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=24391097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A280%3ADC%252BC2czitF2itw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=269-280&author=A.+Kestranekauthor=A.+Chervenakauthor=J.+Longenbergerauthor=S.+Placko&title=Chemiluminescent+Nitrogen+Detection+%28CLND%29+to+Measure+Kinetic+Aqueous+Solubility&doi=10.1002%2F9780470559277.ch130145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Chemiluminescent nitrogen detection (CLND) to measure kinetic aqueous solubility</span></div><div class="casAuthors">Kestranek Aimee; Chervenak Andrew; Longenberger Justin; Placko Steven</div><div class="citationInfo"><span class="NLM_cas:title">Current protocols in chemical biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">269-80</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Solubility is the dose-limiting property for in vitro studies, and therefore is a critical physicochemical property to measure in drug discovery.  Solubility data can be used to guide lead optimization, troubleshoot erratic bioassay results, and identify potential downstream liabilities such as insufficient solubility for bioassays or oral bioavailability.  Typically, early in vitro studies are performed using library compounds prepared as dimethylsulfoxide (DMSO) stock solutions, resulting in in vitro test solutions containing DMSO at low concentration (<5% v/v).  Since DMSO can affect the apparent solubility, it is desirable to obtain solubility data under conditions mimicking the in vitro study.  Kinetic solubility (from DMSO stock solutions) is often preferred over thermodynamic solubility (from dry powder) in early drug discovery.  The protocols in this article describe a general procedure for assessing kinetic aqueous solubility of early drug discovery compounds using a miniaturized shake flask method with chemiluminescent nitrogen detection (CLND).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQa5zXGR-PJU_SAs_PE1QvifW6udTcc2ebq4E_yUWOylLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czitF2itw%253D%253D&md5=d63d6d57c4ff0934379d3c37f82eb1a0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2F9780470559277.ch130145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780470559277.ch130145%26sid%3Dliteratum%253Aachs%26aulast%3DKestranek%26aufirst%3DA.%26aulast%3DChervenak%26aufirst%3DA.%26aulast%3DLongenberger%26aufirst%3DJ.%26aulast%3DPlacko%26aufirst%3DS.%26atitle%3DChemiluminescent%2520Nitrogen%2520Detection%2520%2528CLND%2529%2520to%2520Measure%2520Kinetic%2520Aqueous%2520Solubility%26jtitle%3DCurr.%2520Protoc.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D5%26spage%3D269%26epage%3D280%26doi%3D10.1002%2F9780470559277.ch130145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Young, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. V. S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luscombe, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, A. P.</span><span> </span><span class="NLM_article-title">Getting Physical in Drug Discovery II: The Impact of Chromatographic Hydrophobicity Measurements and Aromaticity</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">822</span><span class="NLM_x">â</span> <span class="NLM_lpage">830</span><span class="refDoi">Â DOI: 10.1016/j.drudis.2011.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1016%2Fj.drudis.2011.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=21704184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=822-830&author=R.+J.+Youngauthor=D.+V.+S.+S.+Greenauthor=C.+N.+Luscombeauthor=A.+P.+Hill&title=Getting+Physical+in+Drug+Discovery+II%3A+The+Impact+of+Chromatographic+Hydrophobicity+Measurements+and+Aromaticity&doi=10.1016%2Fj.drudis.2011.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity</span></div><div class="casAuthors">Young, Robert J.; Green, Darren V. S.; Luscombe, Christopher N.; Hill, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17/18</span>),
    <span class="NLM_cas:pages">822-830</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here, we review the performance of chromatog. hydrophobicity measurements in a data set of 100 000 GlaxoSmithKline compds., demonstrating the advantages of the method over octanol-water partitioning and highlighting new insights for drug discovery.  The value of chromatog. measurements, vs. other hydrophobicity ests., was supported by improved relationships with soly., permeation, cytochrome P450s, intrinsic clearance, hERG binding and promiscuity.  We also obsd. marked differentiation of the relative influence of intrinsic and effective hydrophobicity.  The summing of hydrophobicity values plus arom. ring count [log D pH7.4 (or log P) + #Ar], indicated a wide relevance for simplistic property forecast indexes' in developability assays, clearly enhanced by chromatog. values; therefore establishing new foundations for enriching property-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmIJyWi-DBW7Vg90H21EOLACvtfcHk0lgP5Nsf8ODfrQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF&md5=22788603a45aa77537e8666433473d14</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DGreen%26aufirst%3DD.%2BV.%2BS.%2BS.%26aulast%3DLuscombe%26aufirst%3DC.%2BN.%26aulast%3DHill%26aufirst%3DA.%2BP.%26atitle%3DGetting%2520Physical%2520in%2520Drug%2520Discovery%2520II%253A%2520The%2520Impact%2520of%2520Chromatographic%2520Hydrophobicity%2520Measurements%2520and%2520Aromaticity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D822%26epage%3D830%26doi%3D10.1016%2Fj.drudis.2011.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Leroux, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manteau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vors, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazenok, S.</span><span> </span><span class="NLM_article-title">Trifluoromethyl Ethers-Synthesis and Properties of an Unusual Substituent</span> <span class="citation_source-journal">Beilstein J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="refDoi">Â DOI: 10.3762/bjoc.4.13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.3762%2Fbjoc.4.13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=18941485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvFaqtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=13&author=F.+R.+Lerouxauthor=B.+Manteauauthor=J.-P.+Vorsauthor=S.+Pazenok&title=Trifluoromethyl+Ethers-Synthesis+and+Properties+of+an+Unusual+Substituent&doi=10.3762%2Fbjoc.4.13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluoromethyl ethers: Synthesis and properties of an unusual substituent</span></div><div class="casAuthors">Leroux, Frederic R.; Manteau, Baptiste; Vors, Jean-Pierre; Pazenok, Sergiy</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">No. 13, No pp. given</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">A review.  After nitrogen, fluorine is probably the next most favorite hetero-atom for incorporation into small mols. in life science-oriented research.  This review focuses on a particular fluorinated substituent, the trifluoromethoxy group, which is finding increased utility as a substituent in bioactives, but it is still perhaps the least well understood fluorine substituent in currency.  The present review will give an overview of the synthesis, properties and reactivity of this important substituent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_OnxjuY6OnLVg90H21EOLACvtfcHk0lgP5Nsf8ODfrQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvFaqtrY%253D&md5=779225da5f8a70e0a8e5484b2f250f3e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.4.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.4.13%26sid%3Dliteratum%253Aachs%26aulast%3DLeroux%26aufirst%3DF.%2BR.%26aulast%3DManteau%26aufirst%3DB.%26aulast%3DVors%26aufirst%3DJ.-P.%26aulast%3DPazenok%26aufirst%3DS.%26atitle%3DTrifluoromethyl%2520Ethers-Synthesis%2520and%2520Properties%2520of%2520an%2520Unusual%2520Substituent%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2008%26volume%3D4%26spage%3D13%26doi%3D10.3762%2Fbjoc.4.13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Leiserowitz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagler, A. T.</span><span> </span><span class="NLM_article-title">The Generation of Possible Crystal Structures of Primary Amides</span> <span class="citation_source-journal">Proc. R. Soc. London, Ser. A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">â</span> <span class="NLM_lpage">175</span><span class="refDoi">Â DOI: 10.1098/rspa.1983.0076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1098%2Frspa.1983.0076" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=1983&pages=133-175&author=L.+Leiserowitzauthor=A.+T.+Hagler&title=The+Generation+of+Possible+Crystal+Structures+of+Primary+Amides&doi=10.1098%2Frspa.1983.0076"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1098%2Frspa.1983.0076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frspa.1983.0076%26sid%3Dliteratum%253Aachs%26aulast%3DLeiserowitz%26aufirst%3DL.%26aulast%3DHagler%26aufirst%3DA.%2BT.%26atitle%3DThe%2520Generation%2520of%2520Possible%2520Crystal%2520Structures%2520of%2520Primary%2520Amides%26jtitle%3DProc.%2520R.%2520Soc.%2520London%252C%2520Ser.%2520A%26date%3D1983%26volume%3D388%26spage%3D133%26epage%3D175%26doi%3D10.1098%2Frspa.1983.0076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Ayerst, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duke, J. R. C.</span><span> </span><span class="NLM_article-title">Refinement of the Crystal Structure of Oxamide</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1954</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">588</span><span class="NLM_x">â</span> <span class="NLM_lpage">590</span><span class="refDoi">Â DOI: 10.1107/S0365110X54001909</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1107%2FS0365110X54001909" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1954&pages=588-590&author=E.+M.+Ayerstauthor=J.+R.+C.+Duke&title=Refinement+of+the+Crystal+Structure+of+Oxamide&doi=10.1107%2FS0365110X54001909"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1107%2FS0365110X54001909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0365110X54001909%26sid%3Dliteratum%253Aachs%26aulast%3DAyerst%26aufirst%3DE.%2BM.%26aulast%3DDuke%26aufirst%3DJ.%2BR.%2BC.%26atitle%3DRefinement%2520of%2520the%2520Crystal%2520Structure%2520of%2520Oxamide%26jtitle%3DActa%2520Crystallogr.%26date%3D1954%26volume%3D7%26spage%3D588%26epage%3D590%26doi%3D10.1107%2FS0365110X54001909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Sorrentino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez del Rio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presa Matilla, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres Gomez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez Hoyos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez Herran, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza Losana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Av-Gay, Y.</span><span> </span><span class="NLM_article-title">Development of an Intracellular Screen for New Compounds Able to Inhibit <i>Mycobacterium Tuberculosis</i> Growth in Human Macrophages</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">640</span><span class="NLM_x">â</span> <span class="NLM_lpage">645</span><span class="refDoi">Â DOI: 10.1128/AAC.01920-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1128%2FAAC.01920-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=26503663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVCrs7nF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=640-645&author=F.+Sorrentinoauthor=R.+Gonzalez+del+Rioauthor=X.+Zhengauthor=J.+Presa+Matillaauthor=P.+Torres+Gomezauthor=M.+Martinez+Hoyosauthor=M.+E.+Perez+Herranauthor=A.+Mendoza+Losanaauthor=Y.+Av-Gay&title=Development+of+an+Intracellular+Screen+for+New+Compounds+Able+to+Inhibit+Mycobacterium+Tuberculosis+Growth+in+Human+Macrophages&doi=10.1128%2FAAC.01920-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Development of an intracellular screen for new compounds able to inhibit Mycobacterium tuberculosis growth in human macrophages</span></div><div class="casAuthors">Sorrentino, Flavia; Gonzalez del Rio, Ruben; Zheng, Xingji; Matilla, Jesus Presa; Gomez, Pedro Torres; Hoyos, Maria Martinez; Herran, Maria Esther Perez; Losana, Alfonso Mendoza; Av-Gay, Yossef</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">640-645</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Here we describe the development and validation of an intracellular high-throughput screening assay for finding new antituberculosis compds. active in human macrophages.  The assay consists of a luciferase-based primary identification assay, followed by a green fluorescent protein-based secondary profiling assay.  Std. tuberculosis drugs and 158 previously recognized active antimycobacterial compds. were used to evaluate assay robustness.  Data show that the assay developed is a short and valuable tool for the discovery of new antimycobacterial compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2XIe5jevhLVg90H21EOLACvtfcHk0li7sLiTiCPRsA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVCrs7nF&md5=4ed12b5a9996d37db7a8d023ccabd48a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FAAC.01920-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01920-15%26sid%3Dliteratum%253Aachs%26aulast%3DSorrentino%26aufirst%3DF.%26aulast%3DGonzalez%2Bdel%2BRio%26aufirst%3DR.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DPresa%2BMatilla%26aufirst%3DJ.%26aulast%3DTorres%2BGomez%26aufirst%3DP.%26aulast%3DMartinez%2BHoyos%26aufirst%3DM.%26aulast%3DPerez%2BHerran%26aufirst%3DM.%2BE.%26aulast%3DMendoza%2BLosana%26aufirst%3DA.%26aulast%3DAv-Gay%26aufirst%3DY.%26atitle%3DDevelopment%2520of%2520an%2520Intracellular%2520Screen%2520for%2520New%2520Compounds%2520Able%2520to%2520Inhibit%2520Mycobacterium%2520Tuberculosis%2520Growth%2520in%2520Human%2520Macrophages%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D640%26epage%3D645%26doi%3D10.1128%2FAAC.01920-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Smith, D. A.; van de Waterbeemd, H.; Walker, D. K.; Mannhold, R.; Kubinyi, H.; Timmerman, H.</span>; Eds.  <span class="citation_source-book">Pharmacokinetics and Metabolism in Drug Design</span>; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2001</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">68</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1002%2F3527600213" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=68&author=D.+A.+Smith&author=H.+van+de+Waterbeemd&author=D.+K.+Walker&author=R.+Mannhold&author=H.+Kubinyi&author=H.+Timmerman&title=Pharmacokinetics+and+Metabolism+in+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2F3527600213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F3527600213%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26btitle%3DPharmacokinetics%2520and%2520Metabolism%2520in%2520Drug%2520Design%26pub%3DWiley-VCH%26date%3D2001%26spage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Kokatla, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salunke, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakrishna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malladi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, S. a.</span><span> </span><span class="NLM_article-title">Toll-like Receptor-8 Agonistic Activities in C2, C4, and C8Modified thiazolo[4,5-C]quinolines</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1179</span><span class="NLM_x">â</span> <span class="NLM_lpage">1198</span><span class="refDoi">Â DOI: 10.1039/c2ob26705e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1039%2Fc2ob26705e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=23314908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCnt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=1179-1198&author=H.+P.+Kokatlaauthor=E.+Yooauthor=D.+B.+Salunkeauthor=D.+Silauthor=C.+F.+Ngauthor=R.+Balakrishnaauthor=S.+S.+Malladiauthor=L.+M.+Foxauthor=S.+a.+David&title=Toll-like+Receptor-8+Agonistic+Activities+in+C2%2C+C4%2C+and+C8Modified+thiazolo%5B4%2C5-C%5Dquinolines&doi=10.1039%2Fc2ob26705e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptor-8 agonistic activities in C2, C4, and C8 modified thiazolo[4,5-c]quinolines</span></div><div class="casAuthors">Kokatla, Hari Prasad; Yoo, Euna; Salunke, Deepak B.; Sil, Diptesh; Ng, Cameron F.; Balakrishna, Rajalakshmi; Malladi, Subbalakshmi S.; Fox, Lauren M.; David, Sunil A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1179-1198</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Toll-like receptor (TLR)-8 agonists typified by the 2-alkylthiazolo[4,5-c]quinolin-4-amine (CL075) chemotype are uniquely potent in activating adaptive immune responses by inducing robust prodn. of T helper 1-polarizing cytokines, suggesting that TLR8-active compds. could be promising candidate vaccine adjuvants, esp. for neonatal vaccines.  Alkylthiazoloquinolines with Me, Et, Pr and Bu groups at C2 displayed comparable TLR8-agonistic potencies; activity diminished precipitously in the C2-pentyl compd., and higher homologues were inactive.  The C2-Bu compd. was unique in possessing substantial TLR7-agonistic activity.  Analogs with branched alkyl groups at C2 displayed poor tolerance of terminal steric bulk.  Virtually all modifications at C8 led to abrogation of agonistic activity.  Alkylation on the C4-amine was not tolerated, whereas N-acyl analogs with short acyl groups (other than acetyl) retained TLR8 agonistic activity, but were substantially less water-sol.  Immunization in rabbits with a model subunit antigen adjuvanted with the lead C2-Bu thiazoloquinoline showed enhancements of antigen-specific antibody titers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYAWu83GzZRLVg90H21EOLACvtfcHk0li7sLiTiCPRsA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCnt7o%253D&md5=50ab5984b3920a890201960880e9003e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2Fc2ob26705e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ob26705e%26sid%3Dliteratum%253Aachs%26aulast%3DKokatla%26aufirst%3DH.%2BP.%26aulast%3DYoo%26aufirst%3DE.%26aulast%3DSalunke%26aufirst%3DD.%2BB.%26aulast%3DSil%26aufirst%3DD.%26aulast%3DNg%26aufirst%3DC.%2BF.%26aulast%3DBalakrishna%26aufirst%3DR.%26aulast%3DMalladi%26aufirst%3DS.%2BS.%26aulast%3DFox%26aufirst%3DL.%2BM.%26aulast%3DDavid%26aufirst%3DS.%2Ba.%26atitle%3DToll-like%2520Receptor-8%2520Agonistic%2520Activities%2520in%2520C2%252C%2520C4%252C%2520and%2520C8Modified%2520thiazolo%255B4%252C5-C%255Dquinolines%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26spage%3D1179%26epage%3D1198%26doi%3D10.1039%2Fc2ob26705e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 26 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Olga Balabon, Eleni Pitta, Maciej K. Rogacki, Eugenia Meiler, Ruth Casanueva, Laura Guijarro, Sophie Huss, Eva Maria Lopez-Roman, Ãngel Santos-Villarejo, Koen Augustyns, Lluis Ballell, David Barros Aguirre, Robert H. Bates, Fraser Cunningham, Monica Cacho, <span class="NLM_string-name hlFld-ContribAuthor">Pieter Van der Veken</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-Î²-d-Ribose Oxidase (DprE1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (10)
                                     , 5367-5386. <a href="https://doi.org/10.1021/acs.jmedchem.0c00107" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00107%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BHydantoins%252Bas%252BPotent%252BAntimycobacterial%252BDecaprenylphosphoryl-%2525CE%2525B2-d-Ribose%252BOxidase%252B%252528DprE1%252529%252BInhibitors%26aulast%3DBalabon%26aufirst%3DOlga%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10022020%26date%3D13052020%26date%3D28042020%26volume%3D63%26issue%3D10%26spage%3D5367%26epage%3D5386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jennifer A. Borthwick, Carlos Alemparte, Ian Wall, Benjamin C. Whitehurst, Argyrides Argyrou, Glenn Burley, Paco de Dios-Anton, Laura Guijarro, Maria Candida Monteiro, Fatima Ortega, Colin J Suckling, Julia Castro Pichel, Monica Cacho, <span class="NLM_string-name hlFld-ContribAuthor">Robert J. Young</span>. </span><span class="cited-content_cbyCitation_article-title">Mycobacterium tuberculosis Decaprenylphosphoryl-Î²-d-ribose Oxidase Inhibitors: Expeditious Reconstruction of Suboptimal Hits into a Series with Potent in Vivo Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2557-2576. <a href="https://doi.org/10.1021/acs.jmedchem.9b01561" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01561%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMycobacterium%252Btuberculosis%252BDecaprenylphosphoryl-%2525CE%2525B2-d-ribose%252BOxidase%252BInhibitors%25253A%252BExpeditious%252BReconstruction%252Bof%252BSuboptimal%252BHits%252Binto%252Ba%252BSeries%252Bwith%252BPotent%252Bin%252BVivo%252BActivity%26aulast%3DBorthwick%26aufirst%3DJennifer%2BA.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D19092019%26date%3D22012020%26date%3D10012020%26volume%3D63%26issue%3D5%26spage%3D2557%26epage%3D2576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maciej
K. Rogacki, Eleni Pitta, Olga Balabon, Sophie Huss, Eva Maria Lopez-Roman, Argyrides Argyrou, Delia Blanco-Ruano, Monica Cacho, Christophe M. L. Vande Velde, Koen Augustyns, Lluis Ballell, David Barros, Robert H. Bates, Fraser Cunningham, <span class="NLM_string-name hlFld-ContribAuthor">Pieter Van der Veken</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Profiling of HydantoinsâA Novel Class of Potent Antimycobacterial DprE1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (24)
                                     , 11221-11249. <a href="https://doi.org/10.1021/acs.jmedchem.8b01356" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01356%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Band%252BProfiling%252Bof%252BHydantoins%2525E2%252580%252594A%252BNovel%252BClass%252Bof%252BPotent%252BAntimycobacterial%252BDprE1%252BInhibitors%26aulast%3DRogacki%26aufirst%3DMaciej%2BK.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D30082018%26date%3D13122018%26date%3D30112018%26volume%3D61%26issue%3D24%26spage%3D11221%26epage%3D11249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bao-Qu  Wang</span>, <span class="hlFld-ContribAuthor ">Cong-Hai  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao-Xue  Tian</span>, <span class="hlFld-ContribAuthor ">Jun  Lin</span>, and <span class="hlFld-ContribAuthor ">Sheng-Jiao  Yan</span>  . </span><span class="cited-content_cbyCitation_article-title">Cascade Reaction of Isatins with 1,1-Enediamines: Synthesis of Multisubstituted Quinoline-4-carboxamides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (3)
                                     , 660-663. <a href="https://doi.org/10.1021/acs.orglett.7b03803" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b03803</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b03803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b03803%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCascade%252BReaction%252Bof%252BIsatins%252Bwith%252B1%25252C1-Enediamines%25253A%252BSynthesis%252Bof%252BMultisubstituted%252BQuinoline-4-carboxamides%26aulast%3DWang%26aufirst%3DBao-Qu%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D06122017%26date%3D11012018%26date%3D02022018%26volume%3D20%26issue%3D3%26spage%3D660%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aparna  Bahuguna</span>, <span class="hlFld-ContribAuthor ">Srishti  Rawat</span>, <span class="hlFld-ContribAuthor ">Diwan S.  Rawat</span>. </span><span class="cited-content_cbyCitation_article-title">QcrB in
              Mycobacterium tuberculosis
              : The new drug target of antitubercular agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>41 </em>
                                    (4)
                                     , 2565-2581. <a href="https://doi.org/10.1002/med.21779" title="DOI URL">https://doi.org/10.1002/med.21779</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21779%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DQcrB%252Bin%252BMycobacterium%252Btuberculosis%252B%25253A%252BThe%252Bnew%252Bdrug%252Btarget%252Bof%252Bantitubercular%252Bagents%26aulast%3DBahuguna%26aufirst%3DAparna%26date%3D2021%26date%3D2021%26volume%3D41%26issue%3D4%26spage%3D2565%26epage%3D2581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prashant  Thakare</span>, <span class="hlFld-ContribAuthor ">Abhijit  Shinde</span>, <span class="hlFld-ContribAuthor ">Sagar  Dakhane</span>, <span class="hlFld-ContribAuthor ">Abhijit  Chavan</span>, <span class="hlFld-ContribAuthor ">Vivek D.  Bobade</span>, <span class="hlFld-ContribAuthor ">Pravin C.  Mhaske</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel 4â(6âsubstituted quinolinâ4âyl)â
              N
              âaryl thiazolâ2âamine derivatives as potential antimicrobial agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2021,</strong> <em>98 </em><a href="https://doi.org/10.1002/jhet.4317" title="DOI URL">https://doi.org/10.1002/jhet.4317</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.4317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.4317%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B4%2525E2%252580%252590%2525286%2525E2%252580%252590substituted%252Bquinolin%2525E2%252580%2525904%2525E2%252580%252590yl%252529%2525E2%252580%252590%252BN%252B%2525E2%252580%252590aryl%252Bthiazol%2525E2%252580%2525902%2525E2%252580%252590amine%252Bderivatives%252Bas%252Bpotential%252Bantimicrobial%252Bagents%26aulast%3DThakare%26aufirst%3DPrashant%26date%3D2021%26date%3D2021%26volume%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sapna  Bajeli</span>, <span class="hlFld-ContribAuthor ">Navin  Baid</span>, <span class="hlFld-ContribAuthor ">Manjot  Kaur</span>, <span class="hlFld-ContribAuthor ">Ganesh P.  Pawar</span>, <span class="hlFld-ContribAuthor ">Vinod D.  Chaudhari</span>, <span class="hlFld-ContribAuthor ">Ashwani  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Terminal Respiratory Oxidases: A Targetables Vulnerability of Mycobacterial Bioenergetics?. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cellular and Infection Microbiology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fcimb.2020.589318" title="DOI URL">https://doi.org/10.3389/fcimb.2020.589318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcimb.2020.589318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcimb.2020.589318%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cellular%2520and%2520Infection%2520Microbiology%26atitle%3DTerminal%252BRespiratory%252BOxidases%25253A%252BA%252BTargetables%252BVulnerability%252Bof%252BMycobacterial%252BBioenergetics%25253F%26aulast%3DBajeli%26aufirst%3DSapna%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin J.  Sheehy</span>, <span class="hlFld-ContribAuthor ">Lorraine M.  Bateman</span>, <span class="hlFld-ContribAuthor ">Niko T.  Flosbach</span>, <span class="hlFld-ContribAuthor ">Martin  Breugst</span>, <span class="hlFld-ContribAuthor ">Peter A.  Byrne</span>. </span><span class="cited-content_cbyCitation_article-title">Competition between N and O: use of diazine
              N
              -oxides as a test case for the Marcus theory rationale for ambident reactivity. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (35)
                                     , 9630-9647. <a href="https://doi.org/10.1039/D0SC02834G" title="DOI URL">https://doi.org/10.1039/D0SC02834G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC02834G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC02834G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DCompetition%252Bbetween%252BN%252Band%252BO%25253A%252Buse%252Bof%252Bdiazine%252BN%252B-oxides%252Bas%252Ba%252Btest%252Bcase%252Bfor%252Bthe%252BMarcus%252Btheory%252Brationale%252Bfor%252Bambident%252Breactivity%26aulast%3DSheehy%26aufirst%3DKevin%2BJ.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D35%26spage%3D9630%26epage%3D9647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federico  Appetecchia</span>, <span class="hlFld-ContribAuthor ">Sara  Consalvi</span>, <span class="hlFld-ContribAuthor ">Cristina  Scarpecci</span>, <span class="hlFld-ContribAuthor ">Mariangela  Biava</span>, <span class="hlFld-ContribAuthor ">Giovanna  Poce</span>. </span><span class="cited-content_cbyCitation_article-title">SAR Analysis of Small Molecules Interfering with Energy-Metabolism in Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (9)
                                     , 227. <a href="https://doi.org/10.3390/ph13090227" title="DOI URL">https://doi.org/10.3390/ph13090227</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13090227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13090227%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DSAR%252BAnalysis%252Bof%252BSmall%252BMolecules%252BInterfering%252Bwith%252BEnergy-Metabolism%252Bin%252BMycobacterium%252Btuberculosis%26aulast%3DAppetecchia%26aufirst%3DFederico%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D9%26spage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana FlÃ¡via  Borsoi</span>, <span class="hlFld-ContribAuthor ">Josiane Delgado  Paz</span>, <span class="hlFld-ContribAuthor ">Bruno Lopes  Abbadi</span>, <span class="hlFld-ContribAuthor ">Fernanda Souza  Macchi</span>, <span class="hlFld-ContribAuthor ">Nathalia  Sperotto</span>, <span class="hlFld-ContribAuthor ">Kenia  Pissinate</span>, <span class="hlFld-ContribAuthor ">RaonÃ­ S.  Rambo</span>, <span class="hlFld-ContribAuthor ">Alessandro Silva  Ramos</span>, <span class="hlFld-ContribAuthor ">Diana  Machado</span>, <span class="hlFld-ContribAuthor ">Miguel  Viveiros</span>, <span class="hlFld-ContribAuthor ">Cristiano Valim  Bizarro</span>, <span class="hlFld-ContribAuthor ">Luiz Augusto  Basso</span>, <span class="hlFld-ContribAuthor ">Pablo  Machado</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>192 </em>, 112179. <a href="https://doi.org/10.1016/j.ejmech.2020.112179" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112179%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252Bnew%252B2-%252528quinoline-4-yloxy%252529acetamide-based%252Bantituberculosis%252Bagents%26aulast%3DBorsoi%26aufirst%3DAna%2BFl%25C3%25A1via%26date%3D2020%26volume%3D192%26spage%3D112179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caroline Shi-Yan  Foo</span>, <span class="hlFld-ContribAuthor ">Kevin  Pethe</span>, <span class="hlFld-ContribAuthor ">AndrÃ©anne  Lupien</span>. </span><span class="cited-content_cbyCitation_article-title">Oxidative Phosphorylationâan Update on a New, Essential Target Space for Drug Discovery in Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Applied Sciences</span><span> <strong>2020,</strong> <em>10 </em>
                                    (7)
                                     , 2339. <a href="https://doi.org/10.3390/app10072339" title="DOI URL">https://doi.org/10.3390/app10072339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/app10072339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fapp10072339%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Sciences%26atitle%3DOxidative%252BPhosphorylation%2525E2%252580%252594an%252BUpdate%252Bon%252Ba%252BNew%25252C%252BEssential%252BTarget%252BSpace%252Bfor%252BDrug%252BDiscovery%252Bin%252BMycobacterium%252Btuberculosis%26aulast%3DFoo%26aufirst%3DCaroline%2BShi-Yan%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D7%26spage%3D2339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srikanth  Gatadi</span>, <span class="hlFld-ContribAuthor ">Srinivas  Nanduri</span>. </span><span class="cited-content_cbyCitation_article-title">New potential drug leads against MDR-MTB: A short review. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>95 </em>, 103534. <a href="https://doi.org/10.1016/j.bioorg.2019.103534" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103534</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103534%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNew%252Bpotential%252Bdrug%252Bleads%252Bagainst%252BMDR-MTB%25253A%252BA%252Bshort%252Breview%26aulast%3DGatadi%26aufirst%3DSrikanth%26date%3D2020%26volume%3D95%26spage%3D103534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya-Jen  Chiu</span>, <span class="hlFld-ContribAuthor ">Yu-Hsuan  Hsieh</span>, <span class="hlFld-ContribAuthor ">Te-Hsien  Lin</span>, <span class="hlFld-ContribAuthor ">Guan-Chiun  Lee</span>, <span class="hlFld-ContribAuthor ">Hsiu Mei  Hsieh-Li</span>, <span class="hlFld-ContribAuthor ">Ying-Chieh  Sun</span>, <span class="hlFld-ContribAuthor ">Chiung-Mei  Chen</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsuan  Chang</span>, <span class="hlFld-ContribAuthor ">Guey-Jen  Lee-Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Novel compound VB-037 inhibits AÎ² aggregation and promotes neurite outgrowth through enhancement of HSP27 and reduction of P38 and JNK-mediated inflammation in cell models for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Neurochemistry International</span><span> <strong>2019,</strong> <em>125 </em>, 175-186. <a href="https://doi.org/10.1016/j.neuint.2019.01.021" title="DOI URL">https://doi.org/10.1016/j.neuint.2019.01.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuint.2019.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuint.2019.01.021%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurochemistry%2520International%26atitle%3DNovel%252Bcompound%252BVB-037%252Binhibits%252BA%2525CE%2525B2%252Baggregation%252Band%252Bpromotes%252Bneurite%252Boutgrowth%252Bthrough%252Benhancement%252Bof%252BHSP27%252Band%252Breduction%252Bof%252BP38%252Band%252BJNK-mediated%252Binflammation%252Bin%252Bcell%252Bmodels%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DChiu%26aufirst%3DYa-Jen%26date%3D2019%26volume%3D125%26spage%3D175%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clinton G. L.  Veale</span>. </span><span class="cited-content_cbyCitation_article-title">Unpacking the Pathogen BoxâAn Open Source Tool for Fighting Neglected Tropical Disease. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (4)
                                     , 386-453. <a href="https://doi.org/10.1002/cmdc.201800755" title="DOI URL">https://doi.org/10.1002/cmdc.201800755</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800755%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DUnpacking%252Bthe%252BPathogen%252BBox%2525E2%252580%252594An%252BOpen%252BSource%252BTool%252Bfor%252BFighting%252BNeglected%252BTropical%252BDisease%26aulast%3DVeale%26aufirst%3DClinton%2BG.%2BL.%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D4%26spage%3D386%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew M.  Thompson</span>, <span class="hlFld-ContribAuthor ">William A.  Denny</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of enzymes in the electron transport chain of Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 97-130. <a href="https://doi.org/10.1016/bs.armc.2019.05.001" title="DOI URL">https://doi.org/10.1016/bs.armc.2019.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.armc.2019.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.armc.2019.05.001%26sid%3Dliteratum%253Aachs%26atitle%3DInhibitors%252Bof%252Benzymes%252Bin%252Bthe%252Belectron%252Btransport%252Bchain%252Bof%252BMycobacterium%252Btuberculosis%26aulast%3DThompson%26aufirst%3DAndrew%2BM.%26date%3D2019%26spage%3D97%26epage%3D130%26pub%3DElsevier%26atitle%3DMedicinal%252BChemistry%252BApproaches%252Bto%252BTuberculosis%252Band%252BTrypanosomiasis%26date%3D2019%26volume%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">GyÃ¶ngyi  Vastag</span>, <span class="hlFld-ContribAuthor ">Suzana  Apostolov</span>, <span class="hlFld-ContribAuthor ">Biljana  Kaurinovic</span>, <span class="hlFld-ContribAuthor ">Ljubica  Grbovic</span>. </span><span class="cited-content_cbyCitation_article-title">Applying multivariate methods in the estimation of bioactivity properties of acetamide derivatives. </span><span class="cited-content_cbyCitation_journal-name">JPC - Journal of Planar Chromatography - Modern TLC</span><span> <strong>2018,</strong> <em>31 </em>
                                    (6)
                                     , 497-504. <a href="https://doi.org/10.1556/1006.2018.31.6.10" title="DOI URL">https://doi.org/10.1556/1006.2018.31.6.10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1556/1006.2018.31.6.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1556%2F1006.2018.31.6.10%26sid%3Dliteratum%253Aachs%26jtitle%3DJPC%2520-%2520Journal%2520of%2520Planar%2520Chromatography%2520-%2520Modern%2520TLC%26atitle%3DApplying%252Bmultivariate%252Bmethods%252Bin%252Bthe%252Bestimation%252Bof%252Bbioactivity%252Bproperties%252Bof%252Bacetamide%252Bderivatives%26aulast%3DVastag%26aufirst%3DGy%25C3%25B6ngyi%26date%3D2018%26volume%3D31%26issue%3D6%26spage%3D497%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Henok  Asfaw</span>, <span class="hlFld-ContribAuthor ">Thomas  Wetzlar</span>, <span class="hlFld-ContribAuthor ">Maria Santos  Martinez-Martinez</span>, <span class="hlFld-ContribAuthor ">Peter  Imming</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient synthetic route for preparation of antimycobacterial wollamides and evaluation of their in vitro and in vivo efficacy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (17)
                                     , 2899-2905. <a href="https://doi.org/10.1016/j.bmcl.2018.07.021" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.07.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.07.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAn%252Befficient%252Bsynthetic%252Broute%252Bfor%252Bpreparation%252Bof%252Bantimycobacterial%252Bwollamides%252Band%252Bevaluation%252Bof%252Btheir%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Befficacy%26aulast%3DAsfaw%26aufirst%3DHenok%26date%3D2018%26volume%3D28%26issue%3D17%26spage%3D2899%26epage%3D2905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veronika  Å lachtovÃ¡</span>, <span class="hlFld-ContribAuthor ">Lucie  BrulÃ­kovÃ¡</span>. </span><span class="cited-content_cbyCitation_article-title">Benzoxazole Derivatives as Promising Antitubercular Agents. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (17)
                                     , 4653-4662. <a href="https://doi.org/10.1002/slct.201800631" title="DOI URL">https://doi.org/10.1002/slct.201800631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201800631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201800631%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DBenzoxazole%252BDerivatives%252Bas%252BPromising%252BAntitubercular%252BAgents%26aulast%3D%25C5%25A0lachtov%25C3%25A1%26aufirst%3DVeronika%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D17%26spage%3D4653%26epage%3D4662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernanda Teixeira  Subtil</span>, <span class="hlFld-ContribAuthor ">Anne Drumond  Villela</span>, <span class="hlFld-ContribAuthor ">Bruno Lopes  Abbadi</span>, <span class="hlFld-ContribAuthor ">ValnÃªs S.  Rodrigues-Junior</span>, <span class="hlFld-ContribAuthor ">Cristiano Valim  Bizarro</span>, <span class="hlFld-ContribAuthor ">Luis Fernando Saraiva Macedo  Timmers</span>, <span class="hlFld-ContribAuthor ">Osmar Norberto  de Souza</span>, <span class="hlFld-ContribAuthor ">Kenia  Pissinate</span>, <span class="hlFld-ContribAuthor ">Pablo  Machado</span>, <span class="hlFld-ContribAuthor ">Alexandre  LÃ³pez-GavÃ­n</span>, <span class="hlFld-ContribAuthor ">Griselda  TudÃ³</span>, <span class="hlFld-ContribAuthor ">Julian  GonzÃ¡lez-MartÃ­n</span>, <span class="hlFld-ContribAuthor ">Luiz Augusto  Basso</span>, <span class="hlFld-ContribAuthor ">DiÃ³genes Santiago  Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Activity of 2-(quinolin-4-yloxy)acetamides in Mycobacterium tuberculosis clinical isolates and identification of their molecular target by whole-genome sequencing. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Antimicrobial Agents</span><span> <strong>2018,</strong> <em>51 </em>
                                    (3)
                                     , 378-384. <a href="https://doi.org/10.1016/j.ijantimicag.2017.08.023" title="DOI URL">https://doi.org/10.1016/j.ijantimicag.2017.08.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijantimicag.2017.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijantimicag.2017.08.023%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Antimicrobial%2520Agents%26atitle%3DActivity%252Bof%252B2-%252528quinolin-4-yloxy%252529acetamides%252Bin%252BMycobacterium%252Btuberculosis%252Bclinical%252Bisolates%252Band%252Bidentification%252Bof%252Btheir%252Bmolecular%252Btarget%252Bby%252Bwhole-genome%252Bsequencing%26aulast%3DSubtil%26aufirst%3DFernanda%2BTeixeira%26date%3D2018%26volume%3D51%26issue%3D3%26spage%3D378%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Peng</span>, <span class="hlFld-ContribAuthor ">Jin  Liu</span>, <span class="hlFld-ContribAuthor ">Lili  Li</span>, <span class="hlFld-ContribAuthor ">Zhiwei  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Tandem Reaction of Enamino Esters with
              ortho
              -Halogenated Aromatic Carbonyls: One-Pot Approach to Functionalized Quinolines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (5)
                                     , 666-672. <a href="https://doi.org/10.1002/ejoc.201701472" title="DOI URL">https://doi.org/10.1002/ejoc.201701472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701472%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper-Catalyzed%252BTandem%252BReaction%252Bof%252BEnamino%252BEsters%252Bwith%252Bortho%252B-Halogenated%252BAromatic%252BCarbonyls%25253A%252BOne-Pot%252BApproach%252Bto%252BFunctionalized%252BQuinolines%26aulast%3DPeng%26aufirst%3DFei%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D5%26spage%3D666%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui-Zhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Long  Zhao</span>, <span class="hlFld-ContribAuthor ">Cheng-He  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advance in oxazole-based medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>144 </em>, 444-492. <a href="https://doi.org/10.1016/j.ejmech.2017.12.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.12.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.12.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvance%252Bin%252Boxazole-based%252Bmedicinal%252Bchemistry%26aulast%3DZhang%26aufirst%3DHui-Zhen%26date%3D2018%26volume%3D144%26spage%3D444%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingtao  Ao</span>, <span class="hlFld-ContribAuthor ">Zhenrui  Pan</span>, <span class="hlFld-ContribAuthor ">Yuqing  Qian</span>, <span class="hlFld-ContribAuthor ">Bowen  Tang</span>, <span class="hlFld-ContribAuthor ">Zeming  Feng</span>, <span class="hlFld-ContribAuthor ">Hua  Fang</span>, <span class="hlFld-ContribAuthor ">Zhen  Wu</span>, <span class="hlFld-ContribAuthor ">Jingwei  Chen</span>, <span class="hlFld-ContribAuthor ">Yuhua  Xue</span>, <span class="hlFld-ContribAuthor ">Meijuan  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of AV6 derivatives as novel dual reactivators of latent HIV-1. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (31)
                                     , 17279-17292. <a href="https://doi.org/10.1039/C8RA01216D" title="DOI URL">https://doi.org/10.1039/C8RA01216D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA01216D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA01216D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252BAV6%252Bderivatives%252Bas%252Bnovel%252Bdual%252Breactivators%252Bof%252Blatent%252BHIV-1%26aulast%3DAo%26aufirst%3DMingtao%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D31%26spage%3D17279%26epage%3D17292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan-Qiang  Hu</span>, <span class="hlFld-ContribAuthor ">Shu  Zhang</span>, <span class="hlFld-ContribAuthor ">Feng  Zhao</span>, <span class="hlFld-ContribAuthor ">Chuan  Gao</span>, <span class="hlFld-ContribAuthor ">Lian-Shun  Feng</span>, <span class="hlFld-ContribAuthor ">Zao-Sheng  Lv</span>, <span class="hlFld-ContribAuthor ">Zhi  Xu</span>, <span class="hlFld-ContribAuthor ">Xiang  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Isoniazid derivatives and their anti-tubercular activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>133 </em>, 255-267. <a href="https://doi.org/10.1016/j.ejmech.2017.04.002" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.04.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.04.002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIsoniazid%252Bderivatives%252Band%252Btheir%252Banti-tubercular%252Bactivity%26aulast%3DHu%26aufirst%3DYuan-Qiang%26date%3D2017%26volume%3D133%26spage%3D255%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleni  Pitta</span>, <span class="hlFld-ContribAuthor ">Olga  Balabon</span>, <span class="hlFld-ContribAuthor ">Maciej K.  Rogacki</span>, <span class="hlFld-ContribAuthor ">JesÃºs  GÃ³mez</span>, <span class="hlFld-ContribAuthor ">Fraser  Cunningham</span>, <span class="hlFld-ContribAuthor ">Jurgen  Joosens</span>, <span class="hlFld-ContribAuthor ">Koen  Augustyns</span>, <span class="hlFld-ContribAuthor ">Pieter  van der Veken</span>, <span class="hlFld-ContribAuthor ">Robert  Bates</span>. </span><span class="cited-content_cbyCitation_article-title">Differential characterization using readily accessible NMR experiments of novel N- and O-alkylated quinolin-4-ol, 1,5-naphthyridin-4-ol and quinazolin-4-ol derivatives with antimycobacterial activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>125 </em>, 890-901. <a href="https://doi.org/10.1016/j.ejmech.2016.10.014" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.10.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.10.014%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDifferential%252Bcharacterization%252Busing%252Breadily%252Baccessible%252BNMR%252Bexperiments%252Bof%252Bnovel%252BN-%252Band%252BO-alkylated%252Bquinolin-4-ol%25252C%252B1%25252C5-naphthyridin-4-ol%252Band%252Bquinazolin-4-ol%252Bderivatives%252Bwith%252Bantimycobacterial%252Bactivity%26aulast%3DPitta%26aufirst%3DEleni%26date%3D2017%26volume%3D125%26spage%3D890%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruno Couto  Giacobbo</span>, <span class="hlFld-ContribAuthor ">Kenia  Pissinate</span>, <span class="hlFld-ContribAuthor ">ValnÃªs  Rodrigues-Junior</span>, <span class="hlFld-ContribAuthor ">Anne Drumond  Villela</span>, <span class="hlFld-ContribAuthor ">EstÃªvÃ£o Silveira  Grams</span>, <span class="hlFld-ContribAuthor ">Bruno Lopes  Abbadi</span>, <span class="hlFld-ContribAuthor ">Fernanda Teixeira  Subtil</span>, <span class="hlFld-ContribAuthor ">Nathalia  Sperotto</span>, <span class="hlFld-ContribAuthor ">RogÃ©rio Valim  Trindade</span>, <span class="hlFld-ContribAuthor ">Davi Fernando  Back</span>, <span class="hlFld-ContribAuthor ">Maria Martha  Campos</span>, <span class="hlFld-ContribAuthor ">Luiz Augusto  Basso</span>, <span class="hlFld-ContribAuthor ">Pablo  Machado</span>, <span class="hlFld-ContribAuthor ">DiÃ³genes Santiago  Santos</span>. </span><span class="cited-content_cbyCitation_article-title">New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy)acetamides against Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>126 </em>, 491-501. <a href="https://doi.org/10.1016/j.ejmech.2016.11.048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.11.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.11.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.11.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Binsights%252Binto%252Bthe%252BSAR%252Band%252Bdrug%252Bcombination%252Bsynergy%252Bof%252B2-%252528quinolin-4-yloxy%252529acetamides%252Bagainst%252BMycobacterium%252Btuberculosis%26aulast%3DGiacobbo%26aufirst%3DBruno%2BCouto%26date%3D2017%26volume%3D126%26spage%3D491%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Narisa  Phummarin</span>, <span class="hlFld-ContribAuthor ">Helena I.  Boshoff</span>, <span class="hlFld-ContribAuthor ">Patricia S.  Tsang</span>, <span class="hlFld-ContribAuthor ">James  Dalton</span>, <span class="hlFld-ContribAuthor ">Siouxsie  Wiles</span>, <span class="hlFld-ContribAuthor ">Clifton E.  Barry 3rd</span>, <span class="hlFld-ContribAuthor ">Brent R.  Copp</span>. </span><span class="cited-content_cbyCitation_article-title">SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc
              1
              inhibitors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (11)
                                     , 2122-2127. <a href="https://doi.org/10.1039/C6MD00236F" title="DOI URL">https://doi.org/10.1039/C6MD00236F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00236F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00236F%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSAR%252Band%252Bidentification%252Bof%252B2-%252528quinolin-4-yloxy%252529acetamides%252Bas%252BMycobacterium%252Btuberculosis%252Bcytochrome%252Bbc%252B1%252Binhibitors%26aulast%3DPhummarin%26aufirst%3DNarisa%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D11%26spage%3D2122%26epage%3D2127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00245&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Hit compounds <b>1</b> and <b>2</b> and SAR design.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00245&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds with Quinoline Substitution Modifications<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00245&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Dowtherm A, H<sub>2</sub>SO<sub>4</sub>, 240â250 Â°C, 35â60 min; (b) 130 Â°C, 90 min, then Dowtherm A, 250 Â°C, 1 h; (c) acetic acid, toluene, reflux, 2 h, then Dowtherm A, 240 Â°C, 1 h; (d) triethylamine, anhydrous DCM, rt, 2 h; (e) potassium carbonate, anhydrous DMF, rt, 3 h to 4 days.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds with Introduction of Substituents on the Linker<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00245&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) triethylamine, anhydrous DCM, rt, 2 h to overnight; (b) sodium hydride, (potassium iodide), anhydrous DMF, rt, 6â48 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds with Conformational Constraint of the Linker<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00245&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) 7-(bromomethyl)quinoline or 3-bromo-1-phenylpyrrolidin-2-one, potassium carbonate, anhydrous DMF, rt, 2â72 h; (b) nitric acid, propionic acid, 110 Â°C, 2 h; (c) Zn, THF/satd aq NH<sub>4</sub>Cl: 2/1, rt, 1 h; (d) 0 Â°C, 1 h; (e) anhydrous DCM:DMF (10:1), 0 Â°C, 1 h; (f) phosphorus pentasulfide, anhydrous pyridine, reflux, overnight; (g) phosphorus pentoxide, anhydrous pyridine, reflux, overnight; (h) sodium hydride, anhydrous DMF, rt, overnight.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds Which Contain Other Modifications Types<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00245&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) potassium carbonate, anhydrous DMF, rt, 26 h; (b) PBr<sub>3</sub>, DMF, 50 Â°C, 4 days; (c) 90 Â°C, 4 h; (d) CuI, TMEDA, cesium carbonate, anhydrous DMF, 95 Â°C, 2 days; (e) glycine ethyl esterÂ·HCl, phenol, 120 Â°C, overnight; (f) sodium hydroxide, MeOH, reflux, 90 min; (g) thionyl chloride, anhydrous DCM, reflux, 2 days; (h) 3,5-dimethylaniline (<b>6</b>), anhydrous DCM, rt, 16 h.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds with Modifications of the Northern Aryl Fragment<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00245&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) triethylamine, anhydrous DCM, rt, 2â48 h; (b) potassium carbonate, anhydrous DMF, rt, 3â96 h; (c) potassium hydroxide, MeOH or EtOH, reflux, 1.5â3.5 h; (d) thionyl chloride, anhydrous DCM, 20 to 40 Â°C, 24â48 h; (e) anhydrous DCM, rt to reflux, 18â48 h.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/medium/jm-2016-00245t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds with Amide Bond Replacements<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00245/20160722/images/large/jm-2016-00245t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00245&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) methyl iodide, sodium hydride, anhydrous THF, 0â20 Â°C, overnight; (b) potassium carbonate, anhydrous DMF, rt, overnight; (c) sodium hydride, anhydrous DMF, rt, overnight.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i125">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22104" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22104" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 28 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>Global Tuberculosis Report 2015; <span class="NLM_publisher-name">World Health Organisation</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Global+Tuberculosis+Report+2015%3B+World+Health+Organisation%3A+Geneva%2C+Switzerland%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DGlobal%2520Tuberculosis%2520Report%25202015%26pub%3DWorld%2520Health%2520Organisation%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Onyebujoh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zumla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustomjee, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mwaba, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grange, J. M.</span><span> </span><span class="NLM_article-title">Treatment of Tuberculosis: Present Status and Future Prospects</span> <span class="citation_source-journal">Bull. World Health Organ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">â</span> <span class="NLM_lpage">865</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=16302043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A280%3ADC%252BD2Mnlt1Ortg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2005&pages=857-865&author=P.+Onyebujohauthor=A.+Zumlaauthor=I.+Ribeiroauthor=R.+Rustomjeeauthor=P.+Mwabaauthor=M.+Gomesauthor=J.+M.+Grange&title=Treatment+of+Tuberculosis%3A+Present+Status+and+Future+Prospects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of tuberculosis: present status and future prospects</span></div><div class="casAuthors">Onyebujoh Philip; Zumla Alimuddin; Ribeiro Isabella; Rustomjee Roxana; Mwaba Peter; Gomes Melba; Grange John M</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the World Health Organization</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">857-65</span>
        ISSN:<span class="NLM_cas:issn">0042-9686</span>.
    </div><div class="casAbstract">Over recent years, tuberculosis (TB) and disease caused by human immunodeficiency virus (HIV) have merged in a synergistic pandemic.  The number of new cases of TB is stabilizing and declining, except in countries with a high prevalence of HIV infection.  In these countries, where HIV is driving an increase in the TB burden, the capacity of the current tools and strategies to reduce the burden has been exceeded.  This paper summarizes the current status of TB management and describes recent thinking and strategy adjustments required for the control of TB in settings of high HIV prevalence.  We review the information on anti-TB drugs that is available in the public domain and highlight the need for continued and concerted efforts (including financial, human and infrastructural investments) for the development of new strategies and anti-TB agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTbrBb1cyB6hGx8TEN9K18QfW6udTcc2eb-QlnSysfmerntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mnlt1Ortg%253D%253D&md5=8bd8724e9cd19376124113b2e6bf73c4</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOnyebujoh%26aufirst%3DP.%26aulast%3DZumla%26aufirst%3DA.%26aulast%3DRibeiro%26aufirst%3DI.%26aulast%3DRustomjee%26aufirst%3DR.%26aulast%3DMwaba%26aufirst%3DP.%26aulast%3DGomes%26aufirst%3DM.%26aulast%3DGrange%26aufirst%3DJ.%2BM.%26atitle%3DTreatment%2520of%2520Tuberculosis%253A%2520Present%2520Status%2520and%2520Future%2520Prospects%26jtitle%3DBull.%2520World%2520Health%2520Organ.%26date%3D2005%26volume%3D83%26spage%3D857%26epage%3D865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Ducati, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruffino-Netto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, D. S.</span><span> </span><span class="NLM_article-title">The Resumption of Consumption-A Review on Tuberculosis</span> <span class="citation_source-journal">Mem. Inst. Oswaldo Cruz</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">â</span> <span class="NLM_lpage">714</span><span class="refDoi">Â DOI: 10.1590/S0074-02762006000700001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1590%2FS0074-02762006000700001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=17160276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCisr7F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2006&pages=697-714&author=R.+G.+Ducatiauthor=A.+Ruffino-Nettoauthor=L.+A.+Bassoauthor=D.+S.+Santos&title=The+Resumption+of+Consumption-A+Review+on+Tuberculosis&doi=10.1590%2FS0074-02762006000700001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The resumption of consumption-a review on tuberculosis</span></div><div class="casAuthors">Ducati, Rodrigo Gay; Ruffino-Netto, Antonio; Basso, Luiz Augusto; Santos, Diogenes Santiago</div><div class="citationInfo"><span class="NLM_cas:title">Memorias do Instituto Oswaldo Cruz</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">697-714</span>CODEN:
                <span class="NLM_cas:coden">MIOCAS</span>;
        ISSN:<span class="NLM_cas:issn">0074-0276</span>.
    
            (<span class="NLM_cas:orgname">Instituto Oswaldo Cruz</span>)
        </div><div class="casAbstract">A review.  Among all infectious diseases that afflict humans, tuberculosis (TB) remains the deadliest.  At present, epidemiologists est. that one-third of the world population is infected with tubercle bacilli, which is responsible for 8 to 10 million new cases of TB and 3 million deaths annually throughout the world.  Approx. 95% of new cases and 98% of deaths occur in developing nations, generally due to the few resources available to ensure proper treatment and where human immunodeficiency virus (HIV) infections are common.  In 1882, Dr Robert Koch identified an acid-fast bacterium, Mycobacterium tuberculosis, as the causative agent of TB.  Thirty-nine years later, BCG vaccine was introduced for human use, and became the most widely used prophylactic strategy to fight TB in the world.  The discovery of the properties of first-line antimycobacterial drugs in the past century yielded effective chemotherapies, which considerably decreased TB mortality rates worldwide.  The later introduction of some addnl. drugs to the arsenal used to treat TB seemed to provide an adequate no. of effective antimicrobial agents.  The modern, std. short-course therapy for TB recommended by the World Health Organization is based on a four-drug regimen that must be strictly followed to prevent drug resistance acquisition, and relies on direct observation of patient compliance to ensure effective treatment.  Mycobacteria show a high degree of intrinsic resistance to most antibiotics and chemotherapeutic agents due to the low permeability of its cell wall.  Nevertheless, the cell wall barrier alone cannot produce significant levels of drug resistance.  M. tuberculosis mutants resistant to any single drug are naturally present in any large bacterial population, irresp. of exposure to drugs.  The frequency of mutants resistant to rifampicin and isoniazid, the two principal antimycobacterial drugs currently in use, is relatively high and, therefore, the large extra-cellular population of actively metabolizing and rapidly growing tubercle bacilli in cavitary lesions will contain organisms which are resistant to a single drug.  Consequently, monotherapy or improperly administered two-drug therapies will select for drug-resistant mutants that may lead to drug resistance in the entire bacterial population.  Thereby, despite the availability of effective chemotherapy and the moderately protective vaccine, new anti-TB agents are urgently needed to decrease the global incidence of TB.  The resumption of TB, mainly caused by the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains and HIV epidemics, led to an increased need to understand the mol. mechanisms of drug action and drug resistance, which should provide significant insight into the development of newer compds.  The latter should be effective to combat both drug-susceptible and MDR/XDR-TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvwbi-EwlccbVg90H21EOLACvtfcHk0ljtQ0Rfzc3Y2Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCisr7F&md5=55605c48ab6941766140be6c65c5acdf</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1590%2FS0074-02762006000700001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS0074-02762006000700001%26sid%3Dliteratum%253Aachs%26aulast%3DDucati%26aufirst%3DR.%2BG.%26aulast%3DRuffino-Netto%26aufirst%3DA.%26aulast%3DBasso%26aufirst%3DL.%2BA.%26aulast%3DSantos%26aufirst%3DD.%2BS.%26atitle%3DThe%2520Resumption%2520of%2520Consumption-A%2520Review%2520on%2520Tuberculosis%26jtitle%3DMem.%2520Inst.%2520Oswaldo%2520Cruz%26date%3D2006%26volume%3D101%26spage%3D697%26epage%3D714%26doi%3D10.1590%2FS0074-02762006000700001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Nachega, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaisson, R. E.</span><span> </span><span class="NLM_article-title">Tuberculosis Drug Resistance: A Global Threat</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">S24</span><span class="NLM_x">â</span> <span class="NLM_lpage">S30</span><span class="refDoi">Â DOI: 10.1086/344657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1086%2F344657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=12516027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1ynu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2003&pages=S24-S30&author=J.+B.+Nachegaauthor=R.+E.+Chaisson&title=Tuberculosis+Drug+Resistance%3A+A+Global+Threat&doi=10.1086%2F344657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Tuberculosis drug resistance: a global threat</span></div><div class="casAuthors">Nachega, Jean B.; Chaisson, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S24-S30</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">A review.  Resistance to antituberculosis drugs has been a problem since the era of chemotherapy began.  After dramatic outbreaks of multidrug-resistant tuberculosis (MDR-TB) in the early 1990s, resistance became recognized as a global problem.  MDR-TB now threatens the inhabitants of countries in Europe, Asia, Africa, and the Americas.  An understanding of the mol. basis of drug resistance may contribute to the development of new drugs.  Management of MDR-TB relies on prompt recognition and treatment with at least 3 drugs to which an isolate is susceptible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7eHIIuICjYbVg90H21EOLACvtfcHk0ljtQ0Rfzc3Y2Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1ynu78%253D&md5=188fae134e67ffc38090126897ab0432</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1086%2F344657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F344657%26sid%3Dliteratum%253Aachs%26aulast%3DNachega%26aufirst%3DJ.%2BB.%26aulast%3DChaisson%26aufirst%3DR.%2BE.%26atitle%3DTuberculosis%2520Drug%2520Resistance%253A%2520A%2520Global%2520Threat%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2003%26volume%3D36%26spage%3DS24%26epage%3DS30%26doi%3D10.1086%2F344657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Orenstein, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedland, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moll, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvani, A. P.</span><span> </span><span class="NLM_article-title">Treatment Outcomes among Patients with Multidrug-Resistant Tuberculosis: Systematic Review and Meta-Analysis</span> <span class="citation_source-journal">Lancet Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">â</span> <span class="NLM_lpage">161</span><span class="refDoi">Â DOI: 10.1016/S1473-3099(09)70041-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1016%2FS1473-3099%2809%2970041-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=19246019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ntVGitw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=153-161&author=E.+W.+Orensteinauthor=S.+Basuauthor=N.+S.+Shahauthor=J.+R.+Andrewsauthor=G.+H.+Friedlandauthor=A.+P.+Mollauthor=N.+R.+Gandhiauthor=A.+P.+Galvani&title=Treatment+Outcomes+among+Patients+with+Multidrug-Resistant+Tuberculosis%3A+Systematic+Review+and+Meta-Analysis&doi=10.1016%2FS1473-3099%2809%2970041-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis</span></div><div class="casAuthors">Orenstein Evan W; Basu Sanjay; Shah N Sarita; Andrews Jason R; Friedland Gerald H; Moll Anthony P; Gandhi Neel R; Galvani Alison P</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Infectious diseases</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-61</span>
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    </div><div class="casAbstract">Multidrug-resistant (MDR) tuberculosis is a growing clinical and public-health concern.  To evaluate existing evidence regarding treatment regimens for MDR tuberculosis, we used a Bayesian random-effects meta-analysis of the available therapeutic studies to assess how the reported proportion of patients treated successfully is influenced by differences in treatment regimen design, study methodology, and patient population.  Successful treatment outcome was defined as cure or treatment completion. 34 clinical reports with a mean of 250 patients per report met the inclusion criteria.  Our analysis shows that the proportion of patients treated successfully improved when treatment duration was at least 18 months, and if patients received directly observed therapy throughout treatment.  Studies that combined both factors had significantly higher pooled success proportions (69%, 95% credible interval [CI] 64-73%) than other studies of treatment outcomes (58%, 95% CI 52-64%).  Individualised treatment regimens had higher treatment success (64%, 95% CI 59-68%) than standardised regimens (54%, 95% CI 43-68%), although the difference was not significant.  Treatment approaches and study methodologies were heterogeneous across studies.  Many important variables, including patients' HIV status, were inconsistently reported between studies.  These results underscore the importance of strong patient support and treatment follow-up systems to develop successful MDR tuberculosis treatment programmes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRpKfOIwjMB0zDnmmyUf5qOfW6udTcc2eZ-dgtfOfjL8rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ntVGitw%253D%253D&md5=c7a4824bfc7702a80c98ebfc29beb4fa</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2809%2970041-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252809%252970041-6%26sid%3Dliteratum%253Aachs%26aulast%3DOrenstein%26aufirst%3DE.%2BW.%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DN.%2BS.%26aulast%3DAndrews%26aufirst%3DJ.%2BR.%26aulast%3DFriedland%26aufirst%3DG.%2BH.%26aulast%3DMoll%26aufirst%3DA.%2BP.%26aulast%3DGandhi%26aufirst%3DN.%2BR.%26aulast%3DGalvani%26aufirst%3DA.%2BP.%26atitle%3DTreatment%2520Outcomes%2520among%2520Patients%2520with%2520Multidrug-Resistant%2520Tuberculosis%253A%2520Systematic%2520Review%2520and%2520Meta-Analysis%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2009%26volume%3D9%26spage%3D153%26epage%3D161%26doi%3D10.1016%2FS1473-3099%2809%2970041-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Ballell, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-Gomez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-Ruiz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barroso, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escribano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos-Villarejo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Plaza, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rebollo-Lopez, M. J. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remuinan-Blanco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavandera, J. L. J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Herran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo-Benito, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Bustos, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GonzÃ¡lez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos-Villarejo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MartÃ­n-Plaza, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rebollo-Lopez, M. J. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">RemuiÃ±an-Blanco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavandera, J. L. J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">PÃ©rez-Herran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo-Benito, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GarcÃ­a-Bustos, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span> </span><span class="NLM_article-title">Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">â</span> <span class="NLM_lpage">321</span><span class="refDoi">Â DOI: 10.1002/cmdc.201200428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1002%2Fcmdc.201200428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=23307663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BC3sXls1Omug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=313-321&author=L.+L.+Ballellauthor=R.+H.+Batesauthor=R.+J.+Youngauthor=D.+Alvarez-Gomezauthor=E.+Alvarez-Ruizauthor=V.+Barrosoauthor=D.+Blancoauthor=B.+Crespoauthor=J.+Escribanoauthor=R.+Gonzalezauthor=S.+Lozanoauthor=S.+Hussauthor=A.+Santos-Villarejoauthor=J.+J.+Martin-Plazaauthor=A.+Mendozaauthor=M.+J.+M.+J.+Rebollo-Lopezauthor=M.+Remuinan-Blancoauthor=J.+L.+J.+L.+Lavanderaauthor=E.+Perez-Herranauthor=F.+J.+Gamo-Benitoauthor=J.+F.+Garcia-Bustosauthor=D.+Barrosauthor=J.+P.+Castroauthor=N.+Cammackauthor=R.+Gonz%C3%A1lezauthor=S.+Lozanoauthor=S.+Hussauthor=A.+Santos-Villarejoauthor=J.+J.+Mart%C3%ADn-Plazaauthor=A.+Mendozaauthor=M.+J.+M.+J.+Rebollo-Lopezauthor=M.+Remui%C3%B1an-Blancoauthor=J.+L.+J.+L.+Lavanderaauthor=E.+P%C3%A9rez-Herranauthor=F.+J.+Gamo-Benitoauthor=J.+F.+Garc%C3%ADa-Bustosauthor=D.+Barrosauthor=J.+P.+Castroauthor=N.+Cammack&title=Fueling+Open-Source+Drug+Discovery%3A+177+Small-Molecule+Leads+against+Tuberculosis&doi=10.1002%2Fcmdc.201200428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis</span></div><div class="casAuthors">Ballell, Lluis; Bates, Robert H.; Young, Rob J.; Alvarez-Gomez, Daniel; Alvarez-Ruiz, Emilio; Barroso, Vanessa; Blanco, Delia; Crespo, Benigno; Escribano, Jaime; Gonzalez, Ruben; Lozano, Sonia; Huss, Sophie; Santos-Villarejo, Angel; Martin-Plaza, Jose Julio; Mendoza, Alfonso; Rebollo-Lopez, Maria Jose; Remuinan-Blanco, Modesto; Lavandera, Jose Luis; Perez-Herran, Esther; Gamo-Benito, Francisco Javier; Garcia-Bustos, Jose Francisco; Barros, David; Castro, Julia P.; Cammack, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">313-321</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">With the aim of fuelling open-source, translational, early-stage drug discovery activities, the results of the recently completed antimycobacterial phenotypic screening campaign against Mycobacterium bovis BCG with hit confirmation in M. tuberculosis H37Rv were made publicly accessible.  A set of 177 potent non-cytotoxic H37Rv hits was identified and will be made available to maximize the potential impact of the compds. toward a chem. genetics/proteomics exercise, while at the same time providing a plethora of potential starting points for new synthetic lead-generation activities.  Two addnl. drug-discovery-relevant datasets are included: (a) a drug-like property anal. reflecting the latest lead-like guidelines and (b) an early lead-generation package of the most promising hits within the clusters identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUJ2sVPWfPALVg90H21EOLACvtfcHk0lghj7gvdVWYWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXls1Omug%253D%253D&md5=32c975dbe183849358c701ca697681d3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200428%26sid%3Dliteratum%253Aachs%26aulast%3DBallell%26aufirst%3DL.%2BL.%26aulast%3DBates%26aufirst%3DR.%2BH.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DAlvarez-Gomez%26aufirst%3DD.%26aulast%3DAlvarez-Ruiz%26aufirst%3DE.%26aulast%3DBarroso%26aufirst%3DV.%26aulast%3DBlanco%26aufirst%3DD.%26aulast%3DCrespo%26aufirst%3DB.%26aulast%3DEscribano%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DR.%26aulast%3DLozano%26aufirst%3DS.%26aulast%3DHuss%26aufirst%3DS.%26aulast%3DSantos-Villarejo%26aufirst%3DA.%26aulast%3DMartin-Plaza%26aufirst%3DJ.%2BJ.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DRebollo-Lopez%26aufirst%3DM.%2BJ.%2BM.%2BJ.%26aulast%3DRemuinan-Blanco%26aufirst%3DM.%26aulast%3DLavandera%26aufirst%3DJ.%2BL.%2BJ.%2BL.%26aulast%3DPerez-Herran%26aufirst%3DE.%26aulast%3DGamo-Benito%26aufirst%3DF.%2BJ.%26aulast%3DGarcia-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DCastro%26aufirst%3DJ.%2BP.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DR.%26aulast%3DLozano%26aufirst%3DS.%26aulast%3DHuss%26aufirst%3DS.%26aulast%3DSantos-Villarejo%26aufirst%3DA.%26aulast%3DMart%25C3%25ADn-Plaza%26aufirst%3DJ.%2BJ.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DRebollo-Lopez%26aufirst%3DM.%2BJ.%2BM.%2BJ.%26aulast%3DRemui%25C3%25B1an-Blanco%26aufirst%3DM.%26aulast%3DLavandera%26aufirst%3DJ.%2BL.%2BJ.%2BL.%26aulast%3DP%25C3%25A9rez-Herran%26aufirst%3DE.%26aulast%3DGamo-Benito%26aufirst%3DF.%2BJ.%26aulast%3DGarc%25C3%25ADa-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DCastro%26aufirst%3DJ.%2BP.%26aulast%3DCammack%26aufirst%3DN.%26atitle%3DFueling%2520Open-Source%2520Drug%2520Discovery%253A%2520177%2520Small-Molecule%2520Leads%2520against%2520Tuberculosis%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D313%26epage%3D321%26doi%3D10.1002%2Fcmdc.201200428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Maddry, J. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ananthan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobrath, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secrist, J. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosa, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span> </span><span class="NLM_article-title">Antituberculosis Activity of the Molecular Libraries Screening Center Network Library</span> <span class="citation_source-journal">Tuberculosis (Oxford, U. K.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">354</span><span class="NLM_x">â</span> <span class="NLM_lpage">363</span><span class="refDoi">Â DOI: 10.1016/j.tube.2009.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1016%2Fj.tube.2009.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=19783214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlaktbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2009&pages=354-363&author=J.+a+Maddryauthor=S.+Ananthanauthor=R.+C.+Goldmanauthor=J.+V.+Hobrathauthor=C.+D.+Kwongauthor=C.+Maddoxauthor=L.+Rasmussenauthor=R.+C.+Reynoldsauthor=J.+a+Secristauthor=M.+I.+Sosaauthor=E.+L.+Whiteauthor=W.+Zhang&title=Antituberculosis+Activity+of+the+Molecular+Libraries+Screening+Center+Network+Library&doi=10.1016%2Fj.tube.2009.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Antituberculosis activity of the Molecular Libraries Screening Center Network library</span></div><div class="casAuthors">Maddry, Joseph A.; Ananthan, Subramaniam; Goldman, Robert C.; Hobrath, Judith V.; Kwong, Cecil D.; Maddox, Clinton; Rasmussen, Lynn; Reynolds, Robert C.; Secrist, John A., III; Sosa, Melinda I.; White, E. Lucile; Zhang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Tuberculosis (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">354-363</span>CODEN:
                <span class="NLM_cas:coden">TUBECU</span>;
        ISSN:<span class="NLM_cas:issn">1472-9792</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">There is an urgent need for the discovery and development of new antitubercular agents that target novel biochem. pathways and treat drug-resistant forms of the disease.  One approach to addressing this need is through high-throughput screening of drug-like small mol. libraries against the whole bacterium in order to identify a variety of new, active scaffolds that will stimulate addnl. biol. research and drug discovery.  Through the Mol. Libraries Screening Center Network, the NIAID Tuberculosis Antimicrobial Acquisition and Coordinating Facility tested a 215,110-compd. library against Mycobacterium tuberculosis strain H37Rv.  A medicinal chem. survey of the results from the screening campaign is reported herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH1oCyettJJLVg90H21EOLACvtfcHk0ljQVZqU2d5QhA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlaktbY%253D&md5=2b8d1ea9ef392231534d6eb020771da9</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.tube.2009.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tube.2009.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DMaddry%26aufirst%3DJ.%2Ba%26aulast%3DAnanthan%26aufirst%3DS.%26aulast%3DGoldman%26aufirst%3DR.%2BC.%26aulast%3DHobrath%26aufirst%3DJ.%2BV.%26aulast%3DKwong%26aufirst%3DC.%2BD.%26aulast%3DMaddox%26aufirst%3DC.%26aulast%3DRasmussen%26aufirst%3DL.%26aulast%3DReynolds%26aufirst%3DR.%2BC.%26aulast%3DSecrist%26aufirst%3DJ.%2Ba%26aulast%3DSosa%26aufirst%3DM.%2BI.%26aulast%3DWhite%26aufirst%3DE.%2BL.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DAntituberculosis%2520Activity%2520of%2520the%2520Molecular%2520Libraries%2520Screening%2520Center%2520Network%2520Library%26jtitle%3DTuberculosis%2520%2528Oxford%252C%2520U.%2520K.%2529%26date%3D2009%26volume%3D89%26spage%3D354%26epage%3D363%26doi%3D10.1016%2Fj.tube.2009.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Lilienkampf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationships for a Series of Quinoline-Based Compounds Active against Replicating and Nonreplicating <i>Mycobacterium Tuberculosis</i></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2109</span><span class="NLM_x">â</span> <span class="NLM_lpage">2118</span><span class="refDoi">Â DOI: 10.1021/jm900003c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900003c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2109-2118&author=A.+Lilienkampfauthor=J.+Maoauthor=B.+Wanauthor=Y.+Wangauthor=S.+G.+Franzblauauthor=A.+P.+Kozikowski&title=Structure-Activity+Relationships+for+a+Series+of+Quinoline-Based+Compounds+Active+against+Replicating+and+Nonreplicating+Mycobacterium+Tuberculosis&doi=10.1021%2Fjm900003c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm900003c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900003c%26sid%3Dliteratum%253Aachs%26aulast%3DLilienkampf%26aufirst%3DA.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DStructure-Activity%2520Relationships%2520for%2520a%2520Series%2520of%2520Quinoline-Based%2520Compounds%2520Active%2520against%2520Replicating%2520and%2520Nonreplicating%2520Mycobacterium%2520Tuberculosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2109%26epage%3D2118%26doi%3D10.1021%2Fjm900003c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Eswaran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adhikari, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdhury, I. H.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Some New Quinoline-3-Carbohydrazone Derivatives as Potential Antimycobacterial Agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1040</span><span class="NLM_x">â</span> <span class="NLM_lpage">1044</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2009.12.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1016%2Fj.bmcl.2009.12.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=20056418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGrs7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1040-1044&author=S.+Eswaranauthor=A.+V.+Adhikariauthor=N.+K.+Palauthor=I.+H.+Chowdhury&title=Design+and+Synthesis+of+Some+New+Quinoline-3-Carbohydrazone+Derivatives+as+Potential+Antimycobacterial+Agents&doi=10.1016%2Fj.bmcl.2009.12.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents</span></div><div class="casAuthors">Eswaran, Sumesh; Adhikari, Airody Vasudeva; Pal, Nishith K.; Chowdhury, Imran H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1040-1044</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 26 new quinoline derivs. carrying active pharmacophores has been synthesized and evaluated for their in vitro antituberculosis activity against Mycobacterium tuberculosis H37Rv (MTB), Mycobacterium smegmatis (MC2), and Mycobacterium fortuitum following the broth micro diln. assay method.  Seven compds., e.g., I, exhibited significant min. inhibition concns., when compared with first line drugs isoniazid (INH) and rifampicin (RIF) and could be ideally suited for further modifications to obtain more efficacious compds. in the fight against multi-drug resistant tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpONAgbR5vNwbVg90H21EOLACvtfcHk0ljQVZqU2d5QhA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGrs7s%253D&md5=8b59c409c280db8a573c385c8b47eb85</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.12.045%26sid%3Dliteratum%253Aachs%26aulast%3DEswaran%26aufirst%3DS.%26aulast%3DAdhikari%26aufirst%3DA.%2BV.%26aulast%3DPal%26aufirst%3DN.%2BK.%26aulast%3DChowdhury%26aufirst%3DI.%2BH.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Some%2520New%2520Quinoline-3-Carbohydrazone%2520Derivatives%2520as%2520Potential%2520Antimycobacterial%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1040%26epage%3D1044%26doi%3D10.1016%2Fj.bmcl.2009.12.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Tukulula, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Little, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chibale, K.</span><span> </span><span class="NLM_article-title">The Design, Synthesis, in Silico ADME Profiling, Antiplasmodial and Antimycobacterial Evaluation of New Arylamino Quinoline Derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">â</span> <span class="NLM_lpage">267</span><span class="refDoi">Â DOI: 10.1016/j.ejmech.2012.08.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1016%2Fj.ejmech.2012.08.047" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2012&pages=259-267&author=M.+Tukululaauthor=S.+Littleauthor=J.+Gutauthor=P.+J.+Rosenthalauthor=B.+Wanauthor=S.+G.+Franzblauauthor=K.+Chibale&title=The+Design%2C+Synthesis%2C+in+Silico+ADME+Profiling%2C+Antiplasmodial+and+Antimycobacterial+Evaluation+of+New+Arylamino+Quinoline+Derivatives&doi=10.1016%2Fj.ejmech.2012.08.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.08.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.08.047%26sid%3Dliteratum%253Aachs%26aulast%3DTukulula%26aufirst%3DM.%26aulast%3DLittle%26aufirst%3DS.%26aulast%3DGut%26aufirst%3DJ.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DThe%2520Design%252C%2520Synthesis%252C%2520in%2520Silico%2520ADME%2520Profiling%252C%2520Antiplasmodial%2520and%2520Antimycobacterial%2520Evaluation%2520of%2520New%2520Arylamino%2520Quinoline%2520Derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D57%26spage%3D259%26epage%3D267%26doi%3D10.1016%2Fj.ejmech.2012.08.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Koul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dendouga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergauwen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molenberghs, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vranckx, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willebrords, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ristic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lill, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorange, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillemont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bald, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andries, K.</span><span> </span><span class="NLM_article-title">Diarylquinolines Target Subunit c of Mycobacterial ATP Synthase</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">â</span> <span class="NLM_lpage">324</span><span class="refDoi">Â DOI: 10.1038/nchembio884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1038%2Fnchembio884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=17496888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlOjurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=323-324&author=A.+Koulauthor=N.+Dendougaauthor=K.+Vergauwenauthor=B.+Molenberghsauthor=L.+Vranckxauthor=R.+Willebrordsauthor=Z.+Risticauthor=H.+Lillauthor=I.+Dorangeauthor=J.+Guillemontauthor=D.+Baldauthor=K.+Andries&title=Diarylquinolines+Target+Subunit+c+of+Mycobacterial+ATP+Synthase&doi=10.1038%2Fnchembio884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Diarylquinolines target subunit c of mycobacterial ATP synthase</span></div><div class="casAuthors">Koul, Anil; Dendouga, Najoua; Vergauwen, Karen; Molenberghs, Brenda; Vranckx, Luc; Willebrords, Rudy; Ristic, Zorica; Lill, Holger; Dorange, Ismet; Guillemont, Jerome; Bald, Dirk; Andries, Koen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">323-324</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The diarylquinoline R207910 (TMC207) is a promising candidate in clin. development for the treatment of tuberculosis.  Though R207910-resistant mycobacteria bear mutations in ATP synthase, the compd.'s precise target is not known.  Here we establish by genetic, biochem. and binding assays that the oligomeric subunit c (AtpE) of ATP synthase is the target of R207910.  Thus targeting energy metab. is a new, promising approach for antibacterial drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoo57k1zZdTLVg90H21EOLACvtfcHk0lg9KhtiWMtjWg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlOjurc%253D&md5=f9ba04042bef448f5910cea0e89715f0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnchembio884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio884%26sid%3Dliteratum%253Aachs%26aulast%3DKoul%26aufirst%3DA.%26aulast%3DDendouga%26aufirst%3DN.%26aulast%3DVergauwen%26aufirst%3DK.%26aulast%3DMolenberghs%26aufirst%3DB.%26aulast%3DVranckx%26aufirst%3DL.%26aulast%3DWillebrords%26aufirst%3DR.%26aulast%3DRistic%26aufirst%3DZ.%26aulast%3DLill%26aufirst%3DH.%26aulast%3DDorange%26aufirst%3DI.%26aulast%3DGuillemont%26aufirst%3DJ.%26aulast%3DBald%26aufirst%3DD.%26aulast%3DAndries%26aufirst%3DK.%26atitle%3DDiarylquinolines%2520Target%2520Subunit%2520c%2520of%2520Mycobacterial%2520ATP%2520Synthase%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D3%26spage%3D323%26epage%3D324%26doi%3D10.1038%2Fnchembio884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Moadebi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harder, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elwood, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marra, F.</span><span> </span><span class="NLM_article-title">Fluoroquinolones for the Treatment of Pulmonary Tuberculosis</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2077</span><span class="NLM_x">â</span> <span class="NLM_lpage">2099</span><span class="refDoi">Â DOI: 10.2165/00003495-200767140-00007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.2165%2F00003495-200767140-00007" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=2077-2099&author=S.+Moadebiauthor=C.+K.+Harderauthor=M.+J.+Fitzgeraldauthor=K.+R.+Elwoodauthor=F.+Marra&title=Fluoroquinolones+for+the+Treatment+of+Pulmonary+Tuberculosis&doi=10.2165%2F00003495-200767140-00007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2165%2F00003495-200767140-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003495-200767140-00007%26sid%3Dliteratum%253Aachs%26aulast%3DMoadebi%26aufirst%3DS.%26aulast%3DHarder%26aufirst%3DC.%2BK.%26aulast%3DFitzgerald%26aufirst%3DM.%2BJ.%26aulast%3DElwood%26aufirst%3DK.%2BR.%26aulast%3DMarra%26aufirst%3DF.%26atitle%3DFluoroquinolones%2520for%2520the%2520Treatment%2520of%2520Pulmonary%2520Tuberculosis%26jtitle%3DDrugs%26date%3D2007%26volume%3D67%26spage%3D2077%26epage%3D2099%26doi%3D10.2165%2F00003495-200767140-00007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Brouet, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. D.</span><span> </span><span class="NLM_article-title">A Survey of Solvents for the Conrad-Limpach Synthesis of 4-Hydroxyquinolones</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1593</span><span class="NLM_x">â</span> <span class="NLM_lpage">1596</span><span class="refDoi">Â DOI: 10.1080/00397910802542044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1080%2F00397910802542044" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2009&pages=1593-1596&author=J.-C.+Brouetauthor=S.+Guauthor=N.+P.+Peetauthor=J.+D.+Williams&title=A+Survey+of+Solvents+for+the+Conrad-Limpach+Synthesis+of+4-Hydroxyquinolones&doi=10.1080%2F00397910802542044"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1080%2F00397910802542044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910802542044%26sid%3Dliteratum%253Aachs%26aulast%3DBrouet%26aufirst%3DJ.-C.%26aulast%3DGu%26aufirst%3DS.%26aulast%3DPeet%26aufirst%3DN.%2BP.%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26atitle%3DA%2520Survey%2520of%2520Solvents%2520for%2520the%2520Conrad-Limpach%2520Synthesis%2520of%25204-Hydroxyquinolones%26jtitle%3DSynth.%2520Commun.%26date%3D2009%26volume%3D39%26spage%3D1593%26epage%3D1596%26doi%3D10.1080%2F00397910802542044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Escribano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivero-HernÃ¡ndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Pichel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">PÃ©rez-HerrÃ¡n, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza-Losana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer-Bazaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">JimÃ©nez-Navarro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballell, L.</span><span> </span><span class="NLM_article-title">4-Substituted Thioquinolines and Thiazoloquinolines: Potent, Selective, and Tween-80 in Vitro Dependent Families of Antitubercular Agents with Moderate in Vivo Activity</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2252</span><span class="NLM_x">â</span> <span class="NLM_lpage">2263</span><span class="refDoi">Â DOI: 10.1002/cmdc.201100309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1002%2Fcmdc.201100309" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=2252-2263&author=J.+Escribanoauthor=C.+Rivero-Hern%C3%A1ndezauthor=H.+Riveraauthor=D.+Barrosauthor=J.+Castro-Pichelauthor=E.+P%C3%A9rez-Herr%C3%A1nauthor=A.+Mendoza-Losanaauthor=I.+Angulo-Barturenauthor=S.+Ferrer-Bazagaauthor=E.+Jim%C3%A9nez-Navarroauthor=L.+Ballell&title=4-Substituted+Thioquinolines+and+Thiazoloquinolines%3A+Potent%2C+Selective%2C+and+Tween-80+in+Vitro+Dependent+Families+of+Antitubercular+Agents+with+Moderate+in+Vivo+Activity&doi=10.1002%2Fcmdc.201100309"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100309%26sid%3Dliteratum%253Aachs%26aulast%3DEscribano%26aufirst%3DJ.%26aulast%3DRivero-Hern%25C3%25A1ndez%26aufirst%3DC.%26aulast%3DRivera%26aufirst%3DH.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DCastro-Pichel%26aufirst%3DJ.%26aulast%3DP%25C3%25A9rez-Herr%25C3%25A1n%26aufirst%3DE.%26aulast%3DMendoza-Losana%26aufirst%3DA.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DFerrer-Bazaga%26aufirst%3DS.%26aulast%3DJim%25C3%25A9nez-Navarro%26aufirst%3DE.%26aulast%3DBallell%26aufirst%3DL.%26atitle%3D4-Substituted%2520Thioquinolines%2520and%2520Thiazoloquinolines%253A%2520Potent%252C%2520Selective%252C%2520and%2520Tween-80%2520in%2520Vitro%2520Dependent%2520Families%2520of%2520Antitubercular%2520Agents%2520with%2520Moderate%2520in%2520Vivo%2520Activity%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D2252%26epage%3D2263%26doi%3D10.1002%2Fcmdc.201100309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Tsantrizos, Y.</span><span> </span><span class="NLM_article-title">Inhibitors of Human Immunodeficiency Virus Replication</span>. WO 2009/062285 A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Y.+Tsantrizos&title=Inhibitors+of+Human+Immunodeficiency+Virus+Replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%26atitle%3DInhibitors%2520of%2520Human%2520Immunodeficiency%2520Virus%2520Replication%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Activity of Novel Barbituric and Thiobarbituric Acid Derivatives against Non-Alcoholic Fatty Liver Disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2003</span><span class="NLM_x">â</span> <span class="NLM_lpage">2010</span><span class="refDoi">Â DOI: 10.1016/j.ejmech.2011.02.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1016%2Fj.ejmech.2011.02.033" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2003-2010&author=L.+Maauthor=S.+Liauthor=H.+Zhengauthor=J.+Chenauthor=L.+Linauthor=X.+Yeauthor=Z.+Chenauthor=Q.+Xuauthor=T.+Chenauthor=J.+Yangauthor=N.+Qiuauthor=G.+Wangauthor=A.+Pengauthor=Y.+Dingauthor=Y.+Weiauthor=L.+Chen&title=Synthesis+and+Biological+Activity+of+Novel+Barbituric+and+Thiobarbituric+Acid+Derivatives+against+Non-Alcoholic+Fatty+Liver+Disease&doi=10.1016%2Fj.ejmech.2011.02.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.02.033%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DPeng%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DSynthesis%2520and%2520Biological%2520Activity%2520of%2520Novel%2520Barbituric%2520and%2520Thiobarbituric%2520Acid%2520Derivatives%2520against%2520Non-Alcoholic%2520Fatty%2520Liver%2520Disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D2003%26epage%3D2010%26doi%3D10.1016%2Fj.ejmech.2011.02.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Dvorak, C. A.; Swanson, D. M.; Wong, V. D.</span><span> </span><span class="NLM_article-title">Piperazinyl Derivatives Useful as Modulators of Neuropeptide Y2 Receptor</span>. US 2011/0046151,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+A.+Dvorak&author=D.+M.+Swanson&author=V.+D.+Wong&title=Piperazinyl+Derivatives+Useful+as+Modulators+of+Neuropeptide+Y2+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26atitle%3DPiperazinyl%2520Derivatives%2520Useful%2520as%2520Modulators%2520of%2520Neuropeptide%2520Y2%2520Receptor%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span> </span><span class="NLM_article-title">Copper-Catalyzed Highly Regioselective 2-Aryloxylation of 2,x-Dihalopyridines</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">â</span> <span class="NLM_lpage">333</span><span class="refDoi">Â DOI: 10.1016/j.tet.2012.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1016%2Fj.tet.2012.10.025" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=327-333&author=Q.+Zhouauthor=B.+Zhangauthor=T.+Duauthor=H.+Guauthor=Y.+Yeauthor=H.+Jiangauthor=R.+Chen&title=Copper-Catalyzed+Highly+Regioselective+2-Aryloxylation+of+2%2Cx-Dihalopyridines&doi=10.1016%2Fj.tet.2012.10.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2012.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2012.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DDu%26aufirst%3DT.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DR.%26atitle%3DCopper-Catalyzed%2520Highly%2520Regioselective%25202-Aryloxylation%2520of%25202%252Cx-Dihalopyridines%26jtitle%3DTetrahedron%26date%3D2013%26volume%3D69%26spage%3D327%26epage%3D333%26doi%3D10.1016%2Fj.tet.2012.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">PeÅ¡iÄ, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">StarÄeviÄ, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toplak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herreros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almela, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">JeliÄ, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">AlihodÅ¾iÄ, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaventi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">PeriÄ, M.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and in Vitro Activity of Novel 2â²-O-Substituted 15-Membered Azalides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3216</span><span class="NLM_x">â</span> <span class="NLM_lpage">3227</span><span class="refDoi">Â DOI: 10.1021/jm201676t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201676t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3216-3227&author=D.+Pe%C5%A1i%C4%87author=K.+Star%C4%8Devi%C4%87author=A.+Toplakauthor=E.+Herrerosauthor=J.+Vidalauthor=M.+J.+Almelaauthor=D.+Jeli%C4%87author=S.+Alihod%C5%BEi%C4%87author=R.+Spaventiauthor=M.+Peri%C4%87&title=Design%2C+Synthesis%2C+and+in+Vitro+Activity+of+Novel+2%E2%80%B2-O-Substituted+15-Membered+Azalides&doi=10.1021%2Fjm201676t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm201676t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201676t%26sid%3Dliteratum%253Aachs%26aulast%3DPe%25C5%25A1i%25C4%2587%26aufirst%3DD.%26aulast%3DStar%25C4%258Devi%25C4%2587%26aufirst%3DK.%26aulast%3DToplak%26aufirst%3DA.%26aulast%3DHerreros%26aufirst%3DE.%26aulast%3DVidal%26aufirst%3DJ.%26aulast%3DAlmela%26aufirst%3DM.%2BJ.%26aulast%3DJeli%25C4%2587%26aufirst%3DD.%26aulast%3DAlihod%25C5%25BEi%25C4%2587%26aufirst%3DS.%26aulast%3DSpaventi%26aufirst%3DR.%26aulast%3DPeri%25C4%2587%26aufirst%3DM.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520in%2520Vitro%2520Activity%2520of%2520Novel%25202%25E2%2580%25B2-O-Substituted%252015-Membered%2520Azalides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3216%26epage%3D3227%26doi%3D10.1021%2Fjm201676t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Huang, T.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, B.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syu, W.</span><span> </span><span class="NLM_article-title">Susceptibility of <i>Mycobacterium Tuberculosis</i> to Sulfamethoxazole, Trimethoprim and Their Combination over a 12 Year Period in Taiwan</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">â</span> <span class="NLM_lpage">637</span><span class="refDoi">Â DOI: 10.1093/jac/dkr501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1093%2Fjac%2Fdkr501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=22127584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BC38Xit1Ogt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=633-637&author=T.-S.+Huangauthor=C.+M.+Kuninauthor=B.-S.+Yanauthor=Y.-S.+Chenauthor=S.+S.-J.+Leeauthor=W.+Syu&title=Susceptibility+of+Mycobacterium+Tuberculosis+to+Sulfamethoxazole%2C+Trimethoprim+and+Their+Combination+over+a+12+Year+Period+in+Taiwan&doi=10.1093%2Fjac%2Fdkr501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Susceptibility of Mycobacterium tuberculosis to sulfamethoxazole, trimethoprim and their combination over a 12 year period in Taiwan</span></div><div class="casAuthors">Huang, Tsi-Shu; Kunin, Calvin M.; Yan, Bo-Shiun; Chen, Yao-Shen; Lee, Susan Shin-Jung; Syu, Wan-Jr</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">633-637</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">This study was designed to det. the susceptibility of clin. isolates of multidrug-resistant (MDR) and non-MDR Mycobacterium tuberculosis to sulfamethoxazole, trimethoprim and trimethoprim/sulfamethoxazole over a 12 yr period in Taiwan.  Microbial examd. a total of 117 clin. isolates of M. tuberculosis collected from Southern Taiwan, 116 from 1995 to 2006 and an extensively drug-resistant (XDR) isolate in 2009.  These included 28 isolates susceptible to all four first-line agents, 52 MDR isolates and 36 isolates with a mixed combination of drug resistance patterns other than MDR and 1 XDR isolate.  Sulfamethoxazole inhibited 80% growth of all 117 isolates regardless of their susceptibility to the first-line agents at an MIC90 of 9.5 mg/L.  The concn. required to inhibit 99% growth was 38 mg/L.  There were no significant changes in the MIC50 or MIC90 of sulfamethoxazole over a 12 yr period.  All 117 isolates were resistant to trimethoprim at >8 mg/L.  The combination of trimethoprim/sulfamethoxazole at a ratio of 1 : 19 had no additive or synergistic effects.  Thus, sulfamethoxazole inhibited the growth of clin. isolates of M. tuberculosis at achievable concns. in plasma after oral administration.  Susceptibility to sulfamethoxazole remained const. over a 12 yr period.  Trimethoprim was inactive against M. tuberculosis and trimethoprim/sulfamethoxazole provided no addnl. activity.  Although the current and prior studies demonstrate that sulfamethoxazole is active against M. tuberculosis the search needs to continue for more active, lipid-sol. sulfonamides that are better absorbed into tissues and have improved therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWx43W1uVtUrVg90H21EOLACvtfcHk0lio-qYmxNm02w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xit1Ogt74%253D&md5=fff292ebc9c0a61a72b1c69a2f321460</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkr501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkr501%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DT.-S.%26aulast%3DKunin%26aufirst%3DC.%2BM.%26aulast%3DYan%26aufirst%3DB.-S.%26aulast%3DChen%26aufirst%3DY.-S.%26aulast%3DLee%26aufirst%3DS.%2BS.-J.%26aulast%3DSyu%26aufirst%3DW.%26atitle%3DSusceptibility%2520of%2520Mycobacterium%2520Tuberculosis%2520to%2520Sulfamethoxazole%252C%2520Trimethoprim%2520and%2520Their%2520Combination%2520over%2520a%252012%2520Year%2520Period%2520in%2520Taiwan%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2012%26volume%3D67%26spage%3D633%26epage%3D637%26doi%3D10.1093%2Fjac%2Fdkr501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Kestranek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chervenak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longenberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Placko, S.</span><span> </span><span class="NLM_article-title">Chemiluminescent Nitrogen Detection (CLND) to Measure Kinetic Aqueous Solubility</span> <span class="citation_source-journal">Curr. Protoc. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">â</span> <span class="NLM_lpage">280</span><span class="refDoi">Â DOI: 10.1002/9780470559277.ch130145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1002%2F9780470559277.ch130145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=24391097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A280%3ADC%252BC2czitF2itw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=269-280&author=A.+Kestranekauthor=A.+Chervenakauthor=J.+Longenbergerauthor=S.+Placko&title=Chemiluminescent+Nitrogen+Detection+%28CLND%29+to+Measure+Kinetic+Aqueous+Solubility&doi=10.1002%2F9780470559277.ch130145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Chemiluminescent nitrogen detection (CLND) to measure kinetic aqueous solubility</span></div><div class="casAuthors">Kestranek Aimee; Chervenak Andrew; Longenberger Justin; Placko Steven</div><div class="citationInfo"><span class="NLM_cas:title">Current protocols in chemical biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">269-80</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Solubility is the dose-limiting property for in vitro studies, and therefore is a critical physicochemical property to measure in drug discovery.  Solubility data can be used to guide lead optimization, troubleshoot erratic bioassay results, and identify potential downstream liabilities such as insufficient solubility for bioassays or oral bioavailability.  Typically, early in vitro studies are performed using library compounds prepared as dimethylsulfoxide (DMSO) stock solutions, resulting in in vitro test solutions containing DMSO at low concentration (<5% v/v).  Since DMSO can affect the apparent solubility, it is desirable to obtain solubility data under conditions mimicking the in vitro study.  Kinetic solubility (from DMSO stock solutions) is often preferred over thermodynamic solubility (from dry powder) in early drug discovery.  The protocols in this article describe a general procedure for assessing kinetic aqueous solubility of early drug discovery compounds using a miniaturized shake flask method with chemiluminescent nitrogen detection (CLND).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQa5zXGR-PJU_SAs_PE1QvifW6udTcc2earI6L9yDoeJrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czitF2itw%253D%253D&md5=d63d6d57c4ff0934379d3c37f82eb1a0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2F9780470559277.ch130145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780470559277.ch130145%26sid%3Dliteratum%253Aachs%26aulast%3DKestranek%26aufirst%3DA.%26aulast%3DChervenak%26aufirst%3DA.%26aulast%3DLongenberger%26aufirst%3DJ.%26aulast%3DPlacko%26aufirst%3DS.%26atitle%3DChemiluminescent%2520Nitrogen%2520Detection%2520%2528CLND%2529%2520to%2520Measure%2520Kinetic%2520Aqueous%2520Solubility%26jtitle%3DCurr.%2520Protoc.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D5%26spage%3D269%26epage%3D280%26doi%3D10.1002%2F9780470559277.ch130145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Young, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. V. S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luscombe, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, A. P.</span><span> </span><span class="NLM_article-title">Getting Physical in Drug Discovery II: The Impact of Chromatographic Hydrophobicity Measurements and Aromaticity</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">822</span><span class="NLM_x">â</span> <span class="NLM_lpage">830</span><span class="refDoi">Â DOI: 10.1016/j.drudis.2011.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1016%2Fj.drudis.2011.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=21704184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=822-830&author=R.+J.+Youngauthor=D.+V.+S.+S.+Greenauthor=C.+N.+Luscombeauthor=A.+P.+Hill&title=Getting+Physical+in+Drug+Discovery+II%3A+The+Impact+of+Chromatographic+Hydrophobicity+Measurements+and+Aromaticity&doi=10.1016%2Fj.drudis.2011.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity</span></div><div class="casAuthors">Young, Robert J.; Green, Darren V. S.; Luscombe, Christopher N.; Hill, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17/18</span>),
    <span class="NLM_cas:pages">822-830</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here, we review the performance of chromatog. hydrophobicity measurements in a data set of 100 000 GlaxoSmithKline compds., demonstrating the advantages of the method over octanol-water partitioning and highlighting new insights for drug discovery.  The value of chromatog. measurements, vs. other hydrophobicity ests., was supported by improved relationships with soly., permeation, cytochrome P450s, intrinsic clearance, hERG binding and promiscuity.  We also obsd. marked differentiation of the relative influence of intrinsic and effective hydrophobicity.  The summing of hydrophobicity values plus arom. ring count [log D pH7.4 (or log P) + #Ar], indicated a wide relevance for simplistic property forecast indexes' in developability assays, clearly enhanced by chromatog. values; therefore establishing new foundations for enriching property-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmIJyWi-DBW7Vg90H21EOLACvtfcHk0lhnYC9yFG_QZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF&md5=22788603a45aa77537e8666433473d14</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DGreen%26aufirst%3DD.%2BV.%2BS.%2BS.%26aulast%3DLuscombe%26aufirst%3DC.%2BN.%26aulast%3DHill%26aufirst%3DA.%2BP.%26atitle%3DGetting%2520Physical%2520in%2520Drug%2520Discovery%2520II%253A%2520The%2520Impact%2520of%2520Chromatographic%2520Hydrophobicity%2520Measurements%2520and%2520Aromaticity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D822%26epage%3D830%26doi%3D10.1016%2Fj.drudis.2011.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Leroux, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manteau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vors, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazenok, S.</span><span> </span><span class="NLM_article-title">Trifluoromethyl Ethers-Synthesis and Properties of an Unusual Substituent</span> <span class="citation_source-journal">Beilstein J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="refDoi">Â DOI: 10.3762/bjoc.4.13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.3762%2Fbjoc.4.13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=18941485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvFaqtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=13&author=F.+R.+Lerouxauthor=B.+Manteauauthor=J.-P.+Vorsauthor=S.+Pazenok&title=Trifluoromethyl+Ethers-Synthesis+and+Properties+of+an+Unusual+Substituent&doi=10.3762%2Fbjoc.4.13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluoromethyl ethers: Synthesis and properties of an unusual substituent</span></div><div class="casAuthors">Leroux, Frederic R.; Manteau, Baptiste; Vors, Jean-Pierre; Pazenok, Sergiy</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">No. 13, No pp. given</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">A review.  After nitrogen, fluorine is probably the next most favorite hetero-atom for incorporation into small mols. in life science-oriented research.  This review focuses on a particular fluorinated substituent, the trifluoromethoxy group, which is finding increased utility as a substituent in bioactives, but it is still perhaps the least well understood fluorine substituent in currency.  The present review will give an overview of the synthesis, properties and reactivity of this important substituent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_OnxjuY6OnLVg90H21EOLACvtfcHk0lgyiDAnCtanqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvFaqtrY%253D&md5=779225da5f8a70e0a8e5484b2f250f3e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.4.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.4.13%26sid%3Dliteratum%253Aachs%26aulast%3DLeroux%26aufirst%3DF.%2BR.%26aulast%3DManteau%26aufirst%3DB.%26aulast%3DVors%26aufirst%3DJ.-P.%26aulast%3DPazenok%26aufirst%3DS.%26atitle%3DTrifluoromethyl%2520Ethers-Synthesis%2520and%2520Properties%2520of%2520an%2520Unusual%2520Substituent%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2008%26volume%3D4%26spage%3D13%26doi%3D10.3762%2Fbjoc.4.13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Leiserowitz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagler, A. T.</span><span> </span><span class="NLM_article-title">The Generation of Possible Crystal Structures of Primary Amides</span> <span class="citation_source-journal">Proc. R. Soc. London, Ser. A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">â</span> <span class="NLM_lpage">175</span><span class="refDoi">Â DOI: 10.1098/rspa.1983.0076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1098%2Frspa.1983.0076" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=1983&pages=133-175&author=L.+Leiserowitzauthor=A.+T.+Hagler&title=The+Generation+of+Possible+Crystal+Structures+of+Primary+Amides&doi=10.1098%2Frspa.1983.0076"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1098%2Frspa.1983.0076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frspa.1983.0076%26sid%3Dliteratum%253Aachs%26aulast%3DLeiserowitz%26aufirst%3DL.%26aulast%3DHagler%26aufirst%3DA.%2BT.%26atitle%3DThe%2520Generation%2520of%2520Possible%2520Crystal%2520Structures%2520of%2520Primary%2520Amides%26jtitle%3DProc.%2520R.%2520Soc.%2520London%252C%2520Ser.%2520A%26date%3D1983%26volume%3D388%26spage%3D133%26epage%3D175%26doi%3D10.1098%2Frspa.1983.0076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Ayerst, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duke, J. R. C.</span><span> </span><span class="NLM_article-title">Refinement of the Crystal Structure of Oxamide</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1954</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">588</span><span class="NLM_x">â</span> <span class="NLM_lpage">590</span><span class="refDoi">Â DOI: 10.1107/S0365110X54001909</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1107%2FS0365110X54001909" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1954&pages=588-590&author=E.+M.+Ayerstauthor=J.+R.+C.+Duke&title=Refinement+of+the+Crystal+Structure+of+Oxamide&doi=10.1107%2FS0365110X54001909"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1107%2FS0365110X54001909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0365110X54001909%26sid%3Dliteratum%253Aachs%26aulast%3DAyerst%26aufirst%3DE.%2BM.%26aulast%3DDuke%26aufirst%3DJ.%2BR.%2BC.%26atitle%3DRefinement%2520of%2520the%2520Crystal%2520Structure%2520of%2520Oxamide%26jtitle%3DActa%2520Crystallogr.%26date%3D1954%26volume%3D7%26spage%3D588%26epage%3D590%26doi%3D10.1107%2FS0365110X54001909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Sorrentino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez del Rio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presa Matilla, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres Gomez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez Hoyos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez Herran, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza Losana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Av-Gay, Y.</span><span> </span><span class="NLM_article-title">Development of an Intracellular Screen for New Compounds Able to Inhibit <i>Mycobacterium Tuberculosis</i> Growth in Human Macrophages</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">640</span><span class="NLM_x">â</span> <span class="NLM_lpage">645</span><span class="refDoi">Â DOI: 10.1128/AAC.01920-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1128%2FAAC.01920-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=26503663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVCrs7nF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=640-645&author=F.+Sorrentinoauthor=R.+Gonzalez+del+Rioauthor=X.+Zhengauthor=J.+Presa+Matillaauthor=P.+Torres+Gomezauthor=M.+Martinez+Hoyosauthor=M.+E.+Perez+Herranauthor=A.+Mendoza+Losanaauthor=Y.+Av-Gay&title=Development+of+an+Intracellular+Screen+for+New+Compounds+Able+to+Inhibit+Mycobacterium+Tuberculosis+Growth+in+Human+Macrophages&doi=10.1128%2FAAC.01920-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Development of an intracellular screen for new compounds able to inhibit Mycobacterium tuberculosis growth in human macrophages</span></div><div class="casAuthors">Sorrentino, Flavia; Gonzalez del Rio, Ruben; Zheng, Xingji; Matilla, Jesus Presa; Gomez, Pedro Torres; Hoyos, Maria Martinez; Herran, Maria Esther Perez; Losana, Alfonso Mendoza; Av-Gay, Yossef</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">640-645</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Here we describe the development and validation of an intracellular high-throughput screening assay for finding new antituberculosis compds. active in human macrophages.  The assay consists of a luciferase-based primary identification assay, followed by a green fluorescent protein-based secondary profiling assay.  Std. tuberculosis drugs and 158 previously recognized active antimycobacterial compds. were used to evaluate assay robustness.  Data show that the assay developed is a short and valuable tool for the discovery of new antimycobacterial compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2XIe5jevhLVg90H21EOLACvtfcHk0lgyiDAnCtanqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVCrs7nF&md5=4ed12b5a9996d37db7a8d023ccabd48a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FAAC.01920-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01920-15%26sid%3Dliteratum%253Aachs%26aulast%3DSorrentino%26aufirst%3DF.%26aulast%3DGonzalez%2Bdel%2BRio%26aufirst%3DR.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DPresa%2BMatilla%26aufirst%3DJ.%26aulast%3DTorres%2BGomez%26aufirst%3DP.%26aulast%3DMartinez%2BHoyos%26aufirst%3DM.%26aulast%3DPerez%2BHerran%26aufirst%3DM.%2BE.%26aulast%3DMendoza%2BLosana%26aufirst%3DA.%26aulast%3DAv-Gay%26aufirst%3DY.%26atitle%3DDevelopment%2520of%2520an%2520Intracellular%2520Screen%2520for%2520New%2520Compounds%2520Able%2520to%2520Inhibit%2520Mycobacterium%2520Tuberculosis%2520Growth%2520in%2520Human%2520Macrophages%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D640%26epage%3D645%26doi%3D10.1128%2FAAC.01920-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Smith, D. A.; van de Waterbeemd, H.; Walker, D. K.; Mannhold, R.; Kubinyi, H.; Timmerman, H.</span>; Eds.  <span class="citation_source-book">Pharmacokinetics and Metabolism in Drug Design</span>; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2001</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">68</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1002%2F3527600213" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=68&author=D.+A.+Smith&author=H.+van+de+Waterbeemd&author=D.+K.+Walker&author=R.+Mannhold&author=H.+Kubinyi&author=H.+Timmerman&title=Pharmacokinetics+and+Metabolism+in+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2F3527600213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F3527600213%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26btitle%3DPharmacokinetics%2520and%2520Metabolism%2520in%2520Drug%2520Design%26pub%3DWiley-VCH%26date%3D2001%26spage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Kokatla, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salunke, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakrishna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malladi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, S. a.</span><span> </span><span class="NLM_article-title">Toll-like Receptor-8 Agonistic Activities in C2, C4, and C8Modified thiazolo[4,5-C]quinolines</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1179</span><span class="NLM_x">â</span> <span class="NLM_lpage">1198</span><span class="refDoi">Â DOI: 10.1039/c2ob26705e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=10.1039%2Fc2ob26705e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=23314908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCnt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=1179-1198&author=H.+P.+Kokatlaauthor=E.+Yooauthor=D.+B.+Salunkeauthor=D.+Silauthor=C.+F.+Ngauthor=R.+Balakrishnaauthor=S.+S.+Malladiauthor=L.+M.+Foxauthor=S.+a.+David&title=Toll-like+Receptor-8+Agonistic+Activities+in+C2%2C+C4%2C+and+C8Modified+thiazolo%5B4%2C5-C%5Dquinolines&doi=10.1039%2Fc2ob26705e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptor-8 agonistic activities in C2, C4, and C8 modified thiazolo[4,5-c]quinolines</span></div><div class="casAuthors">Kokatla, Hari Prasad; Yoo, Euna; Salunke, Deepak B.; Sil, Diptesh; Ng, Cameron F.; Balakrishna, Rajalakshmi; Malladi, Subbalakshmi S.; Fox, Lauren M.; David, Sunil A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1179-1198</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Toll-like receptor (TLR)-8 agonists typified by the 2-alkylthiazolo[4,5-c]quinolin-4-amine (CL075) chemotype are uniquely potent in activating adaptive immune responses by inducing robust prodn. of T helper 1-polarizing cytokines, suggesting that TLR8-active compds. could be promising candidate vaccine adjuvants, esp. for neonatal vaccines.  Alkylthiazoloquinolines with Me, Et, Pr and Bu groups at C2 displayed comparable TLR8-agonistic potencies; activity diminished precipitously in the C2-pentyl compd., and higher homologues were inactive.  The C2-Bu compd. was unique in possessing substantial TLR7-agonistic activity.  Analogs with branched alkyl groups at C2 displayed poor tolerance of terminal steric bulk.  Virtually all modifications at C8 led to abrogation of agonistic activity.  Alkylation on the C4-amine was not tolerated, whereas N-acyl analogs with short acyl groups (other than acetyl) retained TLR8 agonistic activity, but were substantially less water-sol.  Immunization in rabbits with a model subunit antigen adjuvanted with the lead C2-Bu thiazoloquinoline showed enhancements of antigen-specific antibody titers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYAWu83GzZRLVg90H21EOLACvtfcHk0lh9LRqRtyQ2pQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCnt7o%253D&md5=50ab5984b3920a890201960880e9003e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2Fc2ob26705e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ob26705e%26sid%3Dliteratum%253Aachs%26aulast%3DKokatla%26aufirst%3DH.%2BP.%26aulast%3DYoo%26aufirst%3DE.%26aulast%3DSalunke%26aufirst%3DD.%2BB.%26aulast%3DSil%26aufirst%3DD.%26aulast%3DNg%26aufirst%3DC.%2BF.%26aulast%3DBalakrishna%26aufirst%3DR.%26aulast%3DMalladi%26aufirst%3DS.%2BS.%26aulast%3DFox%26aufirst%3DL.%2BM.%26aulast%3DDavid%26aufirst%3DS.%2Ba.%26atitle%3DToll-like%2520Receptor-8%2520Agonistic%2520Activities%2520in%2520C2%252C%2520C4%252C%2520and%2520C8Modified%2520thiazolo%255B4%252C5-C%255Dquinolines%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26spage%3D1179%26epage%3D1198%26doi%3D10.1039%2Fc2ob26705e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i121"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00245">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_10008"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00245">10.1021/acs.jmedchem.6b00245</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional data (yield, <sup>1</sup>H NMR, <sup>13</sup>C NMR, and UPLC-MS) for the intermediate compounds <b>5b</b>,<b>c</b>, <b>5f</b>, <b>5h</b>â<b>m</b>, <b>5o</b>,<b>p</b>, <b>26a</b>â<b>d</b>, <b>41</b>, <b>48a</b>â<b>r</b> and <b>67</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00245/suppl_file/jm6b00245_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00245/suppl_file/jm6b00245_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00245/suppl_file/jm6b00245_si_001.pdf">jm6b00245_si_001.pdf (188.7 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00245/suppl_file/jm6b00245_si_002.csv">jm6b00245_si_002.csv (5.98 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-14%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00245%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00245" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998298993c3d06","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
